1	2	3	4	5	6	7	8
NonRel	VA 20 / 50 + 2 , OCT confirms [s1] shallow [e1] SRF .	VA 20 / 50 + 2 , OCT confirms shallow [s2] SRF [e2] .	severity	lesion	T5	T2	876827_note_1263
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 Fluorescein Angiography - [s1] OU [e1] - Both Eyes 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T8	T1	note_439
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 Fluorescein Angiography - [s1] OU [e1] - Both Eyes 362.07 362.02 2 .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3519 250.50 Fluorescein Angiography - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T8	T2	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with [s1] active [e1] NVE OU .	Treatment Hx IVFA - PRP and focal laser scars with active [s2] NVE [e2] OU .	severity	lesion	T9	T4	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with active NVE [s1] OU [e1] .	Treatment Hx IVFA - PRP and focal laser scars with active [s2] NVE [e2] OU .	laterality	lesion	T10	T4	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of [s1] possible [e1] NVE seen clinically .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible [s2] NVE [e2] seen clinically .	severity	lesion	T11	T3	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of [s1] possible [e1] NVE seen clinically .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o [s2] PDR [e2] OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	severity	lesion	T11	T18	note_439
NonRel	Today with active + NVE [s1] OU [e1] demonstrated on IVFA .	Today with active + [s2] NVE [e2] OU demonstrated on IVFA .	laterality	lesion	T12	T5	note_439
NonRel	Today with [s1] active [e1] + NVE OU demonstrated on IVFA .	Today with active + [s2] NVE [e2] OU demonstrated on IVFA .	severity	lesion	T13	T5	note_439
NonRel	OD - [s1] Mild [e1] NVE in mid - periphery , but well - lasered .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	severity	lesion	T14	T6	note_439
NonRel	[s1] OD [e1] - Mild NVE in mid - periphery , but well - lasered .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	laterality	lesion	T15	T6	note_439
NonRel	S / P Focal OS - [s1] Mild [e1] NVE in mid periphery .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	severity	lesion	T16	T7	note_439
NonRel	S / P Focal [s1] OS [e1] - Mild NVE in mid periphery .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	laterality	lesion	T17	T7	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR [s1] OU [e1] s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible [s2] NVE [e2] seen clinically .	laterality	lesion	T19	T3	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR [s1] OU [e1] s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o [s2] PDR [e2] OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	laterality	lesion	T19	T18	note_439
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T1	T2	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T1	T4	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T3	T2	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T3	T4	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T6	T5	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T6	T7	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T6	T9	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T6	T12	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T6	T16	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T6	T17	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T8	T5	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T8	T7	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T8	T9	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T8	T12	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T8	T16	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T8	T17	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T10	T5	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T10	T7	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T10	T9	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T10	T12	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T10	T16	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T10	T17	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T11	T5	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T11	T7	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T11	T9	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T11	T12	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T11	T16	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T11	T17	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T13	T5	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T13	T7	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T13	T9	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T13	T12	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T13	T16	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T13	T17	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T14	T5	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T14	T7	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T14	T9	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T14	T12	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T14	T16	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T14	T17	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T15	T5	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T15	T7	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T15	T9	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T15	T12	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T15	T16	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T15	T17	note_7572
NonRel	Today with [s1] mild [e1] increase in CME .	Today with mild increase in [s2] CME [e2] .	severity	lesion	T18	T24	note_7572
NonRel	[s1] OS [e1] - PDR now s / p PRP .	OS - [s2] PDR [e2] now s / p PRP .	laterality	lesion	T19	T20	note_7572
NonRel	NVE along superior arcade demonstrated on IVFA from 12 / 16 then s / p PRP . 2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with [s1] mild [e1] CME decreased today on Mac OCT as above .	[s2] NVE [e2] along superior arcade demonstrated on IVFA from 12 / 16 then s / p PRP . 2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with mild CME decreased today on Mac OCT as above .	severity	lesion	T22	T21	note_7572
NonRel	NVE along superior arcade demonstrated on IVFA from 12 / 16 then s / p PRP . 2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with [s1] mild [e1] CME decreased today on Mac OCT as above .	NVE along superior arcade demonstrated on IVFA from 12 / 16 then s / p PRP . 2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with mild [s2] CME [e2] decreased today on Mac OCT as above .	severity	lesion	T22	T23	note_7572
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : [s1] Active [e1] PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active [s2] PDR [e2] / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	severity	lesion	T1	T2	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : [s1] Active [e1] PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active [s2] PDR [e2] / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	severity	lesion	T1	T5	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : [s1] Active [e1] PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( [s2] PDR [e2] / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	severity	lesion	T1	T7	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : [s1] Active [e1] PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active [s2] PDR [e2] / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	severity	lesion	T3	T2	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : [s1] Active [e1] PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active [s2] PDR [e2] / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	severity	lesion	T3	T5	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : [s1] Active [e1] PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( [s2] PDR [e2] / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	severity	lesion	T3	T7	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD [s1] OU [e1] IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active [s2] PDR [e2] / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T4	T2	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD [s1] OU [e1] IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active [s2] PDR [e2] / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T4	T5	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD [s1] OU [e1] IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( [s2] PDR [e2] / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T4	T7	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD [s1] OU [e1] 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active [s2] PDR [e2] / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T6	T2	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD [s1] OU [e1] 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active [s2] PDR [e2] / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T6	T5	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD [s1] OU [e1] 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( [s2] PDR [e2] / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T6	T7	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD [s1] OU [e1] ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active [s2] PDR [e2] / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T8	T2	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD [s1] OU [e1] ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active [s2] PDR [e2] / TRD OU 1 ) IDDM - ( PDR / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T8	T5	note_543
NonRel	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( PDR / TRD [s1] OU [e1] ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	S / P 25 g PPV / ML / SDEM / AFx / EL / AGx 16 % C3F8 OS 2 / 6 / 17 Z98.890 V45.69 Treatment History PPV / TRD Repair OS 2 / 6 / 2017 IVFA ( 1 / 26 / 2017 ) : Active PDR / TRD OU IVFA ( 12 / 6 / 16 ) : Active PDR / TRD OU 1 ) IDDM - ( [s2] PDR [e2] / TRD OU ) OD - TRD Stage C4. florid neovascularization , peripheral ischemia .	laterality	lesion	T8	T7	note_543
NonRel	Quantiferon negative Unremarkable Treatment Hx : PPV ( GRT ) / SO OD - 8 / 15 / 18 STK OD - 8 / 7 / 18 STK OD - 7 / 24 / 18 CE / IOL OU ( 4 / 2018 OS , 5 / 2018 OD ) 1 ) Exudative / GRT with Retinal Detachment / Choroidal Effusions [s1] OU [e1] OD - s / p PPV , and GRT repair .	Quantiferon negative Unremarkable Treatment Hx : PPV ( GRT ) / SO OD - 8 / 15 / 18 STK OD - 8 / 7 / 18 STK OD - 7 / 24 / 18 CE / IOL OU ( 4 / 2018 OS , 5 / 2018 OD ) 1 ) [s2] Exudative [e2] / GRT with Retinal Detachment / Choroidal Effusions OU OD - s / p PPV , and GRT repair .	laterality	lesion	T2	T1	note_9335
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new vitreous hemorrhage OS .	Vitreous hemorrhage of left eye H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new [s2] vitreous hemorrhage [e2] OS .	laterality	lesion	T4	T2	2515285_note_7763
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new vitreous hemorrhage OS .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new vitreous hemorrhage OS .	laterality	lesion	T4	T3	2515285_note_7763
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new vitreous hemorrhage [s1] OS [e1] .	Vitreous hemorrhage of left eye H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new [s2] vitreous hemorrhage [e2] OS .	laterality	lesion	T5	T2	2515285_note_7763
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new vitreous hemorrhage [s1] OS [e1] .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 Prophylaxis of Retinal Detachment , Laser - OS - Left Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes Patient referred from the VA for new vitreous hemorrhage OS .	laterality	lesion	T5	T3	2515285_note_7763
NonRel	Diabetic macular edema of left [s1] eye [e1] - Left Eye E11.311 250.50 Appt req Opthalmology H35.81 362.07 OCT , Posterior Segment - OU - Both Eyes 362.01 5 .	[s2] Diabetic macular edema [e2] of left eye - Left Eye E11.311 250.50 Appt req Opthalmology H35.81 362.07 OCT , Posterior Segment - OU - Both Eyes 362.01 5 .	laterality	lesion	T5	T1	2555907_note_7978
NonRel	She has proliferative diabetic retinopathy s / p panretinal photocoagulation ( PRP ) [s1] OU [e1] ( x 1 ; x 2 ) , both eyes ( Bangladesh ) , and s / p IVL OS ( 4 months ago in Bangladesh ) .	She has [s2] proliferative diabetic retinopathy [e2] s / p panretinal photocoagulation ( PRP ) OU ( x 1 ; x 2 ) , both eyes ( Bangladesh ) , and s / p IVL OS ( 4 months ago in Bangladesh ) .	laterality	lesion	T6	T2	2555907_note_7978
NonRel	The neovascularization ( 2 ) is persistent , increasing , or a new area is now present on the retina or iris requiring further PRP treatments [s1] OS [e1] .	The [s2] neovascularization [e2] ( 2 ) is persistent , increasing , or a new area is now present on the retina or iris requiring further PRP treatments OS .	laterality	lesion	T7	T3	2555907_note_7978
NonRel	There also is clinically significant diabetic macular edema [s1] OS [e1] .	There also is clinically significant [s2] diabetic macular edema [e2] OS .	laterality	lesion	T8	T4	2555907_note_7978
NonRel	There also is [s1] clinically significant [e1] diabetic macular edema OS .	There also is clinically significant [s2] diabetic macular edema [e2] OS .	severity	lesion	T9	T4	2555907_note_7978
NonRel	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal mild DME [s1] OS [e1] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal mild [s2] DME [e2] OS Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T11	T10	2555907_note_7978
NonRel	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal [s1] mild [e1] DME OS Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal mild [s2] DME [e2] OS Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T12	T10	2555907_note_7978
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	laterality	lesion	T14	T13	2555907_note_7978
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 2 .	[s2] Vitreous hemorrhage [e2] , right H43.11 379.23 2 .	laterality	lesion	T2	T1	note_5386
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.329 250.50 362.04 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus E11.329 250.50 362.04 2 .	severity	lesion	T7	T1	note_801
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.329 250.50 362.04 2 .	Mild nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.329 250.50 362.04 2 .	severity	lesion	T7	T2	note_801
NonRel	[s1] MILD [e1] NON - PROLIFERATIVE DIABETIC RETINOPATHY ( 362.04 ) NO macular edema - Tight glucose control with target HbA 1 c < 6.5 , as well as tight blood pressure and lipid control .	MILD [s2] NON [e2] - PROLIFERATIVE DIABETIC RETINOPATHY ( 362.04 ) NO macular edema - Tight glucose control with target HbA 1 c < 6.5 , as well as tight blood pressure and lipid control .	severity	lesion	T8	T3	note_801
NonRel	[s1] MILD [e1] NON - PROLIFERATIVE DIABETIC RETINOPATHY ( 362.04 ) NO macular edema - Tight glucose control with target HbA 1 c < 6.5 , as well as tight blood pressure and lipid control .	MILD NON - [s2] PROLIFERATIVE DIABETIC RETINOPATHY [e2] ( 362.04 ) NO macular edema - Tight glucose control with target HbA 1 c < 6.5 , as well as tight blood pressure and lipid control .	severity	lesion	T8	T4	note_801
NonRel	[s1] MILD [e1] NON - PROLIFERATIVE DIABETIC RETINOPATHY ( 362.04 ) NO macular edema - Tight glucose control with target HbA 1 c < 6.5 , as well as tight blood pressure and lipid control .	MILD NON - PROLIFERATIVE DIABETIC RETINOPATHY ( 362.04 ) NO [s2] macular edema [e2] - Tight glucose control with target HbA 1 c < 6.5 , as well as tight blood pressure and lipid control .	severity	lesion	T8	T5	note_801
NonRel	Allergies : No Known Allergies Medical History : Patient Active Problem List Diagnosis • Hypertension • Diabetes mellitus ( CMS - HCC code ) • Type 2 diabetes mellitus with eye manifestations ( CMS - HCC code ) • GERD ( gastroesophageal reflux disease ) • Hyperlipidemia • Sleep apnea • Transplanted kidney , 38 yo m , DD , DATE , Simulect induction • Stage 4 chronic kidney disease ( CMS - HCC code ) • Current use of steroid medication • History of SCC ( squamous cell carcinoma ) of skin • Chromoblastomycosis • Hypoglycemia • Proteinuria • Edema • Hyperparathyroidism due to renal insufficiency ( CMS - HCC code ) • Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) • Epiretinal membrane ( ERM ) of left eye • Primary open angle glaucoma ( POAG ) of left eye , moderate stage • S / p Prosthesis OD Patient History Record : ROS Positive for : Eyes Negative for : Constitutional , Genitourinary , Respiratory Last edited by NAME on DATE 2 : 26 PM .	Allergies : No Known Allergies Medical History : Patient Active Problem List Diagnosis • Hypertension • Diabetes mellitus ( CMS - HCC code ) • Type 2 diabetes mellitus with eye manifestations ( CMS - HCC code ) • GERD ( gastroesophageal reflux disease ) • Hyperlipidemia • Sleep apnea • Transplanted kidney , 38 yo m , DD , DATE , Simulect induction • Stage 4 chronic kidney disease ( CMS - HCC code ) • Current use of steroid medication • History of SCC ( squamous cell carcinoma ) of skin • Chromoblastomycosis • Hypoglycemia • Proteinuria • Edema • Hyperparathyroidism due to renal insufficiency ( CMS - HCC code ) • [s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) • Epiretinal membrane ( ERM ) of left eye • Primary open angle glaucoma ( POAG ) of left eye , moderate stage • S / p Prosthesis OD Patient History Record : ROS Positive for : Eyes Negative for : Constitutional , Genitourinary , Respiratory Last edited by NAME on DATE 2 : 26 PM .	laterality	lesion	T7	T3	1717338_note_4033
NonRel	Allergies : No Known Allergies Medical History : Patient Active Problem List Diagnosis • Hypertension • Diabetes mellitus ( CMS - HCC code ) • Type 2 diabetes mellitus with eye manifestations ( CMS - HCC code ) • GERD ( gastroesophageal reflux disease ) • Hyperlipidemia • Sleep apnea • Transplanted kidney , 38 yo m , DD , DATE , Simulect induction • Stage 4 chronic kidney disease ( CMS - HCC code ) • Current use of steroid medication • History of SCC ( squamous cell carcinoma ) of skin • Chromoblastomycosis • Hypoglycemia • Proteinuria • Edema • Hyperparathyroidism due to renal insufficiency ( CMS - HCC code ) • Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) • Epiretinal membrane ( ERM ) of left eye • Primary open angle glaucoma ( POAG ) of left eye , moderate stage • S / p Prosthesis OD Patient History Record : ROS Positive for : Eyes Negative for : Constitutional , Genitourinary , Respiratory Last edited by NAME on DATE 2 : 26 PM .	Allergies : No Known Allergies Medical History : Patient Active Problem List Diagnosis • Hypertension • Diabetes mellitus ( CMS - HCC code ) • Type 2 diabetes mellitus with eye manifestations ( CMS - HCC code ) • GERD ( gastroesophageal reflux disease ) • Hyperlipidemia • Sleep apnea • Transplanted kidney , 38 yo m , DD , DATE , Simulect induction • Stage 4 chronic kidney disease ( CMS - HCC code ) • Current use of steroid medication • History of SCC ( squamous cell carcinoma ) of skin • Chromoblastomycosis • Hypoglycemia • Proteinuria • Edema • Hyperparathyroidism due to renal insufficiency ( CMS - HCC code ) • Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) • Epiretinal membrane ( ERM ) of left eye • Primary open angle glaucoma ( POAG ) of left eye , moderate stage • S / p Prosthesis OD Patient History Record : ROS Positive for : Eyes Negative for : Constitutional , Genitourinary , Respiratory Last edited by NAME on DATE 2 : 26 PM .	laterality	lesion	T7	T4	1717338_note_4033
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Both Eyes E11.3512 250.50 362.07 362.02 1 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Both Eyes E11.3512 250.50 362.07 362.02 1 .	laterality	lesion	T8	T5	1717338_note_4033
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) - Both Eyes E11.3512 250.50 362.07 362.02 1 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) - Both Eyes E11.3512 250.50 362.07 362.02 1 .	laterality	lesion	T8	T6	1717338_note_4033
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus 2 .	laterality	lesion	T9	T1	1717338_note_4033
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus 2 .	laterality	lesion	T9	T2	1717338_note_4033
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with [s1] mild [e1] non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild [s2] non proliferative diabetic retinopathy [e2] OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T5	T3	note_702
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with [s1] mild [e1] non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild [s2] non proliferative diabetic retinopathy [e2] - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T5	T4	note_702
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy [s1] OS [e1] - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild [s2] non proliferative diabetic retinopathy [e2] OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	laterality	lesion	T6	T3	note_702
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy [s1] OS [e1] - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild [s2] non proliferative diabetic retinopathy [e2] - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	laterality	lesion	T6	T4	note_702
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with [s1] mild [e1] non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild [s2] non proliferative diabetic retinopathy [e2] OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T7	T3	note_702
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with [s1] mild [e1] non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild [s2] non proliferative diabetic retinopathy [e2] - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T7	T4	note_702
NonRel	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages [s1] OS [e1] by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) Branch retinal vein occlusion OS - Patient asymptomatic .	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal [s2] hemorrhages [e2] OS by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) Branch retinal vein occlusion OS - Patient asymptomatic .	laterality	lesion	T8	T1	note_702
NonRel	IDDM w / PDR [s1] OD [e1] , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / [s2] PDR [e2] OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T7	T1	2678512_note_8911
NonRel	IDDM w / PDR [s1] OD [e1] , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , [s2] DME [e2] OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T7	T2	2678512_note_8911
NonRel	IDDM w / PDR [s1] OD [e1] , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no [s2] SRF [e2] / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T7	T3	2678512_note_8911
NonRel	IDDM w / PDR [s1] OD [e1] , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / [s2] IRF [e2] OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T7	T4	2678512_note_8911
NonRel	IDDM w / PDR [s1] OD [e1] , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , [s2] IRF [e2] nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T7	T5	2678512_note_8911
NonRel	IDDM w / PDR [s1] OD [e1] , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without [s2] NVI [e2] .	laterality	lesion	T7	T6	2678512_note_8911
NonRel	IDDM w / PDR OD , DME [s1] OS [e1] - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / [s2] PDR [e2] OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T8	T1	2678512_note_8911
NonRel	IDDM w / PDR OD , DME [s1] OS [e1] - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , [s2] DME [e2] OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T8	T2	2678512_note_8911
NonRel	IDDM w / PDR OD , DME [s1] OS [e1] - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no [s2] SRF [e2] / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T8	T3	2678512_note_8911
NonRel	IDDM w / PDR OD , DME [s1] OS [e1] - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / [s2] IRF [e2] OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T8	T4	2678512_note_8911
NonRel	IDDM w / PDR OD , DME [s1] OS [e1] - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , [s2] IRF [e2] nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T8	T5	2678512_note_8911
NonRel	IDDM w / PDR OD , DME [s1] OS [e1] - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without [s2] NVI [e2] .	laterality	lesion	T8	T6	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF [s1] OD [e1] , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / [s2] PDR [e2] OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T9	T1	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF [s1] OD [e1] , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , [s2] DME [e2] OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T9	T2	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF [s1] OD [e1] , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no [s2] SRF [e2] / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T9	T3	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF [s1] OD [e1] , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / [s2] IRF [e2] OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T9	T4	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF [s1] OD [e1] , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , [s2] IRF [e2] nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T9	T5	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF [s1] OD [e1] , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without [s2] NVI [e2] .	laterality	lesion	T9	T6	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally [s1] OS [e1] - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / [s2] PDR [e2] OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T10	T1	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally [s1] OS [e1] - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , [s2] DME [e2] OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T10	T2	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally [s1] OS [e1] - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no [s2] SRF [e2] / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T10	T3	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally [s1] OS [e1] - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / [s2] IRF [e2] OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T10	T4	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally [s1] OS [e1] - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , [s2] IRF [e2] nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	laterality	lesion	T10	T5	2678512_note_8911
NonRel	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally [s1] OS [e1] - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without NVI .	IDDM w / PDR OD , DME OS - sent for eval of worsening retinopathy with history of dense PRP , consider targeted PRP OU - poor control per pt , last A1c 8.5 - dense PRP of periphery and macula OD > OS - Mac OCT no SRF / IRF OD , IRF nasally OS - IVFA with ischemia , no NV Plan : No indication for focal laser at this time without [s2] NVI [e2] .	laterality	lesion	T10	T6	2678512_note_8911
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Retina - OS - Left Eye 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Retina - OS - Left Eye 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T3	T1	note_4045
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Retina - OS - Left Eye 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3512 250.50 OCT , Retina - OS - Left Eye 362.07 CANCELED : OCT , Retina - OU - Both Eyes 362.02 2 .	laterality	lesion	T3	T2	note_4045
NonRel	Treatment history : Enucleation OD - 2004 with Dr. Sullivan Focal / PRP OS 1 ) IDDM [ dx age 18 , A1c 7.1 12 / 2018 ] [s1] OS [e1] - nciCSME ( superiorly ) near ischemic vessels .	Treatment history : Enucleation OD - 2004 with Dr. Sullivan Focal / PRP OS 1 ) IDDM [ dx age 18 , A1c 7.1 12 / 2018 ] OS - [s2] nciCSME [e2] ( superiorly ) near ischemic vessels .	laterality	lesion	T5	T4	note_4045
NonRel	Pan Retinal Photocoagulation - OS - Left Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP [s1] Left [e1] Diagnosis : Proliferative Diabetic Retinopathy Surgeon : Siva Iyer Power : 300 - 500 Duration : 30 Spot Size : 200 Total shots : 4601 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	Pan Retinal Photocoagulation - OS - Left Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Left Diagnosis : [s2] Proliferative Diabetic Retinopathy [e2] Surgeon : Siva Iyer Power : 300 - 500 Duration : 30 Spot Size : 200 Total shots : 4601 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T1	T2	note_7659
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR [s1] Right [e1] Post - op DX : same Attending : Siva Iyer Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	INVASIVE PROCEDURE NOTE Pre - op DX : [s2] PDR [e2] Right Post - op DX : same Attending : Siva Iyer Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	laterality	lesion	T4	T3	note_7659
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR [s1] Left [e1] Post - op DX : same Attending : Siva Iyer Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	INVASIVE PROCEDURE NOTE Pre - op DX : [s2] PDR [e2] Left Post - op DX : same Attending : Siva Iyer Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	laterality	lesion	T6	T5	note_7659
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 2 diabetes mellitus E11.3591 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus E11.3591 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T8	T7	note_7659
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent 3 .	laterality	lesion	T10	T9	note_7659
NonRel	H / O PRP OU Z98.890 V45.69 referred from Dr. Blake for evaluation of suspected PDR [s1] OU [e1] .	H / O PRP OU Z98.890 V45.69 referred from Dr. Blake for evaluation of suspected [s2] PDR [e2] OU .	laterality	lesion	T12	T11	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T13	T14	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T13	T17	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T15	T14	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T15	T17	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T16	T14	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T16	T17	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T18	T14	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T18	T17	note_7659
NonRel	[s1] OS [e1] - + NVI , + NVD , + NVE , vast ischemia nasally .	OS - + [s2] NVI [e2] , + NVD , + NVE , vast ischemia nasally .	laterality	lesion	T20	T21	note_7659
NonRel	[s1] OS [e1] - + NVI , + NVD , + NVE , vast ischemia nasally .	OS - + NVI , + [s2] NVD [e2] , + NVE , vast ischemia nasally .	laterality	lesion	T20	T22	note_7659
NonRel	[s1] OS [e1] - + NVI , + NVD , + NVE , vast ischemia nasally .	OS - + NVI , + NVD , + [s2] NVE [e2] , vast ischemia nasally .	laterality	lesion	T20	T23	note_7659
NonRel	H / O PRP OU Z98.890 V45.69 referred from Dr. Blake for evaluation of [s1] suspected [e1] PDR OU .	H / O PRP OU Z98.890 V45.69 referred from Dr. Blake for evaluation of suspected [s2] PDR [e2] OU .	severity	lesion	T24	T11	note_7659
NonRel	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT [s1] OD [e1] : areas of IRF and SRF OS : large PED with small areas of IRF NAME , MD participated in the care of this patient .	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of [s2] IRF [e2] and SRF OS : large PED with small areas of IRF NAME , MD participated in the care of this patient .	laterality	lesion	T6	T1	1114244_note_1986
NonRel	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT [s1] OD [e1] : areas of IRF and SRF OS : large PED with small areas of IRF NAME , MD participated in the care of this patient .	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of IRF and [s2] SRF [e2] OS : large PED with small areas of IRF NAME , MD participated in the care of this patient .	laterality	lesion	T6	T2	1114244_note_1986
NonRel	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT [s1] OD [e1] : areas of IRF and SRF OS : large PED with small areas of IRF NAME , MD participated in the care of this patient .	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of IRF and SRF OS : large PED with small areas of [s2] IRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T6	T3	1114244_note_1986
NonRel	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of IRF and SRF [s1] OS [e1] : large PED with small areas of IRF NAME , MD participated in the care of this patient .	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of [s2] IRF [e2] and SRF OS : large PED with small areas of IRF NAME , MD participated in the care of this patient .	laterality	lesion	T7	T1	1114244_note_1986
NonRel	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of IRF and SRF [s1] OS [e1] : large PED with small areas of IRF NAME , MD participated in the care of this patient .	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of IRF and [s2] SRF [e2] OS : large PED with small areas of IRF NAME , MD participated in the care of this patient .	laterality	lesion	T7	T2	1114244_note_1986
NonRel	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of IRF and SRF [s1] OS [e1] : large PED with small areas of IRF NAME , MD participated in the care of this patient .	Dry eye syndrome , bilateral H04 . 123 375.15 OCT , Posterior Segment - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes Baseline MAC OCT OD : areas of IRF and SRF OS : large PED with small areas of [s2] IRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T7	T3	1114244_note_1986
NonRel	There is continued staining and late leakage in the macular in patterns suggestive of CNVM [s1] OU [e1] OCT ( today ) : IRF + SRF , and significant RPED ( OS > OD ) 1 ) ARMD OU ( exudative OU ) OD - + CNVM on exam and confirmed on OCT and IVFA imaging as noted above .	There is continued staining and late leakage in the macular in patterns suggestive of CNVM OU OCT ( today ) : [s2] IRF [e2] + SRF , and significant RPED ( OS > OD ) 1 ) ARMD OU ( exudative OU ) OD - + CNVM on exam and confirmed on OCT and IVFA imaging as noted above .	laterality	lesion	T8	T4	1114244_note_1986
NonRel	There is continued staining and late leakage in the macular in patterns suggestive of CNVM [s1] OU [e1] OCT ( today ) : IRF + SRF , and significant RPED ( OS > OD ) 1 ) ARMD OU ( exudative OU ) OD - + CNVM on exam and confirmed on OCT and IVFA imaging as noted above .	There is continued staining and late leakage in the macular in patterns suggestive of CNVM OU OCT ( today ) : IRF + [s2] SRF [e2] , and significant RPED ( OS > OD ) 1 ) ARMD OU ( exudative OU ) OD - + CNVM on exam and confirmed on OCT and IVFA imaging as noted above .	laterality	lesion	T8	T5	1114244_note_1986
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T1	T3	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without [s2] macular edema [e2] 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T1	T4	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background [s2] diabetic retinopathy [e2] of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T1	T5	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without [s2] macular edema [e2] determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T1	T7	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	severity	lesion	T2	T3	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without [s2] macular edema [e2] 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	severity	lesion	T2	T4	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background [s2] diabetic retinopathy [e2] of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	severity	lesion	T2	T5	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without [s2] macular edema [e2] determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	severity	lesion	T2	T7	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of [s1] left eye [e1] without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T6	T3	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of [s1] left eye [e1] without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without [s2] macular edema [e2] 01 / 29 / 2017 • Background diabetic retinopathy of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T6	T4	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of [s1] left eye [e1] without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background [s2] diabetic retinopathy [e2] of left eye without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T6	T5	note_2570
NonRel	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of [s1] left eye [e1] without macular edema determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	Patient Active Problem List Diagnosis Date Noted • Senile nuclear cataract , right 04 / 25 / 2017 • Status post cataract extraction and insertion of intraocular lens ( phaco / PCIOL ) OS 2017 - 4 - 17 04 / 18 / 2017 • Posterior subcapsular cataract , both eyes - Both Eyes 04 / 05 / 2017 • Uncontrolled type 1 diabetes mellitus with right eye affected by mild nonproliferative retinopathy without macular edema 01 / 29 / 2017 • Background diabetic retinopathy of left eye without [s2] macular edema [e2] determined by examination associated with type 1 diabetes mellitus 01 / 29 / 2017 • Hypertensive retinopathy of both eyes 01 / 29 / 2017 • MGD ( meibomian gland dysfunction ) 01 / 25 / 2017 • Insulin pump titration 07 / 15 / 2016 • High risk medication use 05 / 13 / 2016 • Posterior tibial tendinitis of right leg 02 / 04 / 2016 • Peroneal tendinitis of right lower extremity 01 / 21 / 2016 • Anterior tibialis tendonitis of right foot 01 / 21 / 2016 • Right foot pain 01 / 21 / 2016 • UTI ( lower urinary tract infection ) 09 / 08 / 2015 • Encounter for long - term ( current ) use of other medications 06 / 11 / 2015 • Trigger finger 05 / 01 / 2014 • Status post shoulder replacement - left ( 1 / 22 / 14 ) 01 / 25 / 2014 • Acute blood loss anemia 01 / 25 / 2014 • Abdominal pain 10 / 11 / 2013 • Hyperopia with presbyopia 08 / 08 / 2013 • Type 1 diabetes mellitus without retinopathy 08 / 08 / 2013 • Hypertensive retinopathy , grade 2 08 / 08 / 2013 • Multiple sclerosis 08 / 08 / 2013 • Rheumatoid arteritis 08 / 08 / 2013 • Chest pain 12 / 07 / 2012 • Ankle fracture , left 11 / 22 / 2011 • Diabetes mellitus type 1 , uncontrolled , insulin dependent 11 / 01 / 2011 • Hypothyroidism 12 / 03 / 2010 • Vitamin D deficiency 12 / 03 / 2010 • Carotid artery disease 12 / 03 / 2010 • Hyperlipidemia with target LDL less than 70 12 / 03 / 2010 • Gastroparesis 12 / 03 / 2010 • RLS ( restless legs syndrome ) 12 / 03 / 2010 • Cerebral infarction 12 / 03 / 2010 • Chronic pain 12 / 03 / 2010 • OSA ( obstructive sleep apnea ) 12 / 03 / 2010 • Depression 12 / 03 / 2010 • Postmenopausal symptoms 12 / 03 / 2010 • Coronary artery disease • Hypertension • GERD ( gastroesophageal reflux disease ) • Osteopenia • Rheumatoid arthritis Allergies Allergen Reactions • Captopril Other ( See Comments ) Dry cough • Codeine Swelling Throat swells .	laterality	lesion	T6	T7	note_2570
NonRel	Improvement of [s1] SRF [e1] near RPED .	Improvement of SRF near [s2] RPED [e2] .	lesion	eye_part	T3	T4	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - Both Eyes Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s1] Macular Edema [e1] / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved SRF near [s2] RPED [e2] OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	lesion	eye_part	T5	T8	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - Both Eyes Improved [s1] SRF [e1] near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved SRF near [s2] RPED [e2] OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	lesion	eye_part	T7	T8	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - [s1] Both Eyes [e1] Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] Macular Edema [e2] / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T9	T5	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - [s1] Both Eyes [e1] Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved [s2] SRF [e2] near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T9	T7	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] Improved [e1] SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] Macular Edema [e2] / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	severity	lesion	T10	T5	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] Improved [e1] SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved [s2] SRF [e2] near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	severity	lesion	T10	T7	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - Both Eyes Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] Macular Edema [e2] / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T11	T5	2183432_note_6038
NonRel	OCT , Posterior Segment - OU - Both Eyes Improved SRF near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Improved [s2] SRF [e2] near RPED OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : Macular Edema / Subretinal Fluid Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T11	T7	2183432_note_6038
NonRel	Macular edema - [s1] Right Eye [e1] H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) [s2] ME [e2] / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T12	T1	2183432_note_6038
NonRel	Macular edema - [s1] Right Eye [e1] H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / [s2] SRF [e2] OD - CSC vs idiopathic CNVM .	laterality	lesion	T12	T2	2183432_note_6038
NonRel	Macular edema - [s1] Right Eye [e1] H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	[s2] Macular edema [e2] - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T12	T6	2183432_note_6038
NonRel	Macular edema - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF [s1] OD [e1] - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) [s2] ME [e2] / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T13	T1	2183432_note_6038
NonRel	Macular edema - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF [s1] OD [e1] - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / [s2] SRF [e2] OD - CSC vs idiopathic CNVM .	laterality	lesion	T13	T2	2183432_note_6038
NonRel	Macular edema - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF [s1] OD [e1] - CSC vs idiopathic CNVM .	[s2] Macular edema [e2] - Right Eye H35.81 362.83 OCT , Posterior Segment - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Attending Note : Hx of ocular myasthenia gravis , followed by Dr NAME Seen today for new onset blurry vision OD after IVFA injections by Dr NAME in LOCATION _ CITY Treatment history IVA OD - DATE ( today ) IVA OD - DATE IVFA ( DATE ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T13	T6	2183432_note_6038
NonRel	[s1] Improvement [e1] of SRF near RPED .	Improvement of [s2] SRF [e2] near RPED .	severity	lesion	T14	T3	2183432_note_6038
NonRel	OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : PDR with vit heme Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] PDR [e2] with vit heme Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T1	T2	note_9150
NonRel	OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : PDR with vit heme Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD Pre - op DX : PDR with [s2] vit heme [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T1	T3	note_9150
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T5	T4	note_9150
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T5	T6	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	severity	lesion	T7	T8	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	severity	lesion	T7	T10	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T9	T8	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T9	T10	note_9150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	laterality	lesion	T12	T11	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	1 . [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	laterality	lesion	T14	T13	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe [s2] NPDR [e2] with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T15	T16	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with [s2] macular edema [e2] OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T15	T17	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T15	T19	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T15	T20	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T15	T22	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T15	T23	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T15	T24	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe [s2] NPDR [e2] with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T18	T16	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with [s2] macular edema [e2] OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T18	T17	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T18	T19	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T18	T20	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T18	T22	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T18	T23	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T18	T24	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe [s2] NPDR [e2] with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T21	T16	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with [s2] macular edema [e2] OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T21	T17	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T21	T19	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T21	T20	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T21	T22	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T21	T23	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	severity	lesion	T21	T24	note_9150
NonRel	OCT , Posterior Segment - OU - Both Eyes See note Color Fundus Photography - OU - Both Eyes See note OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : PDR with vit heme Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes See note Color Fundus Photography - OU - Both Eyes See note OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] PDR [e2] with vit heme Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T16	T1	2710850_note_9151
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T17	T2	2710850_note_9151
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T17	T3	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T18	T4	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T18	T5	2710850_note_9151
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	laterality	lesion	T19	T6	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T7	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T8	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T9	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T10	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T11	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T12	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T13	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T14	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T15	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T29	2710850_note_9151
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T20	T30	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T7	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T8	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T9	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T10	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T11	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T12	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T13	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T14	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T15	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T29	2710850_note_9151
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T21	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T22	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T23	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T24	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T25	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T26	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	laterality	lesion	T27	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs [s1] temporally [e1] - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T28	T30	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T7	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T8	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T9	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T10	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T11	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T12	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T13	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T14	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T15	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with [s2] vit heme [e2] , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T29	2710850_note_9151
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea on OCT , likely visually significant with VA DATE - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD today , and RTC 1 month DFE OU , possible IVA vs IVFA NAME , MD participated in the care of this patient .	severity	lesion	T31	T30	2710850_note_9151
NonRel	Patient Active Problem List Diagnosis Date Noted • Ocular hypertension of left eye 05 / 15 / 2014 • Cystoid macular edema , [s1] left eye [e1] 05 / 16 / 2013 • S / P cataract extraction and insertion of intraocular lens - OS 03 / 14 / 2012 • Nuclear sclerotic cataract of right eye 03 / 14 / 2012 • s / p DSAEK with CE / PCIOL OS 02 / 27 / 12 02 / 28 / 2012 • Fuchs ' corneal dystrophy 02 / 09 / 2012 No Known Allergies Current Outpatient Prescriptions Medication Sig Dispense Refill • amlodipine ( NORVASC ) 10 MG tablet Take 10 mg by mouth daily .	Patient Active Problem List Diagnosis Date Noted • Ocular hypertension of left eye 05 / 15 / 2014 • Cystoid [s2] macular edema [e2] , left eye 05 / 16 / 2013 • S / P cataract extraction and insertion of intraocular lens - OS 03 / 14 / 2012 • Nuclear sclerotic cataract of right eye 03 / 14 / 2012 • s / p DSAEK with CE / PCIOL OS 02 / 27 / 12 02 / 28 / 2012 • Fuchs ' corneal dystrophy 02 / 09 / 2012 No Known Allergies Current Outpatient Prescriptions Medication Sig Dispense Refill • amlodipine ( NORVASC ) 10 MG tablet Take 10 mg by mouth daily .	laterality	lesion	T2	T1	note_5213
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 4 .	[s2] Cystoid macular edema [e2] of left eye H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 4 .	laterality	lesion	T2	T1	note_5950
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	laterality	lesion	T4	T3	note_5950
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	Vitreous hemorrhage , left H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new [s2] vit heme [e2] Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	laterality	lesion	T4	T5	note_5950
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	Vitreous hemorrhage , left H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of [s2] retinal edema [e2] / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	laterality	lesion	T4	T6	note_5950
NonRel	OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : PDR with VH [s1] OS [e1] Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : PDR with [s2] VH [e2] OS Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T13	T9	1483426_note_3695
NonRel	Type 2 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E11.3511 250.50 362.02 362.07 2 .	Type 2 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E11.3511 250.50 362.02 362.07 2 .	laterality	lesion	T14	T1	1483426_note_3695
NonRel	Type 2 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E11.3511 250.50 362.02 362.07 2 .	Type 2 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E11.3511 250.50 362.02 362.07 2 .	laterality	lesion	T14	T2	1483426_note_3695
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	laterality	lesion	T15	T3	1483426_note_3695
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	laterality	lesion	T15	T4	1483426_note_3695
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T16	T7	1483426_note_3695
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T16	T10	1483426_note_3695
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T16	T12	1483426_note_3695
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T16	T23	1483426_note_3695
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T16	T25	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T17	T7	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T17	T10	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T17	T12	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T17	T23	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T17	T25	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T18	T7	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T18	T10	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T18	T12	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T18	T23	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T18	T25	1483426_note_3695
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion .	laterality	lesion	T19	T5	1483426_note_3695
NonRel	[s1] Mild [e1] NVD that can be observed at this time .	Mild [s2] NVD [e2] that can be observed at this time .	severity	lesion	T20	T8	1483426_note_3695
NonRel	[s1] OS [e1] - PDR s / p PRP DATE , IVFA demonstrated new areas of NVE on DATE .	OS - PDR s / p PRP DATE , IVFA demonstrated new areas of [s2] NVE [e2] on DATE .	laterality	lesion	T21	T6	1483426_note_3695
NonRel	[s1] OS [e1] - PDR s / p PRP DATE , IVFA demonstrated new areas of NVE on DATE .	OS - [s2] PDR [e2] s / p PRP DATE , IVFA demonstrated new areas of NVE on DATE .	laterality	lesion	T21	T22	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T24	T7	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T24	T10	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T24	T12	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T24	T23	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T24	T25	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T26	T7	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T26	T10	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T26	T12	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T26	T23	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T26	T25	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , [s1] Active [e1] PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T27	T7	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , [s1] Active [e1] PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T27	T10	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , [s1] Active [e1] PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T27	T12	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , [s1] Active [e1] PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T27	T23	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , [s1] Active [e1] PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	severity	lesion	T27	T25	1483426_note_3695
NonRel	Epiretinal membrane ( ERM ) of both eyes H35.373 362.56 Attending Note : PPV / EMM OS - 1 / 30 / 17 YAG OD - 12 / 2 / 16 YAG OS - 11 / 1816 CE / PCIOL toric OS 3 / 21 / 16 ( VA ) CE / PCIOL OD 3 / 11 / 16 ( VA ) Optic neuropathy OU - HVF demonstrating heminopsia 1 ) EMM [s1] OU [e1] OD - foveal inversion without associated IRF . 20 / 50 .	Epiretinal membrane ( ERM ) of both eyes H35.373 362.56 Attending Note : PPV / EMM OS - 1 / 30 / 17 YAG OD - 12 / 2 / 16 YAG OS - 11 / 1816 CE / PCIOL toric OS 3 / 21 / 16 ( VA ) CE / PCIOL OD 3 / 11 / 16 ( VA ) Optic neuropathy OU - HVF demonstrating heminopsia 1 ) EMM OU OD - foveal inversion without associated [s2] IRF [e2] . 20 / 50 .	laterality	lesion	T1	T3	note_7729
NonRel	Epiretinal membrane ( ERM ) of both eyes H35.373 362.56 Attending Note : PPV / EMM OS - 1 / 30 / 17 YAG OD - 12 / 2 / 16 YAG OS - 11 / 1816 CE / PCIOL toric OS 3 / 21 / 16 ( VA ) CE / PCIOL OD 3 / 11 / 16 ( VA ) Optic neuropathy OU - HVF demonstrating heminopsia 1 ) EMM OU [s1] OD [e1] - foveal inversion without associated IRF . 20 / 50 .	Epiretinal membrane ( ERM ) of both eyes H35.373 362.56 Attending Note : PPV / EMM OS - 1 / 30 / 17 YAG OD - 12 / 2 / 16 YAG OS - 11 / 1816 CE / PCIOL toric OS 3 / 21 / 16 ( VA ) CE / PCIOL OD 3 / 11 / 16 ( VA ) Optic neuropathy OU - HVF demonstrating heminopsia 1 ) EMM OU OD - foveal inversion without associated [s2] IRF [e2] . 20 / 50 .	laterality	lesion	T2	T3	note_7729
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T15	T4	2542462_note_7938
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T15	T5	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T16	T6	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T16	T7	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	severity	lesion	T17	T8	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	laterality	lesion	T18	T8	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T19	T9	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T19	T10	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T19	T11	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T20	T9	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T20	T10	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T20	T11	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T21	T12	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T21	T33	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T22	T12	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	laterality	lesion	T22	T33	2542462_note_7938
NonRel	[s1] Mild [e1] temporal macular edema . Treat with IVA concurrently today .	Mild temporal [s2] macular edema [e2] . Treat with IVA concurrently today .	severity	lesion	T23	T13	2542462_note_7938
NonRel	Mild [s1] temporal [e1] macular edema . Treat with IVA concurrently today .	Mild temporal [s2] macular edema [e2] . Treat with IVA concurrently today .	severity	lesion	T24	T13	2542462_note_7938
NonRel	NAME , MD IVFA ( today ) : areas of NVE [s1] OU [e1] with early staining with late leakage and adjacent vast capillary dropout	NAME , MD IVFA ( today ) : areas of [s2] NVE [e2] OU with early staining with late leakage and adjacent vast capillary dropout	laterality	lesion	T25	T14	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE [s1] OU [e1] OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and [s2] NVE [e2] OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T26	T1	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE [s1] OU [e1] OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no [s2] edema [e2] OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T26	T2	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE [s1] OU [e1] OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : [s2] Proliferative Diabetic Retinopathy [e2] Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T26	T3	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE [s1] OU [e1] OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal [s2] edema [e2] Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T26	T28	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and [s2] NVE [e2] OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T27	T1	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no [s2] edema [e2] OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T27	T2	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : [s2] Proliferative Diabetic Retinopathy [e2] Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T27	T3	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal [s2] edema [e2] Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T27	T28	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , [s1] temporal [e1] edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and [s2] NVE [e2] OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	severity	lesion	T29	T1	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , [s1] temporal [e1] edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no [s2] edema [e2] OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	severity	lesion	T29	T2	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , [s1] temporal [e1] edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : [s2] Proliferative Diabetic Retinopathy [e2] Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	severity	lesion	T29	T3	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , [s1] temporal [e1] edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal [s2] edema [e2] Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	severity	lesion	T29	T28	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema [s1] OS [e1] : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and [s2] NVE [e2] OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T30	T1	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema [s1] OS [e1] : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no [s2] edema [e2] OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T30	T2	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema [s1] OS [e1] : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : [s2] Proliferative Diabetic Retinopathy [e2] Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T30	T3	2542462_note_7938
NonRel	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema [s1] OS [e1] : good contour , temporal edema Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	OPH - OU Fluorescein Angiography DIffuse CNP and NVE OU OCT , Posterior Segment - OU - Both Eyes OD : good contour , no edema OS : good contour , temporal [s2] edema [e2] Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : Proliferative Diabetic Retinopathy Surgeon : NAME , MD Power : 600 Duration : 300 Spot Size : 200 Total shots : 4950 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T30	T28	2542462_note_7938
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR [s1] Left [e1] Post - op DX : same Attending : NAME Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	INVASIVE PROCEDURE NOTE Pre - op DX : [s2] PDR [e2] Left Post - op DX : same Attending : NAME Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	laterality	lesion	T32	T31	2542462_note_7938
NonRel	OCT , Retina - OU - [s1] Both [e1] Eyes SRF stable OD , normal OS OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD , OS Pre - op DX : CSC vs .	OCT , Retina - OU - Both Eyes [s2] SRF [e2] stable OD , normal OS OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD , OS Pre - op DX : CSC vs .	laterality	lesion	T1	T2	note_6044
NonRel	OCT , Retina - OU - Both Eyes SRF stable [s1] OD [e1] , normal OS OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD , OS Pre - op DX : CSC vs .	OCT , Retina - OU - Both Eyes [s2] SRF [e2] stable OD , normal OS OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD , OS Pre - op DX : CSC vs .	laterality	lesion	T3	T2	note_6044
NonRel	OCT , Retina - OU - Both Eyes SRF stable OD , normal [s1] OS [e1] OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD , OS Pre - op DX : CSC vs .	OCT , Retina - OU - Both Eyes [s2] SRF [e2] stable OD , normal OS OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD , OS Pre - op DX : CSC vs .	laterality	lesion	T4	T2	note_6044
NonRel	Macular edema - [s1] Right Eye [e1] H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	[s2] Macular edema [e2] - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T6	T5	note_6044
NonRel	Macular edema - [s1] Right Eye [e1] H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) [s2] ME [e2] / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T6	T7	note_6044
NonRel	Macular edema - [s1] Right Eye [e1] H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / [s2] SRF [e2] OD - CSC vs idiopathic CNVM .	laterality	lesion	T6	T8	note_6044
NonRel	Macular edema - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF [s1] OD [e1] - CSC vs idiopathic CNVM .	[s2] Macular edema [e2] - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T10	T5	note_6044
NonRel	Macular edema - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF [s1] OD [e1] - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) [s2] ME [e2] / SRF OD - CSC vs idiopathic CNVM .	laterality	lesion	T10	T7	note_6044
NonRel	Macular edema - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / SRF [s1] OD [e1] - CSC vs idiopathic CNVM .	Macular edema - Right Eye H35.81 362.83 OCT , Retina - OU - Both Eyes OPH - OD Intravitreal Injection , Pharmacologic Agent Hx of ocular myasthenia gravis , followed by Dr Samy Treatment history IVA OD - 1 / 12 / 18 IVA OD - 12 / 8 / 17 IVA OD - 11 / 3 / 17 IVA OD - 9 / 28 / 17 IVFA ( 09 / 28 / 17 ) - Early pooling of fluorescein inferotemporally with late staining 1 ) ME / [s2] SRF [e2] OD - CSC vs idiopathic CNVM .	laterality	lesion	T10	T8	note_6044
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by proliferative retinopathy and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	Type 2 diabetes mellitus with both eyes affected by [s2] proliferative retinopathy [e2] and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	laterality	lesion	T4	T2	2677988_note_8903
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 Patient does not speak English .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 Patient does not speak English .	laterality	lesion	T5	T1	2677988_note_8903
NonRel	1 . IDDM with PDR and macula - involving TRD [s1] OU [e1] - Referred from LOCATION _ INSTITUTE for PDR and TRDs OU - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	1 . IDDM with [s2] PDR [e2] and macula - involving TRD OU - Referred from LOCATION _ INSTITUTE for PDR and TRDs OU - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	laterality	lesion	T6	T3	2677988_note_8903
NonRel	1 . IDDM with PDR and macula - involving TRD [s1] OU [e1] - Referred from LOCATION _ INSTITUTE for PDR and TRDs OU - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	1 . IDDM with PDR and macula - involving TRD OU - Referred from LOCATION _ INSTITUTE for [s2] PDR [e2] and TRDs OU - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	laterality	lesion	T6	T7	2677988_note_8903
NonRel	1 . IDDM with PDR and macula - involving TRD OU - Referred from LOCATION _ INSTITUTE for PDR and TRDs [s1] OU [e1] - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	1 . IDDM with [s2] PDR [e2] and macula - involving TRD OU - Referred from LOCATION _ INSTITUTE for PDR and TRDs OU - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	laterality	lesion	T8	T3	2677988_note_8903
NonRel	1 . IDDM with PDR and macula - involving TRD OU - Referred from LOCATION _ INSTITUTE for PDR and TRDs [s1] OU [e1] - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	1 . IDDM with PDR and macula - involving TRD OU - Referred from LOCATION _ INSTITUTE for [s2] PDR [e2] and TRDs OU - H / o PRP and IVA OS x 2 ? ( exact # unknown ) - VA HM and CF - IOP DATE - DFE with total TRD OD , central TRD OS - IVFA with * * * - Optos obtained today Plan RTC NAME , MD participated in the care of this patient .	laterality	lesion	T8	T7	2677988_note_8903
NonRel	Intravitreal Injection Procedure Note Eye : [s1] OS [e1] Pre - op DX : CRVO with ME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	Intravitreal Injection Procedure Note Eye : OS Pre - op DX : CRVO with [s2] ME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T1	T2	note_3232
NonRel	Central retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8120 362.35 OCT , Posterior Segment - OU - Both Eyes 362.83 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of APL , and CRVO OS now on monthly IVE .	Central retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8120 362.35 OCT , Posterior Segment - OU - Both Eyes 362.83 OPH - OS Intravitreal Injection , Pharmacologic Agent Hx of APL , and CRVO OS now on monthly IVE .	laterality	lesion	T4	T3	note_3232
NonRel	[s1] OS [e1] with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	OS with significant [s2] macular [e2] perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	laterality	lesion	T6	T8	note_3232
NonRel	[s1] OS [e1] with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with [s2] Macular Edema [e2] OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	laterality	lesion	T6	T9	note_3232
NonRel	OS with [s1] significant [e1] macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	OS with significant [s2] macular [e2] perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	severity	lesion	T7	T8	note_3232
NonRel	OS with [s1] significant [e1] macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with [s2] Macular Edema [e2] OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	severity	lesion	T7	T9	note_3232
NonRel	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema [s1] OS [e1] - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	OS with significant [s2] macular [e2] perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	laterality	lesion	T10	T8	note_3232
NonRel	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with Macular Edema [s1] OS [e1] - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	OS with significant macular perivascular leakage and significant nonperfusion in the periphery 1 ) CRVO with [s2] Macular Edema [e2] OS - treated with IVA with refractory IRF then switched to IVE in June 2018 with great improvement in ME and VA .	laterality	lesion	T10	T9	note_3232
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	severity	lesion	T1	T2	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	severity	lesion	T1	T4	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	laterality	lesion	T3	T2	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	laterality	lesion	T3	T4	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	severity	lesion	T5	T6	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	severity	lesion	T5	T8	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	laterality	lesion	T7	T6	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	laterality	lesion	T7	T8	note_3786
NonRel	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T10	T11	note_3786
NonRel	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	laterality	lesion	T12	T11	note_3786
NonRel	[s1] Mild [e1] DME .	Mild [s2] DME [e2] .	severity	lesion	T13	T14	note_3786
NonRel	+ [s1] Mild [e1] NPDR .	+ Mild [s2] NPDR [e2] .	severity	lesion	T1	T2	note_6901
NonRel	normal lipid profile Exam Today - Right 6 th nerve no other cranial nerves involved Impression & Plan Right 6 th nerve plasy complete , advised to control BS and BP Patient taking supplements : Benfotiamine and Alphalipoic acid - [s1] mild [e1] Non proliferative diabetic retinopathy - mild Nuclear cataract U : for observation - New Mrx given today as patients glasses were broken Return to clinic : 3 - 4 months Fouad El Sayyad , MD participated in the care of this patient .	normal lipid profile Exam Today - Right 6 th nerve no other cranial nerves involved Impression & Plan Right 6 th nerve plasy complete , advised to control BS and BP Patient taking supplements : Benfotiamine and Alphalipoic acid - mild [s2] Non proliferative diabetic retinopathy [e2] - mild Nuclear cataract U : for observation - New Mrx given today as patients glasses were broken Return to clinic : 3 - 4 months Fouad El Sayyad , MD participated in the care of this patient .	severity	lesion	T4	T3	note_6901
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] Active [e1] PDR OU 1 .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	severity	lesion	T1	T2	note_1196
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active PDR [s1] OU [e1] 1 .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T3	T2	note_1196
NonRel	DMII - [s1] Active [e1] PDR OU .	DMII - Active [s2] PDR [e2] OU .	severity	lesion	T4	T5	note_1196
NonRel	DMII - Active PDR [s1] OU [e1] .	DMII - Active [s2] PDR [e2] OU .	laterality	lesion	T6	T5	note_1196
NonRel	[s1] OS [e1] - High risk PDR now s / p PRP .	OS - High risk [s2] PDR [e2] now s / p PRP .	laterality	lesion	T7	T8	note_1196
NonRel	[s1] Some [e1] macular edema accumulating temporal to the fovea .	Some [s2] macular edema [e2] accumulating temporal to the fovea .	severity	lesion	T9	T10	note_1196
NonRel	Some [s1] macular edema [e1] accumulating temporal to the fovea .	Some macular edema accumulating temporal to the [s2] fovea [e2] .	lesion	eye_part	T10	T11	note_1196
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] good foveal contour , no srf or irf OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no [s2] srf [e2] or irf OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T6	T1	284259_note_767
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] good foveal contour , no srf or irf OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or [s2] irf [e2] OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T6	T2	284259_note_767
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] good foveal contour , no srf or irf OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf OS good foveal contour , no [s2] srf [e2] or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T6	T3	284259_note_767
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] good foveal contour , no srf or irf OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf OS good foveal contour , no srf or [s2] irf [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T6	T4	284259_note_767
NonRel	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf [s1] OS [e1] good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no [s2] srf [e2] or irf OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T1	284259_note_767
NonRel	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf [s1] OS [e1] good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or [s2] irf [e2] OS good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T2	284259_note_767
NonRel	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf [s1] OS [e1] good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf OS good foveal contour , no [s2] srf [e2] or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T3	284259_note_767
NonRel	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf [s1] OS [e1] good foveal contour , no srf or irf Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD good foveal contour , no srf or irf OS good foveal contour , no srf or [s2] irf [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T7	T4	284259_note_767
NonRel	OS : Active PDR with [s1] large [e1] VH .	OS : Active [s2] PDR [e2] with large VH .	severity	lesion	T3	T1	note_3966
NonRel	OS : Active PDR with [s1] large [e1] VH .	OS : Active PDR with large [s2] VH [e2] .	severity	lesion	T3	T2	note_3966
NonRel	OS : [s1] Active [e1] PDR with large VH .	OS : Active [s2] PDR [e2] with large VH .	severity	lesion	T4	T1	note_3966
NonRel	OS : [s1] Active [e1] PDR with large VH .	OS : Active PDR with large [s2] VH [e2] .	severity	lesion	T4	T2	note_3966
NonRel	[s1] OS [e1] : Active PDR with large VH .	OS : Active [s2] PDR [e2] with large VH .	laterality	lesion	T5	T1	note_3966
NonRel	[s1] OS [e1] : Active PDR with large VH .	OS : Active PDR with large [s2] VH [e2] .	laterality	lesion	T5	T2	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR [s1] OU [e1] , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) [s2] PDR [e2] OU , active with VH OU OD : Active PDR with large VH .	laterality	lesion	T7	T6	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR [s1] OU [e1] , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with [s2] VH [e2] OU OD : Active PDR with large VH .	laterality	lesion	T7	T9	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR [s1] OU [e1] , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active [s2] PDR [e2] with large VH .	laterality	lesion	T7	T10	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR [s1] OU [e1] , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large [s2] VH [e2] .	laterality	lesion	T7	T11	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR [s1] OU [e1] , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active [s2] PDR [e2] OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	laterality	lesion	T7	T17	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , [s1] active [e1] with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) [s2] PDR [e2] OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T8	T6	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , [s1] active [e1] with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with [s2] VH [e2] OU OD : Active PDR with large VH .	severity	lesion	T8	T9	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , [s1] active [e1] with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active [s2] PDR [e2] with large VH .	severity	lesion	T8	T10	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , [s1] active [e1] with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large [s2] VH [e2] .	severity	lesion	T8	T11	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , [s1] active [e1] with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active [s2] PDR [e2] OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T8	T17	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with [s1] large [e1] VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) [s2] PDR [e2] OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T12	T6	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with [s1] large [e1] VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with [s2] VH [e2] OU OD : Active PDR with large VH .	severity	lesion	T12	T9	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with [s1] large [e1] VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active [s2] PDR [e2] with large VH .	severity	lesion	T12	T10	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with [s1] large [e1] VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large [s2] VH [e2] .	severity	lesion	T12	T11	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with [s1] large [e1] VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active [s2] PDR [e2] OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T12	T17	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : [s1] Active [e1] PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) [s2] PDR [e2] OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T13	T6	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : [s1] Active [e1] PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with [s2] VH [e2] OU OD : Active PDR with large VH .	severity	lesion	T13	T9	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : [s1] Active [e1] PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active [s2] PDR [e2] with large VH .	severity	lesion	T13	T10	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : [s1] Active [e1] PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large [s2] VH [e2] .	severity	lesion	T13	T11	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : [s1] Active [e1] PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active [s2] PDR [e2] OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T13	T17	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU [s1] OD [e1] : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) [s2] PDR [e2] OU , active with VH OU OD : Active PDR with large VH .	laterality	lesion	T14	T6	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU [s1] OD [e1] : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with [s2] VH [e2] OU OD : Active PDR with large VH .	laterality	lesion	T14	T9	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU [s1] OD [e1] : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active [s2] PDR [e2] with large VH .	laterality	lesion	T14	T10	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU [s1] OD [e1] : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large [s2] VH [e2] .	laterality	lesion	T14	T11	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU [s1] OD [e1] : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active [s2] PDR [e2] OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	laterality	lesion	T14	T17	note_3966
NonRel	Complications : None I performed this procedure myself OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : PDR Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	Complications : None I performed this procedure myself OPH - OD Intravitreal Injection , Pharmacologic Agent Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] PDR [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T16	T15	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR [s1] OU [e1] Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) [s2] PDR [e2] OU , active with VH OU OD : Active PDR with large VH .	laterality	lesion	T18	T6	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR [s1] OU [e1] Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with [s2] VH [e2] OU OD : Active PDR with large VH .	laterality	lesion	T18	T9	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR [s1] OU [e1] Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active [s2] PDR [e2] with large VH .	laterality	lesion	T18	T10	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR [s1] OU [e1] Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large [s2] VH [e2] .	laterality	lesion	T18	T11	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR [s1] OU [e1] Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active [s2] PDR [e2] OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	laterality	lesion	T18	T17	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - [s1] Active [e1] PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) [s2] PDR [e2] OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T19	T6	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - [s1] Active [e1] PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with [s2] VH [e2] OU OD : Active PDR with large VH .	severity	lesion	T19	T9	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - [s1] Active [e1] PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active [s2] PDR [e2] with large VH .	severity	lesion	T19	T10	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - [s1] Active [e1] PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large [s2] VH [e2] .	severity	lesion	T19	T11	note_3966
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - [s1] Active [e1] PDR OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 Treatment History IVA OU - 3 / 9 / 18 ( today ) IVA OU - 2 / 2 / 18 IVFA ( 2 / 1 / 2018 ) - Active [s2] PDR [e2] OU Outside Retina : Multiple IVA OU PRP OU 1 ) PDR OU , active with VH OU OD : Active PDR with large VH .	severity	lesion	T19	T17	note_3966
NonRel	Type 1 diabetes mellitus with [s1] proliferative retinopathy [e1] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T3	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s1] macular edema [e1] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T4	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s1] NPDR [e1] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T5	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s1] NPDR [e1] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T6	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s1] macular exudates [e1] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T7	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s1] macular exudates [e1] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T8	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s1] NVE [e1] superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T10	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s1] PDR [e1] OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T11	T9	1145464_note_2230
NonRel	Single pinpoint [s1] NVE [e1] superonasal to the nerve .	Single pinpoint NVE superonasal to the [s2] nerve [e2] .	lesion	eye_part	T22	T46	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T25	T1	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T25	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T26	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T26	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T27	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T27	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T28	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T28	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T29	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T29	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T30	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T30	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T31	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T31	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T32	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T32	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T33	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T33	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T34	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T34	T55	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T35	T12	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T35	T13	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T35	T14	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T35	T15	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T35	T16	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T36	T12	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T36	T13	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T36	T14	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T36	T15	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T36	T16	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T37	T12	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T37	T13	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T37	T14	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T37	T15	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T37	T16	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T38	T12	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T38	T13	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T38	T14	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T38	T15	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T38	T16	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T39	T12	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T39	T13	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T39	T14	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T39	T15	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T39	T16	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T40	T12	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T40	T13	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T40	T14	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T40	T15	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T40	T16	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T41	T12	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T41	T13	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T41	T14	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T41	T15	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T41	T16	1145464_note_2230
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T42	T17	1145464_note_2230
NonRel	Repeat of IVFA demonstrated one spot of [s1] mild [e1] NVE .	Repeat of IVFA demonstrated one spot of mild [s2] NVE [e2] .	severity	lesion	T43	T18	1145464_note_2230
NonRel	Rec treatment with PRP OS - [s1] Severe [e1] NPDR with CSME .	Rec treatment with PRP OS - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T44	T20	1145464_note_2230
NonRel	Rec treatment with PRP OS - [s1] Severe [e1] NPDR with CSME .	Rec treatment with PRP OS - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T44	T21	1145464_note_2230
NonRel	Rec treatment with PRP [s1] OS [e1] - Severe NPDR with CSME .	Rec treatment with PRP OS - Severe [s2] NPDR [e2] with CSME .	laterality	lesion	T45	T20	1145464_note_2230
NonRel	Rec treatment with PRP [s1] OS [e1] - Severe NPDR with CSME .	Rec treatment with PRP OS - Severe NPDR with [s2] CSME [e2] .	laterality	lesion	T45	T21	1145464_note_2230
NonRel	[s1] Single pinpoint [e1] NVE superonasal to the nerve .	Single pinpoint [s2] NVE [e2] superonasal to the nerve .	severity	lesion	T47	T22	1145464_note_2230
NonRel	OCT , Retina - OU - Both Eyes [s1] OD [e1] : Edema superiorly with exudation OS : Temporal edema with exudation .	OCT , Retina - OU - Both Eyes OD : Edema superiorly with [s2] exudation [e2] OS : Temporal edema with exudation .	laterality	lesion	T49	T23	1145464_note_2230
NonRel	OCT , Retina - OU - Both Eyes [s1] OD [e1] : Edema superiorly with exudation OS : Temporal edema with exudation .	OCT , Retina - OU - Both Eyes OD : Edema superiorly with exudation OS : Temporal edema with [s2] exudation [e2] .	laterality	lesion	T49	T24	1145464_note_2230
NonRel	OCT , Retina - OU - Both Eyes OD : Edema superiorly with exudation [s1] OS [e1] : Temporal edema with exudation .	OCT , Retina - OU - Both Eyes OD : Edema superiorly with [s2] exudation [e2] OS : Temporal edema with exudation .	laterality	lesion	T50	T23	1145464_note_2230
NonRel	OCT , Retina - OU - Both Eyes OD : Edema superiorly with exudation [s1] OS [e1] : Temporal edema with exudation .	OCT , Retina - OU - Both Eyes OD : Edema superiorly with exudation OS : Temporal edema with [s2] exudation [e2] .	laterality	lesion	T50	T24	1145464_note_2230
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	[s2] Vitreous hemorrhage [e2] , right H43.11 379.23 CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T52	T51	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s1] MAs [e1] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T53	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s1] IRMA [e1] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T54	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s1] vitreous heme [e1] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T55	T9	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T3	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T4	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T5	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T6	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T7	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T8	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T56	T10	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T11	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T53	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T54	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T56	T55	1145464_note_2230
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Clinically still has significant vitreous hemorrhage inferiorly He has [s2] macular edema [e2] .	severity	lesion	T58	T19	1145464_note_2230
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Clinically still has significant [s2] vitreous hemorrhage [e2] inferiorly He has macular edema .	severity	lesion	T58	T57	1145464_note_2230
NonRel	Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP [s1] Right [e1] Diagnosis : Proliferative Diabetic Retinopathy Surgeon : Iyer Power : 500 - 700 Duration : 200 Spot Size : 200 Total shots : 500 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	Pan Retinal Photocoagulation - OD - Right Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Right Diagnosis : [s2] Proliferative Diabetic Retinopathy [e2] Surgeon : Iyer Power : 500 - 700 Duration : 200 Spot Size : 200 Total shots : 500 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T13	T1	note_169
NonRel	Pan Retinal Photocoagulation - OS - Left Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP [s1] Left [e1] Diagnosis : Proliferative Diabetic Retinopathy Surgeon : Iyer Power : 500 - 700 Duration : 200 Spot Size : 200 Total shots : 706 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	Pan Retinal Photocoagulation - OS - Left Eye Time out was taken , correct eye was identified and marked Session # 1 PANRETINAL PHOTOCOAGULATION Procedure Performed : PRP Left Diagnosis : [s2] Proliferative Diabetic Retinopathy [e2] Surgeon : Iyer Power : 500 - 700 Duration : 200 Spot Size : 200 Total shots : 706 Focal as well : no Description of Procedure : Consent was obtained , time out was performed .	laterality	lesion	T14	T2	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T15	T3	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	laterality	lesion	T15	T4	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T15	T20	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T16	T3	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T16	T4	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T16	T20	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T17	T3	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	laterality	lesion	T17	T4	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T17	T20	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T18	T5	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T18	T6	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T18	T7	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T18	T8	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T18	T9	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T18	T10	note_169
NonRel	[s1] Mild [e1] NPDR now .	Mild [s2] NPDR [e2] now .	severity	lesion	T19	T11	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T21	T3	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	laterality	lesion	T21	T4	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T21	T20	note_169
NonRel	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages [s1] OS [e1] by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO OS without ME - Patient asymptomatic .	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal [s2] hemorrhages [e2] OS by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO OS without ME - Patient asymptomatic .	laterality	lesion	T2	T1	note_703
NonRel	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages [s1] OS [e1] by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO OS without ME - Patient asymptomatic .	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages OS by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO OS without [s2] ME [e2] - Patient asymptomatic .	laterality	lesion	T2	T4	note_703
NonRel	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages OS by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO [s1] OS [e1] without ME - Patient asymptomatic .	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal [s2] hemorrhages [e2] OS by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO OS without ME - Patient asymptomatic .	laterality	lesion	T3	T1	note_703
NonRel	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages OS by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO [s1] OS [e1] without ME - Patient asymptomatic .	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages OS by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) BRVO OS without [s2] ME [e2] - Patient asymptomatic .	laterality	lesion	T3	T4	note_703
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with [s1] mild [e1] non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild [s2] non proliferative diabetic retinopathy [e2] OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T7	T8	note_703
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with [s1] mild [e1] non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild [s2] non proliferative diabetic retinopathy [e2] - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T7	T11	note_703
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with [s1] mild [e1] non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild [s2] non proliferative diabetic retinopathy [e2] OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T9	T8	note_703
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with [s1] mild [e1] non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild [s2] non proliferative diabetic retinopathy [e2] - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	severity	lesion	T9	T11	note_703
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy [s1] OS [e1] - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild [s2] non proliferative diabetic retinopathy [e2] OS - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	laterality	lesion	T6	T8	note_703
NonRel	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy [s1] OS [e1] - BCVA 20 / 20 with mild non proliferative diabetic retinopathy - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	Last A1C per patient was 6.2 OD - BCVA 20 / 30 with mild non proliferative diabetic retinopathy OS - BCVA 20 / 20 with mild [s2] non proliferative diabetic retinopathy [e2] - He was explained the ocular and systemic risks of diabetes and that he must make sure that his blood sugar is well controlled to prevent these complications .	laterality	lesion	T6	T11	note_703
NonRel	Exudative age - related macular degeneration , [s1] left eye [e1] , with active choroidal neovascularization H35.3221 362.52 OCT , Posterior Segment - OU - Both Eyes 362.16 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment Hx : IVE OS - 09 / 29 / 17 ( today ) IVE OS - 8 / 23 / 17 IVE OS - 7 / 18 / 17 IVFA ( today ) - CNVM OS IVE - VAMC ( 6 / 2017 ) with prior injections 1 ) ARMD OU ( Nonexudative OD , Exudative OS ) OD - Nonexudative .	Exudative age - related macular degeneration , left eye , with active choroidal [s2] neovascularization [e2] H35.3221 362.52 OCT , Posterior Segment - OU - Both Eyes 362.16 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment Hx : IVE OS - 09 / 29 / 17 ( today ) IVE OS - 8 / 23 / 17 IVE OS - 7 / 18 / 17 IVFA ( today ) - CNVM OS IVE - VAMC ( 6 / 2017 ) with prior injections 1 ) ARMD OU ( Nonexudative OD , Exudative OS ) OD - Nonexudative .	laterality	lesion	T2	T3	note_8556
NonRel	B - Scan Ultrasound - OS - [s1] Left Eye [e1] Choroidals not kissing Vitreous hemorrhage Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	B - Scan Ultrasound - OS - Left Eye Choroidals not kissing [s2] Vitreous hemorrhage [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T3	T1	note_8299
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	severity	lesion	T1	T2	note_50
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by mild nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	severity	lesion	T1	T3	note_50
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	laterality	lesion	T4	T2	note_50
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by mild nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	laterality	lesion	T4	T3	note_50
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	severity	lesion	T5	T6	note_50
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	laterality	lesion	T7	T6	note_50
NonRel	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) [s1] OD [e1] - mild CSME with MAs amenable to laser , no NV .	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) OD - mild [s2] CSME [e2] with MAs amenable to laser , no NV .	laterality	lesion	T8	T10	note_50
NonRel	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) [s1] OD [e1] - mild CSME with MAs amenable to laser , no NV .	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) OD - mild CSME with [s2] MAs [e2] amenable to laser , no NV .	laterality	lesion	T8	T11	note_50
NonRel	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) OD - [s1] mild [e1] CSME with MAs amenable to laser , no NV .	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) OD - mild [s2] CSME [e2] with MAs amenable to laser , no NV .	severity	lesion	T9	T10	note_50
NonRel	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) OD - [s1] mild [e1] CSME with MAs amenable to laser , no NV .	Age - related nuclear cataract of left eye H25.12 366.16 1 ) T2DM , IDDM - HgA 1 C 7.0 ( 2 / 9 / 2017 ) OD - mild CSME with [s2] MAs [e2] amenable to laser , no NV .	severity	lesion	T9	T11	note_50
NonRel	Continue to monitor , continue improved blood sguar control [s1] OS [e1] - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - ME secondary to DM .	Continue to monitor , continue improved blood sguar control OS - without [s2] CSME [e2] , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - ME secondary to DM .	laterality	lesion	T12	T13	note_50
NonRel	Continue to monitor , continue improved blood sguar control [s1] OS [e1] - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - ME secondary to DM .	Continue to monitor , continue improved blood sguar control OS - without CSME , + [s2] MAs [e2] , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - ME secondary to DM .	laterality	lesion	T12	T14	note_50
NonRel	Continue to monitor , continue improved blood sguar control [s1] OS [e1] - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - ME secondary to DM .	Continue to monitor , continue improved blood sguar control OS - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - [s2] ME [e2] secondary to DM .	laterality	lesion	T12	T16	note_50
NonRel	Continue to monitor , continue improved blood sguar control OS - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia [s1] OD [e1] - ME secondary to DM .	Continue to monitor , continue improved blood sguar control OS - without [s2] CSME [e2] , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - ME secondary to DM .	laterality	lesion	T15	T13	note_50
NonRel	Continue to monitor , continue improved blood sguar control OS - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia [s1] OD [e1] - ME secondary to DM .	Continue to monitor , continue improved blood sguar control OS - without CSME , + [s2] MAs [e2] , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - ME secondary to DM .	laterality	lesion	T15	T14	note_50
NonRel	Continue to monitor , continue improved blood sguar control OS - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia [s1] OD [e1] - ME secondary to DM .	Continue to monitor , continue improved blood sguar control OS - without CSME , + MAs , CWS , no NV 2 ) NSC OS - No contraindication to proceed with CE / IOL from retina standpoint , however still with good vision OS 3 ) Pseudophakia OD - [s2] ME [e2] secondary to DM .	laterality	lesion	T15	T16	note_50
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	laterality	lesion	T5	T1	note_1344
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	laterality	lesion	T5	T2	note_1344
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	laterality	lesion	T6	T3	note_1344
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	laterality	lesion	T6	T4	note_1344
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T1	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T2	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T3	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T4	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T13	T27	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T14	T1	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T14	T2	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T14	T3	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T14	T4	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T14	T27	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T15	T1	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T15	T2	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T15	T3	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T15	T4	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T15	T27	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T16	T1	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T16	T2	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T16	T3	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T16	T4	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T16	T27	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T17	T1	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T17	T2	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T17	T3	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T17	T4	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T17	T27	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T18	T5	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T18	T6	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T18	T7	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T18	T8	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T18	T9	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T19	T5	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T19	T6	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T19	T7	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T19	T8	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T19	T9	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T5	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T6	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T7	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T20	T8	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T20	T9	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T5	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T6	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T7	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T21	T8	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T21	T9	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T5	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T6	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T7	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T22	T8	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T22	T9	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T5	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T6	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T7	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T23	T8	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T23	T9	2512733_note_7749
NonRel	Monitor [s1] OS [e1] - Severe NPDR with ciCSME .	Monitor OS - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T24	T10	2512733_note_7749
NonRel	Monitor [s1] OS [e1] - Severe NPDR with ciCSME .	Monitor OS - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T24	T11	2512733_note_7749
NonRel	Monitor OS - [s1] Severe [e1] NPDR with ciCSME .	Monitor OS - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T25	T10	2512733_note_7749
NonRel	Monitor OS - [s1] Severe [e1] NPDR with ciCSME .	Monitor OS - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T25	T11	2512733_note_7749
NonRel	Rec IVA [s1] OS [e1] for ciCSME exacerabation with observation .	Rec IVA OS for [s2] ciCSME [e2] exacerabation with observation .	laterality	lesion	T26	T12	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T1	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T2	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T3	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T4	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T27	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T29	T1	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T29	T2	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T29	T3	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T29	T4	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T29	T27	2512733_note_7749
NonRel	DFE with [s1] large [e1] subhyaloid hemorrhage that is slowly resolving and is removed from the central macula .	DFE with large [s2] subhyaloid hemorrhage [e2] that is slowly resolving and is removed from the central macula .	severity	lesion	T5	T4	note_3172
NonRel	1 ) Subhyaloid Hemorrhage [s1] OD [e1] ( Valsalva ) - Med hx significant for HTN , on metoprolol .	1 ) [s2] Subhyaloid Hemorrhage [e2] OD ( Valsalva ) - Med hx significant for HTN , on metoprolol .	laterality	lesion	T6	T3	note_3172
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 Return patient here today for eval of Valsalva induced SHH during exercise .	[s2] Subhyaloid hemorrhage [e2] of right eye H35.61 362.81 Return patient here today for eval of Valsalva induced SHH during exercise .	laterality	lesion	T7	T1	note_3172
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 Return patient here today for eval of Valsalva induced SHH during exercise .	Subhyaloid hemorrhage of right eye H35.61 362.81 Return patient here today for eval of Valsalva induced [s2] SHH [e2] during exercise .	laterality	lesion	T7	T2	note_3172
NonRel	Allergies : No Known Allergies Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc 20 / 50 + Tonometry ( Applanation , 8 : 44 AM ) Right Left Pressure 10 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Slit Lamp and Fundus Exam External Exam Right Left External Normal Slit Lamp Exam Right Left Lids / Lashes Mild Ptosis Conjunctiva / Sclera Injection , Pigmentation Cornea Clear Anterior Chamber Deep , Hyphema inferiorly , 3 - 4 + RBCs Iris Pharm dilated Lens Pigment deposits Fundus Exam Right Left Vitreous Mild hemorrhage Disc Normal Macula Normal Vessels Normal Periphery Subretinal hemorrhage superior to the nerve , [s1] scattered [e1] dbhs superior hemi - retina .	Allergies : No Known Allergies Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc 20 / 50 + Tonometry ( Applanation , 8 : 44 AM ) Right Left Pressure 10 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Slit Lamp and Fundus Exam External Exam Right Left External Normal Slit Lamp Exam Right Left Lids / Lashes Mild Ptosis Conjunctiva / Sclera Injection , Pigmentation Cornea Clear Anterior Chamber Deep , Hyphema inferiorly , 3 - 4 + RBCs Iris Pharm dilated Lens Pigment deposits Fundus Exam Right Left [s2] Vitreous Mild hemorrhage [e2] Disc Normal Macula Normal Vessels Normal Periphery Subretinal hemorrhage superior to the nerve , scattered dbhs superior hemi - retina .	severity	lesion	T4	T2	2253176_note_6203
NonRel	Allergies : No Known Allergies Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc 20 / 50 + Tonometry ( Applanation , 8 : 44 AM ) Right Left Pressure 10 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Slit Lamp and Fundus Exam External Exam Right Left External Normal Slit Lamp Exam Right Left Lids / Lashes Mild Ptosis Conjunctiva / Sclera Injection , Pigmentation Cornea Clear Anterior Chamber Deep , Hyphema inferiorly , 3 - 4 + RBCs Iris Pharm dilated Lens Pigment deposits Fundus Exam Right Left Vitreous Mild hemorrhage Disc Normal Macula Normal Vessels Normal Periphery Subretinal hemorrhage superior to the nerve , [s1] scattered [e1] dbhs superior hemi - retina .	Allergies : No Known Allergies Objective : Base Eye Exam Visual Acuity ( Snellen - Linear ) Right Left Dist sc 20 / 50 + Tonometry ( Applanation , 8 : 44 AM ) Right Left Pressure 10 Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Slit Lamp and Fundus Exam External Exam Right Left External Normal Slit Lamp Exam Right Left Lids / Lashes Mild Ptosis Conjunctiva / Sclera Injection , Pigmentation Cornea Clear Anterior Chamber Deep , Hyphema inferiorly , 3 - 4 + RBCs Iris Pharm dilated Lens Pigment deposits Fundus Exam Right Left Vitreous Mild hemorrhage Disc Normal Macula Normal Vessels Normal Periphery Subretinal hemorrhage superior to the nerve , scattered [s2] dbhs [e2] superior hemi - retina .	severity	lesion	T4	T3	2253176_note_6203
NonRel	[s1] OD [e1] - mild non proliferative diabetic retinopathy OS - Retinal detachment s / p repair RTC : 2 weeks Valentina Lozano , MD participated in the care of this patient .	OD - mild [s2] non proliferative diabetic retinopathy [e2] OS - Retinal detachment s / p repair RTC : 2 weeks Valentina Lozano , MD participated in the care of this patient .	laterality	lesion	T1	T4	note_8649
NonRel	OD - [s1] mild [e1] non proliferative diabetic retinopathy OS - Retinal detachment s / p repair RTC : 2 weeks Valentina Lozano , MD participated in the care of this patient .	OD - mild [s2] non proliferative diabetic retinopathy [e2] OS - Retinal detachment s / p repair RTC : 2 weeks Valentina Lozano , MD participated in the care of this patient .	severity	lesion	T2	T4	note_8649
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : [s1] CSME [e1] , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T1	T8	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , [s1] exudates [e1] OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T2	T8	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : [s1] IRF [e1] with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T3	T8	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into fovea , [s1] exudates [e1] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T4	T8	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T17	T5	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T17	T6	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T18	T5	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T18	T6	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - [s1] Severe [e1] NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) [s2] NPDR [e2] OU OD - Severe NPDR with ciCSME .	severity	lesion	T19	T9	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - [s1] Severe [e1] NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe [s2] NPDR [e2] OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	severity	lesion	T19	T10	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - [s1] Severe [e1] NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T19	T11	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - [s1] Severe [e1] NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T19	T12	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T20	T1	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , [s2] exudates [e2] OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T20	T2	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : [s2] IRF [e2] with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T20	T3	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into fovea , [s2] exudates [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T20	T4	1036182_note_1786
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	severity	lesion	T21	T7	1036182_note_1786
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	laterality	lesion	T22	T7	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - [s1] Severe [e1] NPDR OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) [s2] NPDR [e2] OU OD - Severe NPDR with ciCSME .	severity	lesion	T23	T9	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - [s1] Severe [e1] NPDR OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe [s2] NPDR [e2] OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	severity	lesion	T23	T10	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - [s1] Severe [e1] NPDR OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T23	T11	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - [s1] Severe [e1] NPDR OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T23	T12	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR [s1] OU [e1] 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) [s2] NPDR [e2] OU OD - Severe NPDR with ciCSME .	laterality	lesion	T24	T9	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR [s1] OU [e1] 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe [s2] NPDR [e2] OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	laterality	lesion	T24	T10	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR [s1] OU [e1] 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T24	T11	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR [s1] OU [e1] 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T24	T12	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR [s1] OU [e1] OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) [s2] NPDR [e2] OU OD - Severe NPDR with ciCSME .	laterality	lesion	T25	T9	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR [s1] OU [e1] OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe [s2] NPDR [e2] OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	laterality	lesion	T25	T10	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR [s1] OU [e1] OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T25	T11	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR [s1] OU [e1] OD - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T25	T12	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU [s1] OD [e1] - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) [s2] NPDR [e2] OU OD - Severe NPDR with ciCSME .	laterality	lesion	T26	T9	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU [s1] OD [e1] - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe [s2] NPDR [e2] OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	laterality	lesion	T26	T10	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU [s1] OD [e1] - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T26	T11	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU [s1] OD [e1] - Severe NPDR with ciCSME .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T26	T12	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	severity	lesion	T27	T13	1036182_note_1786
NonRel	OS - [s1] Severe [e1] NPDR with nciCSME .	OS - Severe [s2] NPDR [e2] with nciCSME .	severity	lesion	T28	T14	1036182_note_1786
NonRel	OS - [s1] Severe [e1] NPDR with nciCSME .	OS - Severe NPDR with [s2] nciCSME [e2] .	severity	lesion	T28	T15	1036182_note_1786
NonRel	[s1] OS [e1] - Severe NPDR with nciCSME .	OS - Severe [s2] NPDR [e2] with nciCSME .	laterality	lesion	T29	T14	1036182_note_1786
NonRel	[s1] OS [e1] - Severe NPDR with nciCSME .	OS - Severe NPDR with [s2] nciCSME [e2] .	laterality	lesion	T29	T15	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T30	T1	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , [s2] exudates [e2] OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T30	T2	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : [s2] IRF [e2] with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T30	T3	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into fovea , [s2] exudates [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T30	T4	1036182_note_1786
NonRel	Posterior subcapsular polar age - related cataract of right eye - Both Eyes H25.041 366.14 Return patient hx of [s1] Severe [e1] NPDR with CSME here for three month follow up visit .	Posterior subcapsular polar age - related cataract of right eye - Both Eyes H25.041 366.14 Return patient hx of Severe NPDR with [s2] CSME [e2] here for three month follow up visit .	severity	lesion	T31	T32	1036182_note_1786
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally [s1] OS [e1] - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no [s2] NVI [e2] Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T4	T1	note_7843
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally [s1] OS [e1] - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with [s2] macular [e2] exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T4	T2	note_7843
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally [s1] OS [e1] - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular [s2] exudates [e2] centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T4	T3	note_7843
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally [s1] OS [e1] - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central [s2] exudates [e2] , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T4	T6	note_7843
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT [s1] OD [e1] with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no [s2] NVI [e2] Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T5	T1	note_7843
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT [s1] OD [e1] with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with [s2] macular [e2] exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T5	T2	note_7843
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT [s1] OD [e1] with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular [s2] exudates [e2] centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T5	T3	note_7843
NonRel	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT [s1] OD [e1] with atrophy and central exudates , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	1 . Ophthalmic Artery Occlusion OD VA Bare LP OD today Brisk APD OD IOP 14 AC quiet / unremarkable , no NVI Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph 20 / 25 , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central [s2] exudates [e2] , resolving inner layer edema , OS normal Plan Emphasized Monocular precautions Recommended polycarbonate glasses in future Extensive discussion with patient regarding permanent vision loss in right eye .	laterality	lesion	T5	T6	note_7843
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T7	T1	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T7	T2	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T8	T3	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T8	T4	note_4013
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	[s2] Vitreous hemorrhage [e2] , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T9	T5	note_4013
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T9	T6	note_4013
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T9	T10	note_4013
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	[s2] Vitreous hemorrhage [e2] , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T11	T5	note_4013
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T11	T6	note_4013
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T11	T10	note_4013
NonRel	Exudative age - related macular degeneration - [s1] Left Eye [e1] H35.3290 362.52 3 .	[s2] Exudative [e2] age - related macular degeneration - Left Eye H35.3290 362.52 3 .	laterality	lesion	T5	T1	note_7183
NonRel	1 ) ARMD OU ( Nonexudative OD , Exudative [s1] OS [e1] s / p PPV for SMH ) OD - stable on exam .	1 ) ARMD OU ( Nonexudative OD , [s2] Exudative [e2] OS s / p PPV for SMH ) OD - stable on exam .	laterality	lesion	T6	T2	note_7183
NonRel	DM type 2 with residual ( old ) diabetic retinopathy signs [s1] OU [e1] - Optic nerve pallor noticed on previous exam OU - PRP 360 , each eye ( likely causing mild ONH pallor ) - pt edu on condition and importance of good BS control , healthy diet , and exercise , along with regular follow ups with PCP - suggested A1C below 7 ( currently 9.0 in 10 / 2015 ) - continue care with PCP and current medications ( will notify PCP of todays exam findings ) * suggested annual eye exam with DFE 3 .	DM type 2 with residual ( old ) [s2] diabetic retinopathy [e2] signs OU - Optic nerve pallor noticed on previous exam OU - PRP 360 , each eye ( likely causing mild ONH pallor ) - pt edu on condition and importance of good BS control , healthy diet , and exercise , along with regular follow ups with PCP - suggested A1C below 7 ( currently 9.0 in 10 / 2015 ) - continue care with PCP and current medications ( will notify PCP of todays exam findings ) * suggested annual eye exam with DFE 3 .	laterality	lesion	T3	T1	note_433
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , [s1] small [e1] intraretinal hemorrhage noted OD lv but not present on exam today .	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , small [s2] intraretinal hemorrhage [e2] noted OD lv but not present on exam today .	laterality	lesion	T1	T2	342322_note_924
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , small intraretinal hemorrhage noted [s1] OD [e1] lv but not present on exam today .	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , small [s2] intraretinal hemorrhage [e2] noted OD lv but not present on exam today .	laterality	lesion	T7	T2	342322_note_924
NonRel	Horseshoe tear of retina of right eye without detachment H33.311 361.32 OPH - OD Prophylaxis of Retinal Detachment , Laser Biochemistry professor at UFCOM Treatment History Laser Retinopexy OD ( to complete barrier ) - 5 / 24 / 18 ( today ) Laser Retinopexy OD - 4 / 10 / 18 1 ) Retinal Horseshoe Tear ( HST ) [s1] OD [e1] with vitreous hemorrhage - S / P laser retinopexy 4 / 10 / 18 , scars matured and well surrounding tear - VA excellent , no subretinal fluid surrouding lesion - Mac OCT unremarkable RTC 6 weeks ( or when returns of travel ) with DFE OD Andres Gonzalez , MD participated in the care of this patient .	Horseshoe tear of retina of right eye without detachment H33.311 361.32 OPH - OD Prophylaxis of Retinal Detachment , Laser Biochemistry professor at UFCOM Treatment History Laser Retinopexy OD ( to complete barrier ) - 5 / 24 / 18 ( today ) Laser Retinopexy OD - 4 / 10 / 18 1 ) Retinal Horseshoe Tear ( HST ) OD with [s2] vitreous hemorrhage [e2] - S / P laser retinopexy 4 / 10 / 18 , scars matured and well surrounding tear - VA excellent , no subretinal fluid surrouding lesion - Mac OCT unremarkable RTC 6 weeks ( or when returns of travel ) with DFE OD Andres Gonzalez , MD participated in the care of this patient .	laterality	lesion	T1	T2	note_1729
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	laterality	lesion	T13	T1	1305452_note_2916
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	laterality	lesion	T13	T2	1305452_note_2916
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe [s2] NPDR [e2] without CSME .	laterality	lesion	T13	T3	1305452_note_2916
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without [s2] CSME [e2] .	laterality	lesion	T13	T4	1305452_note_2916
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	severity	lesion	T14	T1	1305452_note_2916
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	severity	lesion	T14	T2	1305452_note_2916
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe [s2] NPDR [e2] without CSME .	severity	lesion	T14	T3	1305452_note_2916
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without [s2] CSME [e2] .	severity	lesion	T14	T4	1305452_note_2916
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of [s1] Severe [e1] NPDR without CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	severity	lesion	T15	T1	1305452_note_2916
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of [s1] Severe [e1] NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without CSME .	severity	lesion	T15	T2	1305452_note_2916
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of [s1] Severe [e1] NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe [s2] NPDR [e2] without CSME .	severity	lesion	T15	T3	1305452_note_2916
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of [s1] Severe [e1] NPDR without CSME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Return patient hx of Severe NPDR without [s2] CSME [e2] .	severity	lesion	T15	T4	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Treatment Hx : IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	severity	lesion	T16	T5	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Treatment Hx : IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	laterality	lesion	T17	T5	1305452_note_2916
NonRel	[s1] Severe [e1] NPDR without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe [s2] NPDR [e2] without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T18	T6	1305452_note_2916
NonRel	[s1] Severe [e1] NPDR without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without [s2] CSME [e2] OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T18	T7	1305452_note_2916
NonRel	[s1] Severe [e1] NPDR without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of [s2] MA [e2] in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T18	T8	1305452_note_2916
NonRel	[s1] Severe [e1] NPDR without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with [s2] DBH [e2] and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T18	T9	1305452_note_2916
NonRel	[s1] Severe [e1] NPDR without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with DBH and [s2] exudates [e2] throughout macula and periphery , vision still excellent .	severity	lesion	T18	T10	1305452_note_2916
NonRel	Severe NPDR without CSME [s1] OU [e1] OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe [s2] NPDR [e2] without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T19	T6	1305452_note_2916
NonRel	Severe NPDR without CSME [s1] OU [e1] OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without [s2] CSME [e2] OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T19	T7	1305452_note_2916
NonRel	Severe NPDR without CSME [s1] OU [e1] OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of [s2] MA [e2] in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T19	T8	1305452_note_2916
NonRel	Severe NPDR without CSME [s1] OU [e1] OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with [s2] DBH [e2] and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T19	T9	1305452_note_2916
NonRel	Severe NPDR without CSME [s1] OU [e1] OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with DBH and [s2] exudates [e2] throughout macula and periphery , vision still excellent .	laterality	lesion	T19	T10	1305452_note_2916
NonRel	Severe NPDR without CSME OU [s1] OD [e1] - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe [s2] NPDR [e2] without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T20	T6	1305452_note_2916
NonRel	Severe NPDR without CSME OU [s1] OD [e1] - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without [s2] CSME [e2] OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T20	T7	1305452_note_2916
NonRel	Severe NPDR without CSME OU [s1] OD [e1] - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of [s2] MA [e2] in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T20	T8	1305452_note_2916
NonRel	Severe NPDR without CSME OU [s1] OD [e1] - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with [s2] DBH [e2] and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T20	T9	1305452_note_2916
NonRel	Severe NPDR without CSME OU [s1] OD [e1] - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with DBH and [s2] exudates [e2] throughout macula and periphery , vision still excellent .	laterality	lesion	T20	T10	1305452_note_2916
NonRel	OCT , Posterior Segment - OU - Both Eyes See note OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : CSME Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes See note OPH - OD Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op [s2] DX : CSME [e2] Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T13	T12	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T14	T1	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T14	T2	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T15	T1	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T15	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T16	T4	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T16	T5	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T16	T8	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T16	T9	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T16	T28	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T16	T30	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T17	T4	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T17	T5	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T17	T8	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T17	T9	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T17	T28	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T17	T30	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T18	T4	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T18	T5	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T18	T8	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T18	T9	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T18	T28	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T18	T30	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T19	T4	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T19	T5	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T8	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T9	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T28	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T30	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T20	T4	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T20	T5	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T8	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T9	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T28	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T30	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T21	T4	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T21	T5	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T8	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T9	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T28	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T30	2487564_note_7561
NonRel	Today with a [s1] mild [e1] decrease in ME .	Today with a mild decrease in [s2] ME [e2] .	severity	lesion	T22	T3	2487564_note_7561
NonRel	[s1] OS [e1] - PDR now s / p PRP .	OS - [s2] PDR [e2] now s / p PRP .	laterality	lesion	T23	T7	2487564_note_7561
NonRel	[s1] Mild [e1] increase in ME , but given atrophic appearance will observe .	Mild increase in [s2] ME [e2] , but given atrophic appearance will observe .	severity	lesion	T24	T6	2487564_note_7561
NonRel	2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with [s1] mild [e1] ME ( interval increase ) today .	2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with mild [s2] ME [e2] ( interval increase ) today .	severity	lesion	T25	T11	2487564_note_7561
NonRel	2 ) Macular Atrophy [s1] OS [e1] - + subjective APD , OCT confirms atrophic macula with mild ME ( interval increase ) today .	2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with mild [s2] ME [e2] ( interval increase ) today .	laterality	lesion	T26	T11	2487564_note_7561
NonRel	NAME , MD IVFA from DATE showing [s1] mild [e1] NVE along superior and inferior arcade	NAME , MD IVFA from DATE showing mild [s2] NVE [e2] along superior and inferior arcade	severity	lesion	T27	T10	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T29	T4	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T29	T5	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T29	T8	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T29	T9	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T29	T28	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T29	T30	2487564_note_7561
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) OS - now well surrounded by laser as noted above .	Mild [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) OS - now well surrounded by laser as noted above .	severity	lesion	T1	T2	note_6519
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) OS - now well surrounded by laser as noted above .	Mild nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) OS - now well surrounded by laser as noted above .	severity	lesion	T1	T3	note_6519
NonRel	2 ) DM - [s1] mild [e1] NPDR OU without CSME .	2 ) DM - mild [s2] NPDR [e2] OU without CSME .	severity	lesion	T4	T5	note_6519
NonRel	2 ) DM - [s1] mild [e1] NPDR OU without CSME .	2 ) DM - mild NPDR OU without [s2] CSME [e2] .	severity	lesion	T4	T7	note_6519
NonRel	2 ) DM - mild NPDR [s1] OU [e1] without CSME .	2 ) DM - mild [s2] NPDR [e2] OU without CSME .	laterality	lesion	T6	T5	note_6519
NonRel	2 ) DM - mild NPDR [s1] OU [e1] without CSME .	2 ) DM - mild NPDR OU without [s2] CSME [e2] .	laterality	lesion	T6	T7	note_6519
NonRel	Mild nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) [s1] OS [e1] - now well surrounded by laser as noted above .	Mild [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) OS - now well surrounded by laser as noted above .	laterality	lesion	T8	T2	note_6519
NonRel	Mild nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) [s1] OS [e1] - now well surrounded by laser as noted above .	Mild nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3299 250.50 362.04 Attending Note : Treatment Hx : Laser Retinopexy OS ( HST x 3 ) - 8 / 16 / 16 1 ) Retinal Tears ( HST x 3 ) OS - now well surrounded by laser as noted above .	laterality	lesion	T8	T3	note_6519
NonRel	Horseshoe retinal tear of right eye H33.311 361.32 OPH - OD Pneumatic Retinopexy Treatment Hx : Laser Retinopexy OD ( enhancement ) - 8 / 22 / 17 ( today ) Laser Retinopexy OD - 8 / 17 / 17 1 ) HST [s1] OD [e1] - ST with surrounding SRF .	Horseshoe retinal tear of right eye H33.311 361.32 OPH - OD Pneumatic Retinopexy Treatment Hx : Laser Retinopexy OD ( enhancement ) - 8 / 22 / 17 ( today ) Laser Retinopexy OD - 8 / 17 / 17 1 ) HST OD - ST with surrounding [s2] SRF [e2] .	laterality	lesion	T2	T3	note_1744
NonRel	2 ) LD OS - temporally with PVD present but given the hx of HST + SRF [s1] OD [e1] will likely consider laser prophylaxis OS at later date .	2 ) LD OS - temporally with PVD present but given the hx of HST + [s2] SRF [e2] OD will likely consider laser prophylaxis OS at later date .	laterality	lesion	T1	T7	note_1744
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy , without macular edema , associated with type 2 diabetes mellitus - Both Eyes E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] , without macular edema , associated with type 2 diabetes mellitus - Both Eyes E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T1	T2	note_1763
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy , without macular edema , associated with type 2 diabetes mellitus - Both Eyes E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy , without [s2] macular edema [e2] , associated with type 2 diabetes mellitus - Both Eyes E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T1	T3	note_1763
NonRel	Moderate nonproliferative diabetic retinopathy , without macular edema , associated with type 2 diabetes mellitus - [s1] Both Eyes [e1] E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] , without macular edema , associated with type 2 diabetes mellitus - Both Eyes E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T4	T2	note_1763
NonRel	Moderate nonproliferative diabetic retinopathy , without macular edema , associated with type 2 diabetes mellitus - [s1] Both Eyes [e1] E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy , without [s2] macular edema [e2] , associated with type 2 diabetes mellitus - Both Eyes E11.339 250.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T4	T3	note_1763
NonRel	DME ( diabetic macular edema ) - [s1] Left Eye [e1] E11.311 250.50 362.07 362.01 4 .	[s2] DME [e2] ( diabetic macular edema ) - Left Eye E11.311 250.50 362.07 362.01 4 .	laterality	lesion	T6	T5	note_1763
NonRel	DME ( diabetic macular edema ) - [s1] Left Eye [e1] E11.311 250.50 362.07 362.01 4 .	DME ( [s2] diabetic macular edema [e2] ) - Left Eye E11.311 250.50 362.07 362.01 4 .	laterality	lesion	T6	T7	note_1763
NonRel	Trace juxtafoveal DME [s1] OS [e1] - monitor 4 .	Trace juxtafoveal [s2] DME [e2] OS - monitor 4 .	laterality	lesion	T9	T8	note_1763
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s1] neovascularization [e1] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T1	T2	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s1] neovascularization [e1] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T1	T4	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s1] neovascularization [e1] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T1	T7	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s1] neovascularization [e1] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T1	T8	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T3	T2	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T3	T4	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T3	T7	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T3	T8	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T5	T2	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T5	T4	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T5	T7	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T5	T8	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T6	T2	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T6	T4	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T6	T7	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s1] neovascularization [e1] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T6	T8	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T9	T2	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T9	T4	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T9	T7	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s1] hemorrhage [e1] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T9	T8	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s2] neovascularization [e2] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T13	T1	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T13	T3	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T13	T5	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T13	T6	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T13	T9	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s2] neovascularization [e2] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T14	T1	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T14	T3	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T14	T5	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T14	T6	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T14	T9	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s2] neovascularization [e2] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T15	T1	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T15	T3	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T15	T5	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T15	T6	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T15	T9	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T16	T10	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T16	T11	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye [s1] Severe [e1] proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye Severe [s2] proliferative diabetic retinopathy [e2] with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	severity	lesion	T17	T12	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - [s1] Left Eye [e1] Severe proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye Severe [s2] proliferative diabetic retinopathy [e2] with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	laterality	lesion	T18	T12	2482683_note_7206
NonRel	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular [s1] exudates [e1] centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with [s2] macular [e2] exudates centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	lesion	eye_part	T2	T1	2516991_note_7841
NonRel	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central [s1] exudates [e1] , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with [s2] macular [e2] exudates centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	lesion	eye_part	T3	T1	2516991_note_7841
NonRel	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally [s1] OS [e1] - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular [s2] exudates [e2] centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	laterality	lesion	T4	T2	2516991_note_7841
NonRel	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally [s1] OS [e1] - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central [s2] exudates [e2] , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	laterality	lesion	T4	T3	2516991_note_7841
NonRel	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT [s1] OD [e1] with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular [s2] exudates [e2] centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	laterality	lesion	T5	T2	2516991_note_7841
NonRel	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT [s1] OD [e1] with atrophy and central exudates , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	VA NLP OD today Brisk APD OD IOP 13 AC quiet / unremarkable Optic nerve with pallor but no edema Retina atrophic with macular exudates centrally OS - VA 20 / 40 , ph DATE , Exam normal and healthy , retina flat but with lattice degeneration STQ Macula OCT OD with atrophy and central [s2] exudates [e2] , OS normal IVFA OD with delayed patchy choroidal filling and delayed arterial filling , A - V transit time .	laterality	lesion	T5	T3	2516991_note_7841
NonRel	Hx of PDR OU , s / p PRP OU [s1] Quiescent [e1] PDR ( without edema ) on last exam .	Hx of PDR OU , s / p PRP OU Quiescent [s2] PDR [e2] ( without edema ) on last exam .	severity	lesion	T3	T1	note_303
NonRel	Hx of PDR OU , s / p PRP OU [s1] Quiescent [e1] PDR ( without edema ) on last exam .	Hx of PDR OU , s / p PRP OU Quiescent PDR ( without [s2] edema [e2] ) on last exam .	severity	lesion	T3	T2	note_303
NonRel	Hx of PDR OU , s / p PRP OU [s1] Quiescent [e1] PDR ( without edema ) on last exam .	Hx of [s2] PDR [e2] OU , s / p PRP OU Quiescent PDR ( without edema ) on last exam .	severity	lesion	T3	T6	note_303
NonRel	Hx of PDR OU , s / p PRP [s1] OU [e1] Quiescent PDR ( without edema ) on last exam .	Hx of PDR OU , s / p PRP OU Quiescent [s2] PDR [e2] ( without edema ) on last exam .	laterality	lesion	T4	T1	note_303
NonRel	Hx of PDR OU , s / p PRP [s1] OU [e1] Quiescent PDR ( without edema ) on last exam .	Hx of PDR OU , s / p PRP OU Quiescent PDR ( without [s2] edema [e2] ) on last exam .	laterality	lesion	T4	T2	note_303
NonRel	Hx of PDR OU , s / p PRP [s1] OU [e1] Quiescent PDR ( without edema ) on last exam .	Hx of [s2] PDR [e2] OU , s / p PRP OU Quiescent PDR ( without edema ) on last exam .	laterality	lesion	T4	T6	note_303
NonRel	Hx of PDR [s1] OU [e1] , s / p PRP OU Quiescent PDR ( without edema ) on last exam .	Hx of PDR OU , s / p PRP OU Quiescent [s2] PDR [e2] ( without edema ) on last exam .	laterality	lesion	T5	T1	note_303
NonRel	Hx of PDR [s1] OU [e1] , s / p PRP OU Quiescent PDR ( without edema ) on last exam .	Hx of PDR OU , s / p PRP OU Quiescent PDR ( without [s2] edema [e2] ) on last exam .	laterality	lesion	T5	T2	note_303
NonRel	Hx of PDR [s1] OU [e1] , s / p PRP OU Quiescent PDR ( without edema ) on last exam .	Hx of [s2] PDR [e2] OU , s / p PRP OU Quiescent PDR ( without edema ) on last exam .	laterality	lesion	T5	T6	note_303
NonRel	BRVO ( branch retinal vein occlusion ) H34.8392 362.36 Fluorescein Angiography - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes 1 ) Chronic BRVO [s1] OD [e1] - Old vitreous hemorrhage inferiorly .	BRVO ( branch retinal vein occlusion ) H34.8392 362.36 Fluorescein Angiography - OU - Both Eyes OCT , Posterior Segment - OU - Both Eyes 1 ) Chronic BRVO OD - Old [s2] vitreous hemorrhage [e2] inferiorly .	laterality	lesion	T3	T2	85000419_note_9434
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T1	T2	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T1	T4	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T3	T2	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T3	T4	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T5	T6	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T5	T8	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	severity	lesion	T5	T9	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T7	T6	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T7	T8	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T7	T9	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	severity	lesion	T10	T11	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	severity	lesion	T10	T14	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	severity	lesion	T10	T16	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T12	T11	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T12	T14	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	laterality	lesion	T12	T16	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T13	T11	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T13	T14	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	laterality	lesion	T13	T16	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T15	T11	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T15	T14	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	laterality	lesion	T15	T16	note_3801
NonRel	All OCTs reviewed going back to first visit here , this is first scan with [s1] significant [e1] edema in OPL .	All OCTs reviewed going back to first visit here , this is first scan with significant [s2] edema [e2] in OPL .	severity	lesion	T17	T18	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T6	T1	note_2913
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T6	T2	note_2913
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T1	note_2913
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T2	note_2913
NonRel	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with [s1] scattered [e1] IRF and exudates .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered [s2] IRF [e2] and exudates .	severity	lesion	T8	T3	note_2913
NonRel	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with [s1] scattered [e1] IRF and exudates .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered IRF and [s2] exudates [e2] .	severity	lesion	T8	T4	note_2913
NonRel	Suspicious area ITQ OD on exam and OCT of ? [s1] early [e1] NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	Suspicious area ITQ OD on exam and OCT of ? early [s2] NVE [e2] - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	severity	lesion	T9	T5	note_2913
NonRel	Suspicious area ITQ [s1] OD [e1] on exam and OCT of ? early NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	Suspicious area ITQ OD on exam and OCT of ? early [s2] NVE [e2] - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	laterality	lesion	T10	T5	note_2913
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with mild nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with mild nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	laterality	lesion	T10	T2	1296962_note_2855
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with mild nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with mild nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	laterality	lesion	T10	T3	1296962_note_2855
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with mild nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with mild [s2] nonproliferative retinopathy [e2] E11.3211 250.50 362.07 362.04 8 .	laterality	lesion	T10	T4	1296962_note_2855
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] mild [e1] nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with mild nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	severity	lesion	T11	T2	1296962_note_2855
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] mild [e1] nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with mild nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	severity	lesion	T11	T3	1296962_note_2855
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] mild [e1] nonproliferative retinopathy E11.3211 250.50 362.07 362.04 8 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with mild [s2] nonproliferative retinopathy [e2] E11.3211 250.50 362.07 362.04 8 .	severity	lesion	T11	T4	1296962_note_2855
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	laterality	lesion	T6	T2	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	laterality	lesion	T6	T3	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T7	T4	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T7	T5	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	severity	lesion	T8	T2	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	severity	lesion	T8	T3	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T9	T4	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T9	T5	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - nciDME , stable .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	severity	lesion	T10	T1	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - nciDME , stable .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	severity	lesion	T10	T13	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - nciDME , stable .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	laterality	lesion	T11	T1	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - nciDME , stable .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	laterality	lesion	T11	T13	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - nciDME , stable .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	laterality	lesion	T12	T1	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - nciDME , stable .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	laterality	lesion	T12	T13	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - nciDME , [s1] stable [e1] .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	severity	lesion	T14	T1	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - nciDME , [s1] stable [e1] .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	severity	lesion	T14	T13	1590841_note_3799
NonRel	1 ) Maculopathy ( w / RPE loss ) - evidence of prior [s1] SRF [e1] , mild RPE attenuation .	1 ) [s2] Maculopathy [e2] ( w / RPE loss ) - evidence of prior SRF , mild RPE attenuation .	lesion	eye_part	T1	T2	1896876_note_5099
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 1 ) Subhyaloid Hemorrhage OD - Med hx significant for HTN , on metoprolol .	[s2] Subhyaloid hemorrhage [e2] of right eye H35.61 362.81 1 ) Subhyaloid Hemorrhage OD - Med hx significant for HTN , on metoprolol .	laterality	lesion	T2	T1	note_3174
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 1 ) Subhyaloid Hemorrhage OD - Med hx significant for HTN , on metoprolol .	Subhyaloid hemorrhage of right eye H35.61 362.81 1 ) [s2] Subhyaloid Hemorrhage [e2] OD - Med hx significant for HTN , on metoprolol .	laterality	lesion	T2	T3	note_3174
NonRel	DFE with [s1] large [e1] subhyaloid hemorrhage that ppears to be slowly resolving .	DFE with large [s2] subhyaloid hemorrhage [e2] that ppears to be slowly resolving .	severity	lesion	T4	T5	note_3174
NonRel	Subhyaloid hemorrhage of right eye H35.61 362.81 1 ) Subhyaloid Hemorrhage [s1] OD [e1] - Med hx significant for HTN , on metoprolol .	[s2] Subhyaloid hemorrhage [e2] of right eye H35.61 362.81 1 ) Subhyaloid Hemorrhage OD - Med hx significant for HTN , on metoprolol .	laterality	lesion	T6	T1	note_3174
NonRel	Subhyaloid hemorrhage of right eye H35.61 362.81 1 ) Subhyaloid Hemorrhage [s1] OD [e1] - Med hx significant for HTN , on metoprolol .	Subhyaloid hemorrhage of right eye H35.61 362.81 1 ) [s2] Subhyaloid Hemorrhage [e2] OD - Med hx significant for HTN , on metoprolol .	laterality	lesion	T6	T3	note_3174
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / [s1] OU [e1] , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem [s2] PDR [e2] with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T3	T1	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / [s1] OU [e1] , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with [s2] DME [e2] / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T3	T2	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / [s1] OU [e1] , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u [s2] PDR [e2] with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T3	T5	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / [s1] OU [e1] , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with [s2] DME [e2] / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T3	T6	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / [s1] OU [e1] Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem [s2] PDR [e2] with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T4	T1	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / [s1] OU [e1] Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with [s2] DME [e2] / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T4	T2	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / [s1] OU [e1] Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u [s2] PDR [e2] with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T4	T5	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / [s1] OU [e1] Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with [s2] DME [e2] / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T4	T6	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / [s1] OU [e1] , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem [s2] PDR [e2] with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T7	T1	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / [s1] OU [e1] , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with [s2] DME [e2] / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T7	T2	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / [s1] OU [e1] , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u [s2] PDR [e2] with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T7	T5	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / [s1] OU [e1] , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with [s2] DME [e2] / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T7	T6	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / [s1] OU [e1] , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem [s2] PDR [e2] with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T8	T1	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / [s1] OU [e1] , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with [s2] DME [e2] / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T8	T2	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / [s1] OU [e1] , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u [s2] PDR [e2] with DME / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T8	T5	note_4421
NonRel	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with DME / OU , TRD / [s1] OU [e1] , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	provider found Chief Complaint : Chief Complaint Patient presents with • Eye Problem PDR with DME / OU , TRD / OU Subjective : History of Present Illness : Edward Simon Ayer is a 36 y.o. male who is here today for f / u PDR with [s2] DME [e2] / OU , TRD / OU , patient states new floaters / OD yesterday , no flashes , no pain , vision had been stable prior to this .	laterality	lesion	T8	T6	note_4421
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT [s1] OD [e1] : dme OS : dme Assessment and Plan : 1 .	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : [s2] dme [e2] OS : dme Assessment and Plan : 1 .	laterality	lesion	T9	T10	note_4421
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT [s1] OD [e1] : dme OS : dme Assessment and Plan : 1 .	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : dme OS : [s2] dme [e2] Assessment and Plan : 1 .	laterality	lesion	T9	T12	note_4421
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : dme [s1] OS [e1] : dme Assessment and Plan : 1 .	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : [s2] dme [e2] OS : dme Assessment and Plan : 1 .	laterality	lesion	T11	T10	note_4421
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : dme [s1] OS [e1] : dme Assessment and Plan : 1 .	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : dme OS : [s2] dme [e2] Assessment and Plan : 1 .	laterality	lesion	T11	T12	note_4421
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	severity	lesion	T14	T15	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T18	T16	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T18	T17	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal [s1] OD [e1] , diffuse OS , refractory to avastin .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T19	T16	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal [s1] OD [e1] , diffuse OS , refractory to avastin .	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T19	T17	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse [s1] OS [e1] , refractory to avastin .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T20	T16	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse [s1] OS [e1] , refractory to avastin .	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T20	T17	note_4421
NonRel	Tight bs control Intravitreal Injection Pre - op DX : dme [s1] od [e1] Post - op DX : same Attending : Feistmann Anesthesia : Topical Lidocaine Procedure performed : Intravitreal injection of Avastin 1.25 mg / 0.05 ml OD Description of Procedure : Time out performed .	Tight bs control Intravitreal Injection Pre - op DX : [s2] dme [e2] od Post - op DX : same Attending : Feistmann Anesthesia : Topical Lidocaine Procedure performed : Intravitreal injection of Avastin 1.25 mg / 0.05 ml OD Description of Procedure : Time out performed .	laterality	lesion	T23	T22	note_4421
NonRel	Intravitreal Injection Pre - op DX : dme [s1] os [e1] Post - op DX : same Attending : Feistmann Anesthesia : Topical Lidocaine Procedure performed : Intravitreal injection of Avastin 1.25 mg / 0.05 ml OS Description of Procedure : Time out performed .	Intravitreal Injection Pre - op DX : [s2] dme [e2] os Post - op DX : same Attending : Feistmann Anesthesia : Topical Lidocaine Procedure performed : Intravitreal injection of Avastin 1.25 mg / 0.05 ml OS Description of Procedure : Time out performed .	laterality	lesion	T25	T24	note_4421
NonRel	2 ) PDR - inactive , good prp Repeat IVA [s1] OU [e1] done today .	2 ) [s2] PDR [e2] - inactive , good prp Repeat IVA OU done today .	laterality	lesion	T26	T21	note_4421
NonRel	Horseshoe retinal tear of [s1] right eye [e1] : Supero - temporal quadrant horshoe tear with surrounding SRF .	Horseshoe retinal tear of right eye : Supero - temporal quadrant horshoe tear with surrounding [s2] SRF [e2] .	laterality	lesion	T2	T1	note_1742
NonRel	3 ) Choroidal Nevus [s1] OD [e1] - without high risk characteristics : SRF , orange pigment or elevation or change in size .	3 ) Choroidal Nevus OD - without high risk characteristics : [s2] SRF [e2] , orange pigment or elevation or change in size .	laterality	lesion	T4	T3	1230653_note_2636
NonRel	OCT [s1] OS [e1] today with formation of outer retinal tubulations not seen 5 / 2017 consistent with likely progression of dry AMD but without conversion to IRF / SRF .	OCT OS today with formation of outer retinal tubulations not seen 5 / 2017 consistent with likely progression of dry AMD but without conversion to [s2] IRF [e2] / SRF .	laterality	lesion	T5	T1	1230653_note_2636
NonRel	OCT [s1] OS [e1] today with formation of outer retinal tubulations not seen 5 / 2017 consistent with likely progression of dry AMD but without conversion to IRF / SRF .	OCT OS today with formation of outer retinal tubulations not seen 5 / 2017 consistent with likely progression of dry AMD but without conversion to IRF / [s2] SRF [e2] .	laterality	lesion	T5	T2	1230653_note_2636
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	laterality	lesion	T2	T1	note_9154
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	laterality	lesion	T2	T3	note_9154
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe [s2] NPDR [e2] OS .	laterality	lesion	T2	T5	note_9154
NonRel	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and [s1] Severe [e1] NPDR OS .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	severity	lesion	T4	T1	note_9154
NonRel	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and [s1] Severe [e1] NPDR OS .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	severity	lesion	T4	T3	note_9154
NonRel	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and [s1] Severe [e1] NPDR OS .	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe [s2] NPDR [e2] OS .	severity	lesion	T4	T5	note_9154
NonRel	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR [s1] OS [e1] .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	laterality	lesion	T6	T1	note_9154
NonRel	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR [s1] OS [e1] .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR OS .	laterality	lesion	T6	T3	note_9154
NonRel	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe NPDR [s1] OS [e1] .	Proliferative diabetic retinopathy of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 Hx of VH OD , and Severe [s2] NPDR [e2] OS .	laterality	lesion	T6	T5	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T7	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T10	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T13	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T15	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T18	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T19	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T21	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T22	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T23	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T24	note_9154
NonRel	Hx of PDR [s1] OD [e1] , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T8	T25	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T7	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T10	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T13	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T15	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T18	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T19	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T21	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T22	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T23	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T24	note_9154
NonRel	Hx of PDR OD , [s1] Severe [e1] NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T9	T25	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T7	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T10	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T13	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T15	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T18	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T19	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T21	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T22	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T23	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T24	note_9154
NonRel	Hx of PDR OD , Severe NPDR [s1] OS [e1] OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T11	T25	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T7	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T10	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T13	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T15	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T18	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T19	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T21	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T22	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T23	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T24	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS [s1] OD [e1] - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T12	T25	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T7	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T10	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T13	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T15	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T18	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T19	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T21	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T22	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T23	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T24	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T14	T25	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T7	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T10	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T13	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T15	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T18	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T19	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T21	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T22	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T23	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T24	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP [s1] OS [e1] - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T16	T25	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T7	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T10	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T13	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T15	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T18	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T19	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T21	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T22	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T23	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T24	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - [s1] Severe [e1] NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	severity	lesion	T17	T25	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of [s2] PDR [e2] OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T7	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe [s2] NPDR [e2] OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T10	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T13	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - [s2] Vit heme [e2] mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T15	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe [s2] NPDR [e2] with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T18	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with [s2] macular edema [e2] OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T19	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - [s2] DBH [e2] and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T21	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and [s2] MAs [e2] in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T22	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - [s2] Venous beading [e2] in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T23	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T24	note_9154
NonRel	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema [s1] OS [e1] - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	Hx of PDR OD , Severe NPDR OS OD - Vitreous hemorrhage OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - VA 20 / 25 , IOP 19 - Vit heme mostly resolved , no tears / detachment - Inadequate PRP OS - Severe NPDR with macular edema OS - DBH and MAs in posterior pole - VA 20 / 25 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient .	laterality	lesion	T20	T25	note_9154
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Valentina Lozano , MD participated in the care of this patient .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Valentina Lozano , MD participated in the care of this patient .	laterality	lesion	T2	T1	note_5885
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Valentina Lozano , MD participated in the care of this patient .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Valentina Lozano , MD participated in the care of this patient .	laterality	lesion	T2	T3	note_5885
NonRel	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior SRF , [s1] mild [e1] RPE attenuation .	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior [s2] SRF [e2] , mild RPE attenuation .	severity	lesion	T3	T2	note_5103
NonRel	Macular atrophy , retinal - Left Eye H35.89 362.51 OCT , Retina - OU - Both Eyes No [s1] significant [e1] PMH , no hx of steroid usage .	Macular atrophy , retinal - Left Eye H35.89 362.51 OCT , Retina - OU - Both Eyes No significant [s2] PMH [e2] , no hx of steroid usage .	severity	lesion	T5	T1	note_5103
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T9	T1	2487716_note_7588
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T9	T2	2487716_note_7588
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T9	T3	2487716_note_7588
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T9	T4	2487716_note_7588
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T9	T5	2487716_note_7588
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T9	T6	2487716_note_7588
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T9	T7	2487716_note_7588
NonRel	Mac OCT OU : [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T9	T8	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T10	T1	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T10	T2	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T10	T3	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T10	T4	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T10	T5	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T10	T6	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T10	T7	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T10	T8	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T11	T1	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T11	T2	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T11	T3	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T11	T4	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T11	T5	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T11	T6	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T11	T7	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T11	T8	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T12	T1	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T12	T2	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T12	T3	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T12	T4	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no [s2] IRF [e2] / SRF OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T12	T5	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / [s2] SRF [e2] OS : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T12	T6	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T12	T7	2487716_note_7588
NonRel	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF [s1] OS [e1] : blunted foveal contour , no IRF / SRF NAME , MD participated in the care of this patient .	Mac OCT OU : OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / SRF RTC in 1 week OCT , Posterior Segment - OU - Both Eyes OD : disruption of all retinal layers , loss of foveal contour , no IRF / SRF OS : blunted foveal contour , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T12	T8	2487716_note_7588
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T17	T1	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T17	T2	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T17	T3	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T17	T4	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T17	T5	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T1	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T2	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T3	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T4	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T18	T5	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T19	T1	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T19	T2	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T19	T3	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T19	T4	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T19	T5	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T1	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T2	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T3	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T4	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T5	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T1	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T2	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T3	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T4	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T5	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T1	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T2	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T3	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T4	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T5	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T1	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T2	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T3	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T4	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T5	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T24	T6	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T24	T8	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T24	T9	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T24	T10	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T24	T11	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T24	T29	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T25	T6	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T25	T8	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T25	T9	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T25	T10	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T25	T11	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T25	T29	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T6	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T8	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T9	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T7	T10	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T7	T11	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T7	T29	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T26	T6	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T26	T8	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T26	T9	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T26	T10	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T26	T11	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T26	T29	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T27	T6	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T27	T8	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T27	T9	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T27	T10	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T27	T11	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T27	T29	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T6	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T8	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T9	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T28	T10	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T28	T11	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T29	note_7750
NonRel	Monitor OS - [s1] Severe [e1] NPDR with ciCSME .	Monitor OS - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T30	T12	note_7750
NonRel	Monitor OS - [s1] Severe [e1] NPDR with ciCSME .	Monitor OS - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T30	T13	note_7750
NonRel	Monitor [s1] OS [e1] - Severe NPDR with ciCSME .	Monitor OS - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T31	T12	note_7750
NonRel	Monitor [s1] OS [e1] - Severe NPDR with ciCSME .	Monitor OS - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T31	T13	note_7750
NonRel	[s1] OD [e1] - VMA w / small temp pocket of IRF and few exudates OS - large intraretinal cystic pockets foveally and temporally ; stable Gavin Reed , MD . participated in the care of this patient .	OD - VMA w / small temp pocket of [s2] IRF [e2] and few exudates OS - large intraretinal cystic pockets foveally and temporally ; stable Gavin Reed , MD . participated in the care of this patient .	laterality	lesion	T14	T15	note_7750
NonRel	[s1] OD [e1] - VMA w / small temp pocket of IRF and few exudates OS - large intraretinal cystic pockets foveally and temporally ; stable Gavin Reed , MD . participated in the care of this patient .	OD - VMA w / small temp pocket of IRF and few [s2] exudates [e2] OS - large intraretinal cystic pockets foveally and temporally ; stable Gavin Reed , MD . participated in the care of this patient .	laterality	lesion	T14	T16	note_7750
NonRel	Cystoid macular edema , [s1] left eye [e1] H35.352 362.53 2 .	[s2] Cystoid macular edema [e2] , left eye H35.352 362.53 2 .	laterality	lesion	T2	T1	1816965_note_4518
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	laterality	lesion	T6	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active [s2] PDR [e2] .	laterality	lesion	T7	T2	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - Active PDR .	laterality	lesion	T7	T8	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	laterality	lesion	T7	T13	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active [s2] PDR [e2] .	laterality	lesion	T9	T2	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - Active PDR .	laterality	lesion	T9	T8	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	laterality	lesion	T9	T13	note_8730
NonRel	[s1] OS [e1] - Active PDR .	OS - Active [s2] PDR [e2] .	laterality	lesion	T10	T5	note_8730
NonRel	OS - [s1] Active [e1] PDR .	OS - Active [s2] PDR [e2] .	severity	lesion	T11	T5	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active [s2] PDR [e2] .	severity	lesion	T12	T2	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - Active PDR .	severity	lesion	T12	T8	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	severity	lesion	T12	T13	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active [s2] PDR [e2] .	laterality	lesion	T14	T2	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - Active PDR .	laterality	lesion	T14	T8	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	laterality	lesion	T14	T13	note_8730
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T5	T1	note_3664
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.07 362.02 2 .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T5	T2	note_3664
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 3 .	[s2] Subhyaloid hemorrhage [e2] of right eye H35.61 362.81 3 .	laterality	lesion	T6	T3	note_3664
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - OU - Both Eyes 362.04 362.07 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - OU - Both Eyes 362.04 362.07 2 .	laterality	lesion	T15	T1	20773_note_35
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - OU - Both Eyes 362.04 362.07 2 .	Mild nonproliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - OU - Both Eyes 362.04 362.07 2 .	laterality	lesion	T15	T2	20773_note_35
NonRel	Mild nonproliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - [s1] OU [e1] - Both Eyes 362.04 362.07 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - OU - Both Eyes 362.04 362.07 2 .	laterality	lesion	T16	T1	20773_note_35
NonRel	Mild nonproliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - [s1] OU [e1] - Both Eyes 362.04 362.07 2 .	Mild nonproliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.321 250.50 OCT , Retina - OU - Both Eyes 362.04 362.07 2 .	laterality	lesion	T16	T2	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T17	T3	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T17	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T18	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T18	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	severity	lesion	T19	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	severity	lesion	T19	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T20	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T20	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T21	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T21	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	severity	lesion	T22	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	severity	lesion	T22	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	severity	lesion	T23	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	severity	lesion	T23	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	laterality	lesion	T24	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T24	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T5	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T6	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T7	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T8	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T9	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T10	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T11	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T12	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	severity	lesion	T25	T13	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	severity	lesion	T25	T14	20773_note_35
NonRel	Retinal hemorrhage of [s1] right eye [e1] H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal MAs OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	Retinal [s2] hemorrhage [e2] of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal MAs OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	laterality	lesion	T2	T1	note_469
NonRel	Retinal hemorrhage of [s1] right eye [e1] H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal MAs OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	Retinal hemorrhage of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal [s2] MAs [e2] OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	laterality	lesion	T2	T3	note_469
NonRel	2 ) DM - [s1] Mild [e1] NPDR OU ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild [s2] NPDR [e2] OU ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	severity	lesion	T4	T5	note_469
NonRel	2 ) DM - [s1] Mild [e1] NPDR OU ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild NPDR OU ( without [s2] ME [e2] either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	severity	lesion	T4	T7	note_469
NonRel	2 ) DM - [s1] Mild [e1] NPDR OU ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild NPDR OU ( without ME either eye ) - albeit with [s2] MAs [e2] in all four peripheral quadrants but a paucity of findings otherwise .	severity	lesion	T4	T9	note_469
NonRel	2 ) DM - Mild NPDR [s1] OU [e1] ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild [s2] NPDR [e2] OU ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	laterality	lesion	T6	T5	note_469
NonRel	2 ) DM - Mild NPDR [s1] OU [e1] ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild NPDR OU ( without [s2] ME [e2] either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	laterality	lesion	T6	T7	note_469
NonRel	2 ) DM - Mild NPDR [s1] OU [e1] ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild NPDR OU ( without ME either eye ) - albeit with [s2] MAs [e2] in all four peripheral quadrants but a paucity of findings otherwise .	laterality	lesion	T6	T9	note_469
NonRel	2 ) DM - Mild NPDR OU ( without ME [s1] either eye [e1] ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild [s2] NPDR [e2] OU ( without ME either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	laterality	lesion	T8	T5	note_469
NonRel	2 ) DM - Mild NPDR OU ( without ME [s1] either eye [e1] ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild NPDR OU ( without [s2] ME [e2] either eye ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	laterality	lesion	T8	T7	note_469
NonRel	2 ) DM - Mild NPDR OU ( without ME [s1] either eye [e1] ) - albeit with MAs in all four peripheral quadrants but a paucity of findings otherwise .	2 ) DM - Mild NPDR OU ( without ME either eye ) - albeit with [s2] MAs [e2] in all four peripheral quadrants but a paucity of findings otherwise .	laterality	lesion	T8	T9	note_469
NonRel	Retinal hemorrhage of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal MAs [s1] OU [e1] 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	Retinal [s2] hemorrhage [e2] of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal MAs OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	laterality	lesion	T10	T1	note_469
NonRel	Retinal hemorrhage of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal MAs [s1] OU [e1] 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	Retinal hemorrhage of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal [s2] MAs [e2] OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	laterality	lesion	T10	T3	note_469
NonRel	Retinal hemorrhage of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , [s1] temporal [e1] MAs OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	Retinal [s2] hemorrhage [e2] of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal MAs OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	severity	lesion	T11	T1	note_469
NonRel	Retinal hemorrhage of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , [s1] temporal [e1] MAs OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	Retinal hemorrhage of right eye H35.61 362.81 Fluorescein Angiography - OU - Both Eyes OCT , Retina - OU - Both Eyes Attending Note : IVFA ( today ) : without NV , or CNVM OD , wnl OS , temporal [s2] MAs [e2] OU 1 ) Mac Tel OD - significantly improved on exam and mac OCT today .	severity	lesion	T11	T3	note_469
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Drusen , no SRF OS : Geo atrophy , Drusen .	OCT , Posterior Segment - OU - Both Eyes OD : Drusen , no [s2] SRF [e2] OS : Geo atrophy , Drusen .	laterality	lesion	T4	T1	note_1142
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Drusen , no SRF [s1] OS [e1] : Geo atrophy , Drusen .	OCT , Posterior Segment - OU - Both Eyes OD : Drusen , no [s2] SRF [e2] OS : Geo atrophy , Drusen .	laterality	lesion	T5	T1	note_1142
NonRel	Periorbital Pain - no intraocular findings to explain pain - Could be related to allergies or [s1] possibly [e1] sinus hemorrhage from extreme acute hypertensive episode in the setting of Eloquis use - Subjectively improving per patient 2 .	Periorbital Pain - no intraocular findings to explain pain - Could be related to allergies or possibly sinus [s2] hemorrhage [e2] from extreme acute hypertensive episode in the setting of Eloquis use - Subjectively improving per patient 2 .	severity	lesion	T6	T3	note_1142
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s1] exudates [e1] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T5	T30	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s1] exudates [e1] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T5	T33	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s1] exudates [e1] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T6	T30	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s1] exudates [e1] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T6	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T7	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T8	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T9	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T10	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T11	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T12	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T13	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T14	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T15	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	laterality	lesion	T19	T16	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T7	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T8	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T9	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T10	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T11	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T12	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T13	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T14	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T15	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	laterality	lesion	T20	T16	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T7	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T8	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T9	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T10	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T11	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T12	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T13	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T14	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T15	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	laterality	lesion	T21	T16	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T7	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T8	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T9	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T10	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T11	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T12	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T13	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T14	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T22	T15	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T22	T16	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T7	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T8	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T9	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T10	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T11	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T12	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T13	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T14	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T15	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	laterality	lesion	T23	T16	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T7	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T8	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T9	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T10	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T11	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T12	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T13	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T14	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T24	T15	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T24	T16	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T25	T5	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T25	T6	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T25	T29	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T25	T31	257077_note_501
NonRel	2 . PDR OS - multiple areas of NVE [s1] OS [e1] .	2 . PDR OS - multiple areas of [s2] NVE [e2] OS .	laterality	lesion	T26	T17	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	severity	lesion	T27	T18	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T28	T18	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea [s1] ma ' s [e1] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T29	T30	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea [s1] ma ' s [e1] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T29	T33	257077_note_501
NonRel	no neo Macula few [s1] ma ' s [e1] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T31	T30	257077_note_501
NonRel	no neo Macula few [s1] ma ' s [e1] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T31	T33	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T32	T5	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T32	T6	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T32	T29	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T32	T31	257077_note_501
NonRel	[s1] OD [e1] - midperipheral ischemia on IVFA with NVE . + ME .	OD - midperipheral ischemia on IVFA with [s2] NVE [e2] . + ME .	laterality	lesion	T3	T1	2485245_note_7318
NonRel	OS - [s1] extensive [e1] ME , ERM , midperipheral ischemia .	OS - extensive [s2] ME [e2] , ERM , midperipheral ischemia .	severity	lesion	T4	T2	2485245_note_7318
NonRel	[s1] OS [e1] - extensive ME , ERM , midperipheral ischemia .	OS - extensive [s2] ME [e2] , ERM , midperipheral ischemia .	laterality	lesion	T5	T2	2485245_note_7318
NonRel	Exam today with [s1] significant [e1] macular edema and heme in the left eye .	Exam today with significant [s2] macular edema [e2] and heme in the left eye .	severity	lesion	T4	T5	note_3194
NonRel	Exam today with [s1] significant [e1] macular edema and heme in the left eye .	Exam today with significant macular edema and [s2] heme [e2] in the left eye .	severity	lesion	T4	T6	note_3194
NonRel	Exam today with significant macular edema and heme in the [s1] left eye [e1] .	Exam today with significant [s2] macular edema [e2] and heme in the left eye .	laterality	lesion	T7	T5	note_3194
NonRel	Exam today with significant macular edema and heme in the [s1] left eye [e1] .	Exam today with significant macular edema and [s2] heme [e2] in the left eye .	laterality	lesion	T7	T6	note_3194
NonRel	VA down 20 / 70 - vs 20 / 60 LV No NVA on gonio today [s1] OU [e1] History of newly diagnosed APL currently on treatment .	VA down 20 / 70 - vs 20 / 60 LV No [s2] NVA [e2] on gonio today OU History of newly diagnosed APL currently on treatment .	laterality	lesion	T1	T3	note_3194
NonRel	RTC : next week for IVA left eye OD Normal [s1] OS [e1] Worsening IRF Collin Ohning , MD participated in the care of this patient .	RTC : next week for IVA left eye OD Normal OS Worsening [s2] IRF [e2] Collin Ohning , MD participated in the care of this patient .	laterality	lesion	T9	T8	note_3194
NonRel	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA [s1] OS [e1] - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + [s2] NVI [e2] noted at DATE appointment with ectropion uveae which was not seen previously .	laterality	lesion	T5	T1	2654416_note_8704
NonRel	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA [s1] OS [e1] - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no [s2] NVE [e2] , no NVD IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	laterality	lesion	T5	T2	2654416_note_8704
NonRel	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA [s1] OS [e1] - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no [s2] NVD [e2] IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	laterality	lesion	T5	T3	2654416_note_8704
NonRel	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME [s1] OS [e1] - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + [s2] NVI [e2] noted at DATE appointment with ectropion uveae which was not seen previously .	laterality	lesion	T6	T1	2654416_note_8704
NonRel	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME [s1] OS [e1] - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no [s2] NVE [e2] , no NVD IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	laterality	lesion	T6	T2	2654416_note_8704
NonRel	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no NVD IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME [s1] OS [e1] - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	NVG ( neovascular glaucoma ) , left , severe stage H40.52X3 365.63 365.73 Treatment Hx : IVA OS - DATE ( today ) IVA OS - DATE IVA OS - DATE IVA OS - DATE IVA OS - DATE IVFA ( DATE ) - vessel tortuosity with temporal scarring , perioheral nasal and inferior nonperfusion , no NVE , no [s2] NVD [e2] IVA OS - DATE IVT OS - DATE CE / IOL + PPV / SO removal - DATE PPV / Total Funnel RD / SO OS - DATE 1 ) NAME OS - florid 4 + NVI noted at DATE appointment with ectropion uveae which was not seen previously .	laterality	lesion	T6	T3	2654416_note_8704
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T1	T3	note_2442
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T1	T4	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T2	T3	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T2	T4	note_2442
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T5	T7	note_2442
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T5	T8	note_2442
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T5	T9	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T6	T7	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T6	T8	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T6	T9	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T10	T7	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T10	T8	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T10	T9	note_2442
NonRel	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] [s1] OD [e1] - Severe NPDR without CSME .	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe [s2] NPDR [e2] without CSME .	laterality	lesion	T11	T13	note_2442
NonRel	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] [s1] OD [e1] - Severe NPDR without CSME .	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe NPDR without [s2] CSME [e2] .	laterality	lesion	T11	T14	note_2442
NonRel	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - [s1] Severe [e1] NPDR without CSME .	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe [s2] NPDR [e2] without CSME .	severity	lesion	T12	T13	note_2442
NonRel	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - [s1] Severe [e1] NPDR without CSME .	Treatment HX - - EXTEND 10 WEEKS - - IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 - - - EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe NPDR without [s2] CSME [e2] .	severity	lesion	T12	T14	note_2442
NonRel	[s1] OS [e1] - Severe NPDR with ciCSME .	OS - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T15	T17	note_2442
NonRel	[s1] OS [e1] - Severe NPDR with ciCSME .	OS - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T15	T18	note_2442
NonRel	OS - [s1] Severe [e1] NPDR with ciCSME .	OS - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T16	T17	note_2442
NonRel	OS - [s1] Severe [e1] NPDR with ciCSME .	OS - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T16	T18	note_2442
NonRel	RTC 12 weeks DFE OU , Mac OCT OU and possible IVA OS OCT OD stable without fluid OCT [s1] OS [e1] with stable small superior DME , good foveal contour Jason Ludlow , MD participated in the care of this patient .	RTC 12 weeks DFE OU , Mac OCT OU and possible IVA OS OCT OD stable without fluid OCT OS with stable small superior [s2] DME [e2] , good foveal contour Jason Ludlow , MD participated in the care of this patient .	laterality	lesion	T20	T19	note_2442
NonRel	OCT , Posterior Segment - OU - Both Eyes See note OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 1 / 16 / 2018 Patient Name : David Cummings Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : [s1] Right Eye [e1] Pre - op DX : CSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis 3 U standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes See note OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 1 / 16 / 2018 Patient Name : David Cummings Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : Right Eye Pre - op DX : [s2] CSME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis 3 U standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T13	T1	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T14	T3	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T14	T2	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T15	T3	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T15	T2	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T16	T4	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T16	T5	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T16	T6	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T16	T7	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T16	T8	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T16	T9	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T17	T4	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T17	T5	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T17	T6	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T17	T7	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T17	T8	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T17	T9	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T18	T4	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T18	T5	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T18	T6	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T18	T7	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T18	T8	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T18	T9	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T4	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T5	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T6	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T19	T7	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T19	T8	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T19	T9	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T4	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T5	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T6	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T20	T7	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T20	T8	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T20	T9	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T4	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T5	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T6	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T21	T7	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T21	T8	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T21	T9	note_7563
NonRel	[s1] OS [e1] - PDR now s / p PRP .	OS - [s2] PDR [e2] now s / p PRP .	laterality	lesion	T22	T11	note_7563
NonRel	2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with [s1] mild [e1] ME ( interval increase ) today .	2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with mild [s2] ME [e2] ( interval increase ) today .	severity	lesion	T24	T12	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T25	T4	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T25	T5	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T25	T6	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T25	T7	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T25	T8	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T25	T9	note_7563
NonRel	Microcystic edema of [s1] right [e1] cornea - Right Eye H18.211 371.24 1 - 2 .	[s2] Microcystic edema [e2] of right cornea - Right Eye H18.211 371.24 1 - 2 .	laterality	lesion	T2	T1	note_5975
NonRel	[s1] OS [e1] - central profound RPE involvement with associated perivascular hemorrhages , 1 CWS .	OS - central profound RPE involvement with associated perivascular hemorrhages , 1 [s2] CWS [e2] .	laterality	lesion	T2	T1	2183623_note_6078
NonRel	Shallow RD , OD - IOP WNL 13 - Anterior exam unremarkable - DFE shows superotemporal retinal hole with SRF and shallow retinal detachement [s1] OD [e1] s / p pneumatic retionpexy & Cryopexy - Pt on PF QID and atropine BID OS Fouad El Sayyad , MD participated in the care of this patient .	Shallow RD , OD - IOP WNL 13 - Anterior exam unremarkable - DFE shows superotemporal retinal hole with [s2] SRF [e2] and shallow retinal detachement OD s / p pneumatic retionpexy & Cryopexy - Pt on PF QID and atropine BID OS Fouad El Sayyad , MD participated in the care of this patient .	laterality	lesion	T2	T1	note_1245
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T8	T1	2447977_note_6711
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T8	T2	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active [s2] NVE [e2] OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T9	T3	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and [s2] NVE [e2] , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T9	T4	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex [s2] TRD [e2] OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T9	T5	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active [s2] PDR [e2] OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T9	T6	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active [s2] NVE [e2] OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T10	T3	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and [s2] NVE [e2] , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T10	T4	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex [s2] TRD [e2] OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T10	T5	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active [s2] PDR [e2] OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T10	T6	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active [s2] NVE [e2] OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T11	T3	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and [s2] NVE [e2] , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T11	T4	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex [s2] TRD [e2] OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T11	T5	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active [s2] PDR [e2] OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T11	T6	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active [s2] NVE [e2] OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T12	T3	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and [s2] NVE [e2] , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T12	T4	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex [s2] TRD [e2] OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T12	T5	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active [s2] PDR [e2] OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T12	T6	2447977_note_6711
NonRel	[s1] OS [e1] - extensive active proliferative disease with temporal ischemia , NVE .	OS - extensive active proliferative disease with temporal ischemia , [s2] NVE [e2] .	laterality	lesion	T13	T7	2447977_note_6711
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 2 diabetes mellitus E11.3591 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus E11.3591 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	laterality	lesion	T2	T1	note_7667
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3592 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3592 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 3 .	laterality	lesion	T4	T3	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T5	T6	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T5	T9	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T7	T6	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T7	T9	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T8	T6	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	severity	lesion	T8	T9	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active [s2] PDR [e2] OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T10	T6	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active [s2] PDR [e2] OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	laterality	lesion	T10	T9	note_7667
NonRel	[s1] OS [e1] - no NVI on exam today , angle open on gonio .	OS - no [s2] NVI [e2] on exam today , angle open on gonio .	laterality	lesion	T12	T13	note_7667
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR [s1] Right [e1] Post - op DX : same Attending : Siva Iyer Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	INVASIVE PROCEDURE NOTE Pre - op DX : [s2] PDR [e2] Right Post - op DX : same Attending : Siva Iyer Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine .	laterality	lesion	T18	T1	note_2162
NonRel	NVE inf [s1] OS [e1] : Diffuse NVE / NVD .	[s2] NVE [e2] inf OS : Diffuse NVE / NVD .	laterality	lesion	T19	T3	note_2162
NonRel	NVE inf [s1] OS [e1] : Diffuse NVE / NVD .	NVE inf OS : Diffuse [s2] NVE [e2] / NVD .	laterality	lesion	T19	T4	note_2162
NonRel	NVE inf [s1] OS [e1] : Diffuse NVE / NVD .	NVE inf OS : Diffuse NVE / [s2] NVD [e2] .	laterality	lesion	T19	T5	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	[s2] Proliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T20	T6	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified [s2] proliferative retinopathy [e2] type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T20	T7	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T20	T8	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk [s2] PDR [e2] with NVD / NVE / NVI / NVA .	laterality	lesion	T20	T9	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with [s2] NVD [e2] / NVE / NVI / NVA .	laterality	lesion	T20	T10	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / [s2] NVE [e2] / NVI / NVA .	laterality	lesion	T20	T11	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / [s2] NVI [e2] / NVA .	laterality	lesion	T20	T12	note_2162
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / [s2] NVA [e2] .	laterality	lesion	T20	T13	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	[s2] Proliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	severity	lesion	T21	T6	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified [s2] proliferative retinopathy [e2] type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	severity	lesion	T21	T7	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU OD with high risk PDR with NVD / NVE / NVI / NVA .	severity	lesion	T21	T8	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk [s2] PDR [e2] with NVD / NVE / NVI / NVA .	severity	lesion	T21	T9	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with [s2] NVD [e2] / NVE / NVI / NVA .	severity	lesion	T21	T10	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / [s2] NVE [e2] / NVI / NVA .	severity	lesion	T21	T11	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / [s2] NVI [e2] / NVA .	severity	lesion	T21	T12	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s1] unspecified [e1] proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / [s2] NVA [e2] .	severity	lesion	T21	T13	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	[s2] Proliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T22	T6	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified [s2] proliferative retinopathy [e2] type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T22	T7	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T22	T8	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk [s2] PDR [e2] with NVD / NVE / NVI / NVA .	laterality	lesion	T22	T9	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with [s2] NVD [e2] / NVE / NVI / NVA .	laterality	lesion	T22	T10	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / [s2] NVE [e2] / NVI / NVA .	laterality	lesion	T22	T11	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / [s2] NVI [e2] / NVA .	laterality	lesion	T22	T12	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / [s2] NVA [e2] .	laterality	lesion	T22	T13	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	[s2] Proliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	severity	lesion	T23	T6	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified [s2] proliferative retinopathy [e2] type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	severity	lesion	T23	T7	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU OD with high risk PDR with NVD / NVE / NVI / NVA .	severity	lesion	T23	T8	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk [s2] PDR [e2] with NVD / NVE / NVI / NVA .	severity	lesion	T23	T9	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with [s2] NVD [e2] / NVE / NVI / NVA .	severity	lesion	T23	T10	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / [s2] NVE [e2] / NVI / NVA .	severity	lesion	T23	T11	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / [s2] NVI [e2] / NVA .	severity	lesion	T23	T12	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - [s1] Active [e1] Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / [s2] NVA [e2] .	severity	lesion	T23	T13	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	[s2] Proliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T24	T6	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified [s2] proliferative retinopathy [e2] type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T24	T7	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T24	T8	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk [s2] PDR [e2] with NVD / NVE / NVI / NVA .	laterality	lesion	T24	T9	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with [s2] NVD [e2] / NVE / NVI / NVA .	laterality	lesion	T24	T10	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / [s2] NVE [e2] / NVI / NVA .	laterality	lesion	T24	T11	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / [s2] NVI [e2] / NVA .	laterality	lesion	T24	T12	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy [s1] OU [e1] OD with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / [s2] NVA [e2] .	laterality	lesion	T24	T13	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	[s2] Proliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T25	T6	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified [s2] proliferative retinopathy [e2] type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T25	T7	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active [s2] Proliferative Diabetic retinopathy [e2] OU OD with high risk PDR with NVD / NVE / NVI / NVA .	laterality	lesion	T25	T8	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk [s2] PDR [e2] with NVD / NVE / NVI / NVA .	laterality	lesion	T25	T9	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with [s2] NVD [e2] / NVE / NVI / NVA .	laterality	lesion	T25	T10	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / [s2] NVE [e2] / NVI / NVA .	laterality	lesion	T25	T11	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / [s2] NVI [e2] / NVA .	laterality	lesion	T25	T12	note_2162
NonRel	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU [s1] OD [e1] with high risk PDR with NVD / NVE / NVI / NVA .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , unspecified proliferative retinopathy type E11.3593 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 OPH - OU Fluorescein Angiography CANCELED : Pan Retinal Photocoagulation - OD - Right Eye Treatment Hx : IVA OD 6 / 15 / 17 ( today ) DM 2 x 24 years on no meds Lab Results Component Value Date HGBA1C 9.7 ( H ) 06 / 09 / 2017 1 ) DM - Active Proliferative Diabetic retinopathy OU OD with high risk PDR with NVD / NVE / NVI / [s2] NVA [e2] .	laterality	lesion	T25	T13	note_2162
NonRel	[s1] OS [e1] + NVD / NVE / NVI / NVA .	OS + [s2] NVD [e2] / NVE / NVI / NVA .	laterality	lesion	T26	T14	note_2162
NonRel	[s1] OS [e1] + NVD / NVE / NVI / NVA .	OS + NVD / [s2] NVE [e2] / NVI / NVA .	laterality	lesion	T26	T15	note_2162
NonRel	[s1] OS [e1] + NVD / NVE / NVI / NVA .	OS + NVD / NVE / [s2] NVI [e2] / NVA .	laterality	lesion	T26	T16	note_2162
NonRel	[s1] OS [e1] + NVD / NVE / NVI / NVA .	OS + NVD / NVE / NVI / [s2] NVA [e2] .	laterality	lesion	T26	T17	note_2162
NonRel	[s1] Right eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 2 .	Right eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 2 .	laterality	lesion	T1	T2	note_8850
NonRel	[s1] Left eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 3 .	Left eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 3 .	laterality	lesion	T3	T4	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / [s2] VH [e2] OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	laterality	lesion	T7	T5	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	laterality	lesion	T7	T6	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - s / p PPV / TRD .	laterality	lesion	T7	T8	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / [s2] VH [e2] OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	laterality	lesion	T9	T5	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	laterality	lesion	T9	T6	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - s / p PPV / TRD .	laterality	lesion	T9	T8	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH [s1] OD [e1] - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / [s2] VH [e2] OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	laterality	lesion	T10	T5	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH [s1] OD [e1] - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	laterality	lesion	T10	T6	note_8850
NonRel	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH [s1] OD [e1] - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - s / p PPV / TRD .	Most recently saw Dr. Gray and now s / p CE / IOL OD Treatment Hx : CE / PCIOL OD - 5 / 15 / 18 PPV / TRD + RRD OS - 3 / 12 / 18 IVA OS - 3 / 9 / 18 ( preop ) PPV / VH OD - 1 / 26 / 18 PPV ( TRD ) OD - 12 / 4 / 17 IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - s / p PPV / TRD .	laterality	lesion	T10	T8	note_8850
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T2	T1	note_5884
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T2	T3	note_5884
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T2	T6	note_5884
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T2	T9	note_5884
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T2	T11	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T4	T1	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T4	T3	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T4	T6	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T4	T9	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - [s1] OD [e1] Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T4	T11	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T5	T1	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T5	T3	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T5	T6	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T5	T9	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - [s1] Active [e1] PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T5	T11	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T7	T1	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T7	T3	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T7	T6	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T7	T9	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR [s1] OD [e1] , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T7	T11	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . [s1] Severe [e1] PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T8	T1	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . [s1] Severe [e1] PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T8	T3	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . [s1] Severe [e1] PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T8	T6	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . [s1] Severe [e1] PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T8	T9	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . [s1] Severe [e1] PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	severity	lesion	T8	T11	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR [s1] OU [e1] , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T10	T1	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR [s1] OU [e1] , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T10	T3	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR [s1] OU [e1] , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T10	T6	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR [s1] OU [e1] , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T10	T9	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR [s1] OU [e1] , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T10	T11	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH [s1] OS [e1] OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T12	T1	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH [s1] OS [e1] OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T12	T3	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH [s1] OS [e1] OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T12	T6	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH [s1] OS [e1] OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T12	T9	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH [s1] OS [e1] OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T12	T11	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view [s1] OS [e1] 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T13	T1	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view [s1] OS [e1] 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T13	T3	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view [s1] OS [e1] 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active [s2] PDR [e2] OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T13	T6	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view [s1] OS [e1] 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe [s2] PDR [e2] OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T13	T9	note_5884
NonRel	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view [s1] OS [e1] 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , VH OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	Proliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.02 Treatment Hx : IVA OU - 2 / 23 / 18 PRP OD ( IVFA guided ) - 2 / 2 / 18 IVA OU - 1 / 25 / 18 IVFA ( 1 / 25 / 18 ) - Active PDR OD , no view OS 1 ) DM [ hx of poorly controlled diabetes and HTN with unknown A1c ] . Severe PDR OU , [s2] VH [e2] OS OD - Will treat today with IVFA guided PRP ( directed to the nasal periphery from about 1 to 5 o ' clock ) OS - NCVH .	laterality	lesion	T13	T11	note_5884
NonRel	Notes Date : 3 / 2 / 2018 Patient Name : John Brown Procedure : Panretinal Photocoagulation , [s1] OD [e1] Preop Diagnosis : PDR Postop Diagnosis : Same Description of Procedure : Patient was identified and consented .	Notes Date : 3 / 2 / 2018 Patient Name : John Brown Procedure : Panretinal Photocoagulation , OD Preop Diagnosis : [s2] PDR [e2] Postop Diagnosis : Same Description of Procedure : Patient was identified and consented .	laterality	lesion	T1	T2	note_8321
NonRel	NPDR ( nonproliferative diabetic retinopathy ) [s1] OD [e1] E11.3299 250.50 362.03 2 .	[s2] NPDR [e2] ( nonproliferative diabetic retinopathy ) OD E11.3299 250.50 362.03 2 .	laterality	lesion	T5	T3	note_8321
NonRel	NPDR ( nonproliferative diabetic retinopathy ) [s1] OD [e1] E11.3299 250.50 362.03 2 .	NPDR ( [s2] nonproliferative diabetic retinopathy [e2] ) OD E11.3299 250.50 362.03 2 .	laterality	lesion	T5	T4	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	[s2] Proliferative diabetic retinopathy [e2] and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T10	T6	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	Proliferative diabetic retinopathy and [s2] neovascularization of iris [e2] , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T10	T7	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without [s2] macular edema [e2] E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T10	T9	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 [s2] Proliferative diabetic retinopathy [e2] OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T10	T11	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy [s1] OD [e1] In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	[s2] Proliferative diabetic retinopathy [e2] and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T8	T6	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy [s1] OD [e1] In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	Proliferative diabetic retinopathy and [s2] neovascularization of iris [e2] , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T8	T7	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy [s1] OD [e1] In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without [s2] macular edema [e2] E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T8	T9	note_8321
NonRel	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 Proliferative diabetic retinopathy [s1] OD [e1] In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	Proliferative diabetic retinopathy and neovascularization of iris , due to underlying condition , without macular edema E08 . 3599 249.50 Pan Retinal Photocoagulation - OD - Right Eye H21.1X9 362.02 E08 . 39 364.42 [s2] Proliferative diabetic retinopathy [e2] OD In setting of SC + Seen in the hospital 11 / 14 / 17 and received PRP with indirect laser at bedside Also received IVA NVI regressed on exam today and resolution of hyphema Discussed with patient that further PRP needed , patient understands Familial AD drusen Continue to monitor RTC 1 month , DFE / Mac OCT Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T8	T11	note_8321
NonRel	Left eye injury , subsequent encounter S05 . 92XD 921.9 29 yo AA man with history of sickle cell trait who we are following for : Traumatic Hyphema OS Commotioe Retinae OS Vitreous Base Avulsion OS VA 20 / 100 today IOP 12 by applanation today , trending down AC today with stable hyphema ( 1.8 mm ) , still with significant but improving clotted heme covering anterior lens capsule and iris , 2 - 3 + RBCs , corneal edema clearing View to fundus today with sub - retinal heme superior to the nerve , intra - retinal heme superior hemi - retina , [s1] clearing [e1] vitreous hemorrhage Plan Continue Cyclogyl TID OS Continue PF QID OS Continue Timolol BID OS Stop Alphagan Continue bedrest Eye shield at all times Avoid ASA / NSAIDs RTC Tomorrow to see Dr. Lukowski Zachary Lukowski , MD participated in the care of this patient .	Left eye injury , subsequent encounter S05 . 92XD 921.9 29 yo AA man with history of sickle cell trait who we are following for : Traumatic Hyphema OS Commotioe Retinae OS Vitreous Base Avulsion OS VA 20 / 100 today IOP 12 by applanation today , trending down AC today with stable hyphema ( 1.8 mm ) , still with significant but improving [s2] clotted heme [e2] covering anterior lens capsule and iris , 2 - 3 + RBCs , corneal edema clearing View to fundus today with sub - retinal heme superior to the nerve , intra - retinal heme superior hemi - retina , clearing vitreous hemorrhage Plan Continue Cyclogyl TID OS Continue PF QID OS Continue Timolol BID OS Stop Alphagan Continue bedrest Eye shield at all times Avoid ASA / NSAIDs RTC Tomorrow to see Dr. Lukowski Zachary Lukowski , MD participated in the care of this patient .	severity	lesion	T3	T1	note_6192
NonRel	Left eye injury , subsequent encounter S05 . 92XD 921.9 29 yo AA man with history of sickle cell trait who we are following for : Traumatic Hyphema OS Commotioe Retinae OS Vitreous Base Avulsion OS VA 20 / 100 today IOP 12 by applanation today , trending down AC today with stable hyphema ( 1.8 mm ) , still with significant but improving clotted heme covering anterior lens capsule and iris , 2 - 3 + RBCs , corneal edema clearing View to fundus today with sub - retinal heme superior to the nerve , intra - retinal heme superior hemi - retina , [s1] clearing [e1] vitreous hemorrhage Plan Continue Cyclogyl TID OS Continue PF QID OS Continue Timolol BID OS Stop Alphagan Continue bedrest Eye shield at all times Avoid ASA / NSAIDs RTC Tomorrow to see Dr. Lukowski Zachary Lukowski , MD participated in the care of this patient .	Left eye injury , subsequent encounter S05 . 92XD 921.9 29 yo AA man with history of sickle cell trait who we are following for : Traumatic Hyphema OS Commotioe Retinae OS Vitreous Base Avulsion OS VA 20 / 100 today IOP 12 by applanation today , trending down AC today with stable hyphema ( 1.8 mm ) , still with significant but improving clotted heme covering anterior lens capsule and iris , 2 - 3 + RBCs , corneal edema clearing View to fundus today with sub - retinal heme superior to the nerve , intra - retinal heme superior hemi - retina , clearing [s2] vitreous hemorrhage [e2] Plan Continue Cyclogyl TID OS Continue PF QID OS Continue Timolol BID OS Stop Alphagan Continue bedrest Eye shield at all times Avoid ASA / NSAIDs RTC Tomorrow to see Dr. Lukowski Zachary Lukowski , MD participated in the care of this patient .	severity	lesion	T3	T2	note_6192
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T11	T1	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	laterality	lesion	T11	T2	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Nonproliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T11	T17	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T13	T3	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T13	T4	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T13	T5	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T13	T6	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T13	T7	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T13	T8	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T12	T1	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T12	T2	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	[s2] Nonproliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T12	T17	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	Mild [s2] NPDR [e2] now .	severity	lesion	T14	T9	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	laterality	lesion	T16	T15	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T18	T1	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	laterality	lesion	T18	T2	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Nonproliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T18	T17	39541_note_166
NonRel	Notes Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : PDR Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	Notes Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] PDR [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T1	T2	note_8432
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	laterality	lesion	T4	T3	note_8432
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	laterality	lesion	T4	T5	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	severity	lesion	T6	T7	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T8	T7	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with [s2] PDR [e2] OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T10	T9	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : [s2] PDR [e2] with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T10	T13	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : PDR with [s2] NVD [e2] , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T10	T14	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of [s2] intraretinal hemorrhages [e2] , NVE .	laterality	lesion	T10	T15	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , [s2] NVE [e2] .	laterality	lesion	T10	T16	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with [s2] PDR [e2] OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T12	T9	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : [s2] PDR [e2] with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T12	T13	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : PDR with [s2] NVD [e2] , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T12	T14	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of [s2] intraretinal hemorrhages [e2] , NVE .	laterality	lesion	T12	T15	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , [s2] NVE [e2] .	laterality	lesion	T12	T16	note_8432
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T14	T1	note_2415
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T14	T2	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T15	T1	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T15	T2	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T16	T3	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T16	T4	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T16	T5	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T17	T3	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T17	T4	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T17	T5	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T18	T3	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T18	T4	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T18	T5	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T19	T6	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T19	T7	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T20	T6	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T20	T7	note_2415
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	OS - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T21	T8	note_2415
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	OS - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T21	T9	note_2415
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	OS - Severe [s2] NPDR [e2] with CSME .	laterality	lesion	T22	T8	note_2415
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	OS - Severe NPDR with [s2] CSME [e2] .	laterality	lesion	T22	T9	note_2415
NonRel	Siva S.R. Iyer , MD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T23	T10	note_2415
NonRel	Siva S.R. Iyer , MD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T23	T11	note_2415
NonRel	Siva S.R. Iyer , MD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T23	T12	note_2415
NonRel	Siva S.R. Iyer , MD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage	laterality	lesion	T23	T13	note_2415
NonRel	Siva S.R. Iyer , MD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T23	T25	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T24	T10	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T24	T11	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T24	T12	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage	laterality	lesion	T24	T13	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T24	T25	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	severity	lesion	T26	T10	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	severity	lesion	T26	T11	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage	severity	lesion	T26	T12	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage	severity	lesion	T26	T13	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage	severity	lesion	T26	T25	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T27	T10	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T27	T11	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T27	T12	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage	laterality	lesion	T27	T13	note_2415
NonRel	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage	Siva S.R. Iyer , MD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage	laterality	lesion	T27	T25	note_2415
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T2	T1	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	laterality	lesion	T3	T1	note_3797
NonRel	[s1] Mild [e1] DME that has improved with better BS and observation .	Mild [s2] DME [e2] that has improved with better BS and observation .	severity	lesion	T5	T4	note_3797
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T8	T6	note_3797
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T8	T7	note_3797
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T9	T6	note_3797
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T9	T7	note_3797
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s2] vit heme [e2] and layered heme .	severity	lesion	T4	T1	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s2] MA [e2] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T4	T2	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s2] exudates [e2] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T4	T3	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s2] MA [e2] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T4	T5	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s2] exudates [e2] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T4	T6	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s2] NVE [e2] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T4	T8	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s2] NVE [e2] along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T4	T9	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s2] vit heme [e2] and layered heme .	severity	lesion	T7	T1	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s2] MA [e2] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T7	T2	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s2] exudates [e2] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T7	T3	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s2] MA [e2] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T7	T5	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s2] exudates [e2] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T7	T6	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s2] NVE [e2] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T7	T8	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s2] NVE [e2] along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T7	T9	note_4416
NonRel	Senile nuclear sclerosis ( 366.16 ) 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	Senile nuclear sclerosis ( 366.16 ) 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T12	T11	note_4416
NonRel	[s1] NVE [e1] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T16	T19	note_4416
NonRel	NVE along arcades , temporal [s1] DBH [e1] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T17	T19	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T18	T16	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T18	T17	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T18	T20	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s1] DBH [e1] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T20	T19	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T21	T16	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T21	T17	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T21	T20	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	laterality	lesion	T23	T22	note_4416
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T1	T3	note_2433
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T1	T4	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	severity	lesion	T2	T3	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	severity	lesion	T2	T4	note_2433
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T5	T7	note_2433
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T5	T8	note_2433
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T5	T9	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T6	T7	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T6	T8	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T6	T9	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T10	T7	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T10	T8	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T10	T9	note_2433
NonRel	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] [s1] OD [e1] - Severe NPDR without CSME .	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe [s2] NPDR [e2] without CSME .	laterality	lesion	T11	T13	note_2433
NonRel	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] [s1] OD [e1] - Severe NPDR without CSME .	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe NPDR without [s2] CSME [e2] .	laterality	lesion	T11	T14	note_2433
NonRel	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - [s1] Severe [e1] NPDR without CSME .	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe [s2] NPDR [e2] without CSME .	severity	lesion	T12	T13	note_2433
NonRel	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - [s1] Severe [e1] NPDR without CSME .	Treatment HX IVA OS - 6 / 1 / 18 ( today ) IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe NPDR without [s2] CSME [e2] .	severity	lesion	T12	T14	note_2433
NonRel	[s1] OS [e1] - Severe NPDR with ciCSME .	OS - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T15	T17	note_2433
NonRel	[s1] OS [e1] - Severe NPDR with ciCSME .	OS - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T15	T18	note_2433
NonRel	OS - [s1] Severe [e1] NPDR with ciCSME .	OS - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T16	T17	note_2433
NonRel	OS - [s1] Severe [e1] NPDR with ciCSME .	OS - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T16	T18	note_2433
NonRel	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS [s1] OD [e1] : no DME OS : DME throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS OD : no [s2] DME [e2] OS : DME throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	laterality	lesion	T19	T20	note_2433
NonRel	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS [s1] OD [e1] : no DME OS : DME throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS OD : no DME OS : [s2] DME [e2] throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	laterality	lesion	T19	T22	note_2433
NonRel	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS OD : no DME [s1] OS [e1] : DME throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS OD : no [s2] DME [e2] OS : DME throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	laterality	lesion	T21	T20	note_2433
NonRel	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS OD : no DME [s1] OS [e1] : DME throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	RTC 6 weeks DFE OU , Mac OCT OU and IVA OS OD : no DME OS : [s2] DME [e2] throughout , appears stable , center - involving Andres Gonzalez , MD participated in the care of this patient .	laterality	lesion	T21	T22	note_2433
NonRel	POW # ID [s1] OD [e1] from PPV for VH , vitritis , TRD from secondary complications .	POW # ID OD from PPV for [s2] VH [e2] , vitritis , TRD from secondary complications .	laterality	lesion	T4	T1	2748168_note_9227
NonRel	Hx of previous exudative RD [s1] OU [e1] .	Hx of previous [s2] exudative [e2] RD OU .	laterality	lesion	T5	T2	2748168_note_9227
NonRel	Hx of [s1] previous [e1] exudative RD OU .	Hx of previous [s2] exudative [e2] RD OU .	severity	lesion	T6	T2	2748168_note_9227
NonRel	[s1] OS [e1] - VH , vitritis .	OS - [s2] VH [e2] , vitritis .	laterality	lesion	T7	T3	2748168_note_9227
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : [s1] Mild [e1] DME OS : CI - DME .	OCT , Posterior Segment - OU - Both Eyes OD : Mild [s2] DME [e2] OS : CI - DME .	severity	lesion	T14	T1	460233_note_1091
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : [s1] Mild [e1] DME OS : CI - DME .	OCT , Posterior Segment - OU - Both Eyes OD : Mild DME OS : [s2] CI - DME [e2] .	severity	lesion	T14	T2	460233_note_1091
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Mild DME OS : CI - DME .	OCT , Posterior Segment - OU - Both Eyes OD : Mild [s2] DME [e2] OS : CI - DME .	laterality	lesion	T15	T1	460233_note_1091
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Mild DME OS : CI - DME .	OCT , Posterior Segment - OU - Both Eyes OD : Mild DME OS : [s2] CI - DME [e2] .	laterality	lesion	T15	T2	460233_note_1091
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Mild DME [s1] OS [e1] : CI - DME .	OCT , Posterior Segment - OU - Both Eyes OD : Mild [s2] DME [e2] OS : CI - DME .	laterality	lesion	T16	T1	460233_note_1091
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Mild DME [s1] OS [e1] : CI - DME .	OCT , Posterior Segment - OU - Both Eyes OD : Mild DME OS : [s2] CI - DME [e2] .	laterality	lesion	T16	T2	460233_note_1091
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : [s1] Moderate [e1] NDPR with DME Left Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Moderate [s2] NDPR [e2] with DME Left Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	severity	lesion	T17	T3	460233_note_1091
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : [s1] Moderate [e1] NDPR with DME Left Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Moderate NDPR with [s2] DME [e2] Left Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	severity	lesion	T17	T4	460233_note_1091
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : Moderate NDPR with DME [s1] Left [e1] Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Moderate [s2] NDPR [e2] with DME Left Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T18	T3	460233_note_1091
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : Moderate NDPR with DME [s1] Left [e1] Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Moderate NDPR with [s2] DME [e2] Left Post - op DX : same Attending : NAME , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T18	T4	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T19	T5	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T19	T6	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T19	T7	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T20	T5	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T20	T6	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T20	T7	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	severity	lesion	T21	T8	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	severity	lesion	T21	T9	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	laterality	lesion	T22	T8	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	laterality	lesion	T22	T9	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD [s1] Moderate [e1] NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate [s2] NPDR [e2] with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T23	T10	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD [s1] Moderate [e1] NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild [s2] DME [e2] OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T23	T11	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD [s1] Moderate [e1] NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate [s2] NPDR [e2] with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T23	T12	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD [s1] Moderate [e1] NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate NPDR with [s2] CI - DME [e2] Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T23	T13	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with [s1] mild [e1] DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate [s2] NPDR [e2] with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T24	T10	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with [s1] mild [e1] DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild [s2] DME [e2] OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T24	T11	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with [s1] mild [e1] DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate [s2] NPDR [e2] with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T24	T12	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with [s1] mild [e1] DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate NPDR with [s2] CI - DME [e2] Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T24	T13	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS [s1] Moderate [e1] NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate [s2] NPDR [e2] with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T25	T10	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS [s1] Moderate [e1] NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild [s2] DME [e2] OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T25	T11	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS [s1] Moderate [e1] NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate [s2] NPDR [e2] with CI - DME Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T25	T12	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS [s1] Moderate [e1] NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate NPDR with [s2] CI - DME [e2] Patient now under the care of internal medicine and gastroenterology .	severity	lesion	T25	T13	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) [s1] OD [e1] Moderate NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate [s2] NPDR [e2] with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T26	T10	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) [s1] OD [e1] Moderate NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild [s2] DME [e2] OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T26	T11	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) [s1] OD [e1] Moderate NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate [s2] NPDR [e2] with CI - DME Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T26	T12	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) [s1] OD [e1] Moderate NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate NPDR with [s2] CI - DME [e2] Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T26	T13	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME [s1] OS [e1] Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate [s2] NPDR [e2] with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T27	T10	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME [s1] OS [e1] Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild [s2] DME [e2] OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T27	T11	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME [s1] OS [e1] Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate [s2] NPDR [e2] with CI - DME Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T27	T12	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME [s1] OS [e1] Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS Moderate NPDR with [s2] CI - DME [e2] Patient now under the care of internal medicine and gastroenterology .	laterality	lesion	T27	T13	460233_note_1091
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral [s1] NVE [e1] with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior [s2] midperipheral [e2] NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	lesion	eye_part	T12	T11	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior [s1] NVE [e1] OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior [s2] midperipheral [e2] NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	lesion	eye_part	T13	T11	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior [s1] NVE [e1] and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior [s2] midperipheral [e2] NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	lesion	eye_part	T14	T11	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active [s1] PDR [e1] OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior [s2] midperipheral [e2] NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	lesion	eye_part	T15	T11	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T16	T3	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T16	T4	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T17	T5	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T17	T6	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	severity	lesion	T17	T7	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	severity	lesion	T17	T8	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	severity	lesion	T17	T9	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	severity	lesion	T17	T10	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T17	T27	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T18	T5	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T18	T6	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	laterality	lesion	T18	T7	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	laterality	lesion	T18	T8	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	laterality	lesion	T18	T9	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	laterality	lesion	T18	T10	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T18	T27	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T19	T5	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T19	T6	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	laterality	lesion	T19	T7	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	laterality	lesion	T19	T8	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	laterality	lesion	T19	T9	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	laterality	lesion	T19	T10	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T19	T27	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE [s1] OD [e1] , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral [s2] NVE [e2] with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T20	T12	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE [s1] OD [e1] , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior [s2] NVE [e2] OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T20	T13	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE [s1] OD [e1] , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior [s2] NVE [e2] and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T20	T14	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE [s1] OD [e1] , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active [s2] PDR [e2] OU NAME , MD participated in the care of this patient .	laterality	lesion	T20	T15	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE [s1] OD [e1] , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including [s2] NVE [e2] OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T20	T30	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR [s1] OU [e1] NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral [s2] NVE [e2] with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T21	T12	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR [s1] OU [e1] NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior [s2] NVE [e2] OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T21	T13	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR [s1] OU [e1] NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior [s2] NVE [e2] and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T21	T14	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR [s1] OU [e1] NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active [s2] PDR [e2] OU NAME , MD participated in the care of this patient .	laterality	lesion	T21	T15	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR [s1] OU [e1] NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including [s2] NVE [e2] OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T21	T30	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , [s1] OS [e1] with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral [s2] NVE [e2] with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T22	T12	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , [s1] OS [e1] with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior [s2] NVE [e2] OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T22	T13	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , [s1] OS [e1] with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior [s2] NVE [e2] and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T22	T14	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , [s1] OS [e1] with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active [s2] PDR [e2] OU NAME , MD participated in the care of this patient .	laterality	lesion	T22	T15	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , [s1] OS [e1] with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including [s2] NVE [e2] OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T22	T30	1158336_note_2399
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	OS - Moderate [s2] NPDR [e2] without CSME .	severity	lesion	T25	T23	1158336_note_2399
NonRel	OS - [s1] Moderate [e1] NPDR without CSME .	OS - Moderate NPDR without [s2] CSME [e2] .	severity	lesion	T25	T24	1158336_note_2399
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	OS - Moderate [s2] NPDR [e2] without CSME .	laterality	lesion	T26	T23	1158336_note_2399
NonRel	[s1] OS [e1] - Moderate NPDR without CSME .	OS - Moderate NPDR without [s2] CSME [e2] .	laterality	lesion	T26	T24	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T28	T5	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T28	T6	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	severity	lesion	T28	T7	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	severity	lesion	T28	T8	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	severity	lesion	T28	T9	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	severity	lesion	T28	T10	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	severity	lesion	T28	T27	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T29	T5	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T29	T6	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	laterality	lesion	T29	T7	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	laterality	lesion	T29	T8	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	laterality	lesion	T29	T9	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	laterality	lesion	T29	T10	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T29	T27	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including [s1] NVE [e1] OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior [s2] midperipheral [e2] NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	lesion	eye_part	T30	T11	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE [s1] OU [e1] consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral [s2] NVE [e2] with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T31	T12	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE [s1] OU [e1] consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior [s2] NVE [e2] OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T31	T13	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE [s1] OU [e1] consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior [s2] NVE [e2] and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T31	T14	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE [s1] OU [e1] consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active [s2] PDR [e2] OU NAME , MD participated in the care of this patient .	laterality	lesion	T31	T15	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE [s1] OU [e1] consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including [s2] NVE [e2] OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	laterality	lesion	T31	T30	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of [s1] Active [e1] PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral [s2] NVE [e2] with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	severity	lesion	T32	T12	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of [s1] Active [e1] PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior [s2] NVE [e2] OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	severity	lesion	T32	T13	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of [s1] Active [e1] PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior [s2] NVE [e2] and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	severity	lesion	T32	T14	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of [s1] Active [e1] PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of Active [s2] PDR [e2] OU NAME , MD participated in the care of this patient .	severity	lesion	T32	T15	1158336_note_2399
NonRel	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including NVE OU consistent with a diagnosis of [s1] Active [e1] PDR OU NAME , MD participated in the care of this patient .	PRP OD ( IVFA - Guided ) Today RTC 2 - 3 weeks for PRP OS IVFA ( today ) : superior midperipheral NVE with adjacent capillary dropout , nasal far peripheral dropout , inferior NVE OD , OS with superior NVE and adjacent dropout Color Fundus photos ( today ) : diabetic changes OU including [s2] NVE [e2] OU consistent with a diagnosis of Active PDR OU NAME , MD participated in the care of this patient .	severity	lesion	T32	T30	1158336_note_2399
NonRel	OPH - OU Fluorescein Angiography NVE [s1] OU [e1] , Active PDR OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	OPH - OU Fluorescein Angiography [s2] NVE [e2] OU , Active PDR OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	laterality	lesion	T33	T1	1158336_note_2399
NonRel	OPH - OU Fluorescein Angiography NVE [s1] OU [e1] , Active PDR OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	OPH - OU Fluorescein Angiography NVE OU , Active [s2] PDR [e2] OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	laterality	lesion	T33	T2	1158336_note_2399
NonRel	OPH - OU Fluorescein Angiography NVE OU , [s1] Active [e1] PDR OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	OPH - OU Fluorescein Angiography [s2] NVE [e2] OU , Active PDR OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	severity	lesion	T34	T1	1158336_note_2399
NonRel	OPH - OU Fluorescein Angiography NVE OU , [s1] Active [e1] PDR OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	OPH - OU Fluorescein Angiography NVE OU , Active [s2] PDR [e2] OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	severity	lesion	T34	T2	1158336_note_2399
NonRel	OPH - OU Fluorescein Angiography NVE OU , Active PDR [s1] OU [e1] Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	OPH - OU Fluorescein Angiography [s2] NVE [e2] OU , Active PDR OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	laterality	lesion	T35	T1	1158336_note_2399
NonRel	OPH - OU Fluorescein Angiography NVE OU , Active PDR [s1] OU [e1] Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	OPH - OU Fluorescein Angiography NVE OU , Active [s2] PDR [e2] OU Pan Retinal Photocoagulation - OD - Right Eye Date : DATE Patient Name : NAME Procedure : Panretinal Photocoagulation , OD Laser Procedure Note Eye : OD IC Obtained : Yes Anesthesia : Topical Proparacaine Procedure : PRP Laser Type : PASCAL Lens : PRP 165 Power : 200 - 550 mW Spot Size : 200 um Exposure : 30 - 40 ms # Spots : 640 Complications : None I performed this procedure myself .	laterality	lesion	T35	T2	1158336_note_2399
NonRel	OS - IVFA showing PED [s1] OS [e1] with no changes since the last visit and no IRF / SRF on OCT .	OS - IVFA showing PED OS with no changes since the last visit and no [s2] IRF [e2] / SRF on OCT .	laterality	lesion	T7	T3	1342474_note_3109
NonRel	OS - IVFA showing PED [s1] OS [e1] with no changes since the last visit and no IRF / SRF on OCT .	OS - IVFA showing PED OS with no changes since the last visit and no IRF / [s2] SRF [e2] on OCT .	laterality	lesion	T7	T4	1342474_note_3109
NonRel	NAME , MD Soft drusen without IRF / SRF ; subfoveal druse [s1] OS [e1] is without changes	NAME , MD Soft drusen without [s2] IRF [e2] / SRF ; subfoveal druse OS is without changes	laterality	lesion	T8	T5	1342474_note_3109
NonRel	NAME , MD Soft drusen without IRF / SRF ; subfoveal druse [s1] OS [e1] is without changes	NAME , MD Soft drusen without IRF / [s2] SRF [e2] ; subfoveal druse OS is without changes	laterality	lesion	T8	T6	1342474_note_3109
NonRel	No diabetic retinopathy in [s1] both eyes [e1] V71.89 5 .	No [s2] diabetic retinopathy [e2] in both eyes V71.89 5 .	laterality	lesion	T8	T7	217884_note_474
NonRel	DM type 2 w / o diabetic retinopathy [s1] OU [e1] - pt edu on condition and importance of good BS control , healthy diet , and exercise , along with regular follow ups with PCP - suggested A1C below 7 - continue care with PCP and current medications ( will notify PCP of todays exam findings ) * suggested annual eye exam with DFE 5 .	DM type 2 w / o [s2] diabetic retinopathy [e2] OU - pt edu on condition and importance of good BS control , healthy diet , and exercise , along with regular follow ups with PCP - suggested A1C below 7 - continue care with PCP and current medications ( will notify PCP of todays exam findings ) * suggested annual eye exam with DFE 5 .	laterality	lesion	T9	T1	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or [s2] SRF [e2] OS : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	laterality	lesion	T15	T10	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Other testing : OCT MAC [s2] OD [e2] : thickness : 221 , good foveal contour ( - ) IRF or SRF OS : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	laterality	lesion	T15	T11	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF OS : thickness : 217 , good foveal contour ( - ) IRF or [s2] SRF [e2] Assessment and Plan : ICD - 9 - CM 1 .	laterality	lesion	T15	T14	217884_note_474
NonRel	2 ) HTN retinopathy - small incidental [s1] IRH [e1] near nerve OS ( under vessel loop ) noted last visit , that has now resolved .	2 ) HTN retinopathy - small incidental IRH near [s2] nerve [e2] OS ( under vessel loop ) noted last visit , that has now resolved .	lesion	eye_part	T3	T4	2484779_note_7312
NonRel	2 ) HTN retinopathy - small incidental IRH near nerve [s1] OS [e1] ( under vessel loop ) noted last visit , that has now resolved .	2 ) HTN retinopathy - small incidental [s2] IRH [e2] near nerve OS ( under vessel loop ) noted last visit , that has now resolved .	laterality	lesion	T5	T3	2484779_note_7312
NonRel	Hypertensive retinopathy , bilateral H35.033 362.11 Color Fundus Photography - [s1] OU [e1] - Both Eyes 3 .	[s2] Hypertensive retinopathy [e2] , bilateral H35.033 362.11 Color Fundus Photography - OU - Both Eyes 3 .	laterality	lesion	T6	T1	2484779_note_7312
NonRel	Branch retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8320 362.36 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 Treatment Hx : IVA OS - 2 / 2 / 18 ( today ) 1 ) BRVO with ME - heme in NFL .	Branch retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8320 362.36 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 Treatment Hx : IVA OS - 2 / 2 / 18 ( today ) 1 ) BRVO with ME - heme in NFL .	laterality	lesion	T2	T1	note_9103
NonRel	Branch retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8320 362.36 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 Treatment Hx : IVA OS - 2 / 2 / 18 ( today ) 1 ) BRVO with ME - heme in NFL .	Branch retinal vein occlusion with macular edema of left eye H34.8320 362.36 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 Treatment Hx : IVA OS - 2 / 2 / 18 ( today ) 1 ) BRVO with [s2] ME [e2] - heme in NFL .	laterality	lesion	T2	T3	note_9103
NonRel	Branch retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8320 362.36 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 Treatment Hx : IVA OS - 2 / 2 / 18 ( today ) 1 ) BRVO with ME - heme in NFL .	Branch retinal vein occlusion with macular edema of left eye H34.8320 362.36 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.83 Treatment Hx : IVA OS - 2 / 2 / 18 ( today ) 1 ) BRVO with ME - [s2] heme [e2] in NFL .	laterality	lesion	T2	T4	note_9103
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	severity	lesion	T4	T2	2453695_note_6919
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	severity	lesion	T4	T9	2453695_note_6919
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	laterality	lesion	T5	T2	2453695_note_6919
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3313 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 3 .	laterality	lesion	T5	T9	2453695_note_6919
NonRel	Otherwise [s1] mild [e1] NPDR and cataract Impression / Plan : 1 .	Otherwise mild [s2] NPDR [e2] and cataract Impression / Plan : 1 .	severity	lesion	T6	T3	2453695_note_6919
NonRel	( History ) Patient Active Problem List Diagnosis Date Noted • Brain lesion DATE • Migraine syndrome DATE • History of stroke DATE • Tobacco abuse DATE • Dyslipidemia DATE • Kidney stones DATE • Type 2 diabetes mellitus with [s1] mild [e1] nonproliferative retinopathy DATE • Essential hypertension DATE No Known Allergies Current Outpatient Prescriptions Medication Sig Dispense Refill • atorvastatin ( LIPITOR ) 20 MG PO Tablet Take 1 tablet by mouth nightly at bedtime .	( History ) Patient Active Problem List Diagnosis Date Noted • Brain lesion DATE • Migraine syndrome DATE • History of stroke DATE • Tobacco abuse DATE • Dyslipidemia DATE • Kidney stones DATE • Type 2 diabetes mellitus with mild [s2] nonproliferative retinopathy [e2] DATE • Essential hypertension DATE No Known Allergies Current Outpatient Prescriptions Medication Sig Dispense Refill • atorvastatin ( LIPITOR ) 20 MG PO Tablet Take 1 tablet by mouth nightly at bedtime .	severity	lesion	T8	T7	2453695_note_6919
NonRel	[s1] Mild [e1] NPDR with macular edema OS : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	Mild [s2] NPDR [e2] with macular edema OS : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	severity	lesion	T10	T11	2453695_note_6919
NonRel	[s1] Mild [e1] NPDR with macular edema OS : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	Mild NPDR with [s2] macular edema [e2] OS : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	severity	lesion	T10	T12	2453695_note_6919
NonRel	[s1] Mild [e1] NPDR with macular edema OS : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	Mild NPDR with macular edema OS : [s2] Macular edema [e2] OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	severity	lesion	T10	T13	2453695_note_6919
NonRel	Mild NPDR with macular edema [s1] OS [e1] : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	Mild [s2] NPDR [e2] with macular edema OS : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	laterality	lesion	T14	T11	2453695_note_6919
NonRel	Mild NPDR with macular edema [s1] OS [e1] : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	Mild NPDR with [s2] macular edema [e2] OS : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	laterality	lesion	T14	T12	2453695_note_6919
NonRel	Mild NPDR with macular edema [s1] OS [e1] : Macular edema OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	Mild NPDR with macular edema OS : [s2] Macular edema [e2] OS today , likely combination of HTN retinopathy and DM 2 retinopathy Stressed tight BG / BP control with goal A1c < 6.5 % - Discussed with Dr. NAME , patient will see him next week for consideration of focal laser vs anti - vegf injections 3 .	laterality	lesion	T14	T13	2453695_note_6919
NonRel	Hypertensive Retinopathy OU Arteriolar narrowing , AV crossing changes and significant CWS OU with macular edema superiorly [s1] OS [e1] today , likely combination of HTN / DM 2 BP elevated at 170 / 90 today Stressed importance of HNT control , especially in the setting of DM 2 , patient voiced understanding 6 .	Hypertensive Retinopathy OU Arteriolar narrowing , AV crossing changes and significant CWS OU with [s2] macular edema [e2] superiorly OS today , likely combination of HTN / DM 2 BP elevated at 170 / 90 today Stressed importance of HNT control , especially in the setting of DM 2 , patient voiced understanding 6 .	laterality	lesion	T16	T15	2453695_note_6919
NonRel	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Continued superior and superotemporal edema and exudation OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes OD : Continued superior and superotemporal edema and [s2] exudation [e2] OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	laterality	lesion	T2	T1	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR with DME [s1] Right Post [e1] - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : [s2] PDR [e2] with DME Right Post - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T5	T3	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR with DME [s1] Right Post [e1] - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : PDR with [s2] DME [e2] Right Post - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T5	T4	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : [s1] Severe [e1] NPDR with DME Left Post - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Severe [s2] NPDR [e2] with DME Left Post - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	severity	lesion	T6	T7	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : [s1] Severe [e1] NPDR with DME Left Post - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Severe NPDR with [s2] DME [e2] Left Post - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	severity	lesion	T6	T8	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : Severe NPDR with DME [s1] Left Post [e1] - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Severe [s2] NPDR [e2] with DME Left Post - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T9	T7	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : Severe NPDR with DME [s1] Left Post [e1] - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	INVASIVE PROCEDURE NOTE Pre - op DX : Severe NPDR with [s2] DME [e2] Left Post - op DX : Same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T9	T8	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T11	T10	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T11	T13	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T14	T12	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T14	T15	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T14	T16	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T14	T18	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T14	T20	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T17	T12	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T17	T15	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T17	T16	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T17	T18	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T17	T20	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T19	T12	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T19	T15	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T19	T16	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T19	T18	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T19	T20	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Severe [s2] NPDR [e2] OS .	severity	lesion	T21	T22	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T23	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T24	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T24	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T24	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T24	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	severity	lesion	T24	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	severity	lesion	T24	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T26	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T26	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T26	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T26	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	laterality	lesion	T26	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	laterality	lesion	T26	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T27	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T27	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T27	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T27	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	severity	lesion	T27	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	severity	lesion	T27	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T29	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T29	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T29	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T29	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	laterality	lesion	T29	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	laterality	lesion	T29	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T31	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T31	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T31	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T31	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	laterality	lesion	T31	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	laterality	lesion	T31	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T32	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T32	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T32	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T32	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	severity	lesion	T32	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	severity	lesion	T32	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T34	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T34	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T34	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T34	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	laterality	lesion	T34	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	laterality	lesion	T34	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T35	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T35	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T35	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T35	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	laterality	lesion	T35	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	laterality	lesion	T35	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T36	T25	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T36	T28	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T36	T30	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T36	T33	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	severity	lesion	T36	T37	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	severity	lesion	T36	T38	note_2248
NonRel	[s1] OS [e1] - Severe NPDR with CSME . IVA OS today .	OS - Severe [s2] NPDR [e2] with CSME . IVA OS today .	laterality	lesion	T40	T42	note_2248
NonRel	[s1] OS [e1] - Severe NPDR with CSME . IVA OS today .	OS - Severe NPDR with [s2] CSME [e2] . IVA OS today .	laterality	lesion	T40	T43	note_2248
NonRel	OS - [s1] Severe [e1] NPDR with CSME . IVA OS today .	OS - Severe [s2] NPDR [e2] with CSME . IVA OS today .	severity	lesion	T41	T42	note_2248
NonRel	OS - [s1] Severe [e1] NPDR with CSME . IVA OS today .	OS - Severe NPDR with [s2] CSME [e2] . IVA OS today .	severity	lesion	T41	T43	note_2248
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by retinopathy without macular edema , with long - term current use of insulin , unspecified retinopathy severity E11.319 250.50 Z79.4 362.01 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by retinopathy without [s2] macular edema [e2] , with long - term current use of insulin , unspecified retinopathy severity E11.319 250.50 Z79.4 362.01 V58.67 2 .	laterality	lesion	T10	T5	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - [s1] Severe [e1] NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe [s2] NPDR [e2] without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T11	T1	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - [s1] Severe [e1] NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without [s2] CSME [e2] OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T11	T2	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - [s1] Severe [e1] NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active [s2] PDR [e2] without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T11	T3	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - [s1] Severe [e1] NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without [s2] CSME [e2] , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T11	T4	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - [s1] Severe [e1] NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without CSME , + [s2] SHH [e2] inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T11	T8	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) [s1] OD [e1] - Severe NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe [s2] NPDR [e2] without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T12	T1	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) [s1] OD [e1] - Severe NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without [s2] CSME [e2] OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T12	T2	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) [s1] OD [e1] - Severe NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active [s2] PDR [e2] without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T12	T3	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) [s1] OD [e1] - Severe NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without [s2] CSME [e2] , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T12	T4	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) [s1] OD [e1] - Severe NPDR without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without CSME , + [s2] SHH [e2] inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T12	T8	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME [s1] OS [e1] - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe [s2] NPDR [e2] without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T13	T1	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME [s1] OS [e1] - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without [s2] CSME [e2] OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T13	T2	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME [s1] OS [e1] - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active [s2] PDR [e2] without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T13	T3	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME [s1] OS [e1] - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without [s2] CSME [e2] , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T13	T4	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME [s1] OS [e1] - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without CSME , + [s2] SHH [e2] inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	laterality	lesion	T13	T8	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - [s1] Active [e1] PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe [s2] NPDR [e2] without CSME OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T14	T1	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - [s1] Active [e1] PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without [s2] CSME [e2] OS - Active PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T14	T2	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - [s1] Active [e1] PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active [s2] PDR [e2] without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T14	T3	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - [s1] Active [e1] PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without [s2] CSME [e2] , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T14	T4	1741070_note_4310
NonRel	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - [s1] Active [e1] PDR without CSME , + SHH inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	Status post corneal transplant DSEK OD DATE , OS 2 / 11 Z94.7 V42.5 1 ) DM ( Type II ; 6.9 % last A1C ) OD - Severe NPDR without CSME OS - Active PDR without CSME , + [s2] SHH [e2] inferiorly Retinal Ischemia OS . - VA OS 20 / 50 OS , improved from DATE .	severity	lesion	T14	T8	1741070_note_4310
NonRel	Inferior subhyaloid hemorrhage [s1] OS [e1] .	Inferior [s2] subhyaloid hemorrhage [e2] OS .	laterality	lesion	T15	T9	1741070_note_4310
NonRel	[s1] Inferior [e1] subhyaloid hemorrhage OS .	Inferior [s2] subhyaloid hemorrhage [e2] OS .	severity	lesion	T16	T9	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] - blunted foveal contour , no macular edema OS - blunted foveal contour , no macular edema NAME .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no [s2] macular edema [e2] OS - blunted foveal contour , no macular edema NAME .	laterality	lesion	T17	T6	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] - blunted foveal contour , no macular edema OS - blunted foveal contour , no macular edema NAME .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema OS - blunted foveal contour , no [s2] macular edema [e2] NAME .	laterality	lesion	T17	T7	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema [s1] OS [e1] - blunted foveal contour , no macular edema NAME .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no [s2] macular edema [e2] OS - blunted foveal contour , no macular edema NAME .	laterality	lesion	T18	T6	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema [s1] OS [e1] - blunted foveal contour , no macular edema NAME .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema OS - blunted foveal contour , no [s2] macular edema [e2] NAME .	laterality	lesion	T18	T7	1741070_note_4310
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 4 .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 4 .	laterality	lesion	T20	T19	1741070_note_4310
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T2	T1	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T2	T3	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T5	T4	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T5	T6	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T5	T8	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T5	T9	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T7	T4	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T7	T6	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T7	T8	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T7	T9	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T2	T1	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T2	T3	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T5	T4	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T5	T6	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of [s2] PDR [e2] OU , s / p PPV OS , and PRP OD .	laterality	lesion	T5	T12	note_4017
NonRel	[s1] OD [e1] VH has responded very well to treatment with IVA .	OD [s2] VH [e2] has responded very well to treatment with IVA .	laterality	lesion	T7	T8	note_4017
NonRel	Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T9	T10	note_4017
NonRel	Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T9	T11	note_4017
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR [s1] OU [e1] , s / p PPV OS , and PRP OD .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T13	T4	note_4017
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR [s1] OU [e1] , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T13	T6	note_4017
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR [s1] OU [e1] , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of [s2] PDR [e2] OU , s / p PPV OS , and PRP OD .	laterality	lesion	T13	T12	note_4017
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T1	T3	note_2444
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T1	T4	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T2	T3	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T2	T4	note_2444
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T5	T7	note_2444
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T5	T8	note_2444
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T5	T9	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T6	T7	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T6	T8	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T6	T9	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T10	T7	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T10	T8	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T10	T9	note_2444
NonRel	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] [s1] OD [e1] - Severe NPDR without CSME .	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe [s2] NPDR [e2] without CSME .	laterality	lesion	T11	T13	note_2444
NonRel	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] [s1] OD [e1] - Severe NPDR without CSME .	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe NPDR without [s2] CSME [e2] .	laterality	lesion	T11	T14	note_2444
NonRel	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - [s1] Severe [e1] NPDR without CSME .	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe [s2] NPDR [e2] without CSME .	severity	lesion	T12	T13	note_2444
NonRel	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - [s1] Severe [e1] NPDR without CSME .	Treatment HX IVA OS - 7 / 27 / 18 EXTEND 8 WEEKS IVA OS - 6 / 1 / 18 EXTEND 7 WEEKS IVA OS - 4 / 6 / 18 IVA OS - 3 / 2 / 18 IVA OS - 1 / 12 / 18 IVA OS - 12 / 8 / 17 1 ) IDDM [ Type 2 , A1C 7.2 ( 02 / 2018 ) ] OD - Severe NPDR without [s2] CSME [e2] .	severity	lesion	T12	T14	note_2444
NonRel	[s1] OS [e1] - Severe NPDR with ciCSME .	OS - Severe [s2] NPDR [e2] with ciCSME .	laterality	lesion	T15	T17	note_2444
NonRel	[s1] OS [e1] - Severe NPDR with ciCSME .	OS - Severe NPDR with [s2] ciCSME [e2] .	laterality	lesion	T15	T18	note_2444
NonRel	OS - [s1] Severe [e1] NPDR with ciCSME .	OS - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T16	T17	note_2444
NonRel	OS - [s1] Severe [e1] NPDR with ciCSME .	OS - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T16	T18	note_2444
NonRel	OD - small new cystic pocket temporally [s1] OS [e1] - stable IRF temporally RTC 12 weeks DFE OU , Optos IVFA ( Transit OS ) Mac OCT OU Gavin Reed , MD . participated in the care of this patient .	OD - small new cystic pocket temporally OS - stable [s2] IRF [e2] temporally RTC 12 weeks DFE OU , Optos IVFA ( Transit OS ) Mac OCT OU Gavin Reed , MD . participated in the care of this patient .	laterality	lesion	T22	T21	note_2444
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 OCT , Retina - OU - Both Eyes Color Fundus Photography - OD - Right Eye Return patient here today for eval of Valsalva induced SHH during exercise .	Subhyaloid hemorrhage of right eye H35.61 362.81 OCT , Retina - OU - Both Eyes Color Fundus Photography - OD - Right Eye Return patient here today for eval of Valsalva induced [s2] SHH [e2] during exercise .	laterality	lesion	T7	T1	1424866_note_3176
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 OCT , Retina - OU - Both Eyes Color Fundus Photography - OD - Right Eye Return patient here today for eval of Valsalva induced SHH during exercise .	[s2] Subhyaloid hemorrhage [e2] of right eye H35.61 362.81 OCT , Retina - OU - Both Eyes Color Fundus Photography - OD - Right Eye Return patient here today for eval of Valsalva induced SHH during exercise .	laterality	lesion	T7	T5	1424866_note_3176
NonRel	1 ) Subhyaloid Hemorrhage OD ( Valsalva ) - Continues to decrease in size , with now some break through [s1] mild [e1] diffuse VH .	1 ) Subhyaloid Hemorrhage OD ( Valsalva ) - Continues to decrease in size , with now some break through mild diffuse [s2] VH [e2] .	severity	lesion	T8	T4	1424866_note_3176
NonRel	1 ) Subhyaloid Hemorrhage OD ( Valsalva ) - Continues to decrease in size , with now some break through [s1] mild [e1] diffuse VH .	1 ) [s2] Subhyaloid Hemorrhage [e2] OD ( Valsalva ) - Continues to decrease in size , with now some break through mild diffuse VH .	severity	lesion	T8	T6	1424866_note_3176
NonRel	1 ) Subhyaloid Hemorrhage [s1] OD [e1] ( Valsalva ) - Continues to decrease in size , with now some break through mild diffuse VH .	1 ) Subhyaloid Hemorrhage OD ( Valsalva ) - Continues to decrease in size , with now some break through mild diffuse [s2] VH [e2] .	laterality	lesion	T9	T4	1424866_note_3176
NonRel	1 ) Subhyaloid Hemorrhage [s1] OD [e1] ( Valsalva ) - Continues to decrease in size , with now some break through mild diffuse VH .	1 ) [s2] Subhyaloid Hemorrhage [e2] OD ( Valsalva ) - Continues to decrease in size , with now some break through mild diffuse VH .	laterality	lesion	T9	T6	1424866_note_3176
NonRel	NAME , MD [s1] mild [e1] VH break through , previous location was SHH	NAME , MD mild VH break through , previous location was [s2] SHH [e2]	severity	lesion	T10	T2	1424866_note_3176
NonRel	NAME , MD [s1] mild [e1] VH break through , previous location was SHH	NAME , MD mild [s2] VH [e2] break through , previous location was SHH	severity	lesion	T10	T3	1424866_note_3176
NonRel	OCT , Posterior Segment - OU - [s1] Both Eyes [e1] Interval resolution of ME OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with Macular Edema OS Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Interval resolution of [s2] ME [e2] OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with Macular Edema OS Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T7	T1	1936668_note_5255
NonRel	OCT , Posterior Segment - OU - [s1] Both Eyes [e1] Interval resolution of ME OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with Macular Edema OS Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Interval resolution of ME OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with [s2] Macular Edema [e2] OS Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T7	T4	1936668_note_5255
NonRel	OCT , Posterior Segment - OU - Both Eyes Interval resolution of ME OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with Macular Edema [s1] OS [e1] Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Interval resolution of [s2] ME [e2] OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with Macular Edema OS Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T8	T1	1936668_note_5255
NonRel	OCT , Posterior Segment - OU - Both Eyes Interval resolution of ME OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with Macular Edema [s1] OS [e1] Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes Interval resolution of ME OPH - OS Intravitreal Injection , Pharmacologic Agent Date : DATE Patient Name : NAME Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : BRVO with [s2] Macular Edema [e2] OS Post - op DX : same Attending : NAME , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of bevacizumab standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T8	T4	1936668_note_5255
NonRel	Branch retinal vein occlusion with macular edema of [s1] left eye [e1] H34.8320 362.36 OCT , Posterior Segment - OU - Both Eyes 362.83 OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	Branch retinal vein occlusion with [s2] macular edema [e2] of left eye H34.8320 362.36 OCT , Posterior Segment - OU - Both Eyes 362.83 OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T9	T5	1936668_note_5255
NonRel	BRVO with macular edema [s1] OS [e1] - Previously treated at UFH , saw retina MD in LOCATION _ CITY , FL and was receiving IVA injections OS q6 - 8 weeks , last ~ DATE .	BRVO with [s2] macular edema [e2] OS - Previously treated at UFH , saw retina MD in LOCATION _ CITY , FL and was receiving IVA injections OS q6 - 8 weeks , last ~ DATE .	laterality	lesion	T10	T6	1936668_note_5255
NonRel	OCT , Posterior Segment - OU - Both Eyes IRF [s1] OU [e1] , exudates OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : ciCSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF OU , [s2] exudates [e2] OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : ciCSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T1	T2	note_5742
NonRel	OCT , Posterior Segment - OU - Both Eyes IRF [s1] OU [e1] , exudates OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : ciCSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF OU , exudates OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] ciCSME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T1	T4	note_5742
NonRel	OCT , Posterior Segment - OU - Both Eyes IRF OU , exudates OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : ciCSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF OU , [s2] exudates [e2] OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : ciCSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T3	T2	note_5742
NonRel	OCT , Posterior Segment - OU - Both Eyes IRF OU , exudates OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : ciCSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF OU , exudates OU interval improvement OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] ciCSME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T3	T4	note_5742
NonRel	OPH - OS Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Intravitreal Injection Procedure Note Eye : [s1] OS [e1] Pre - op DX : ciCSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	OPH - OS Intravitreal Injection , Pharmacologic Agent Date : 7 / 22 / 2018 Patient Name : Bryan Scott Crawford Intravitreal Injection Procedure Note Eye : OS Pre - op DX : [s2] ciCSME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Lucentis standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T5	T6	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T7	T8	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T7	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T9	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T9	T10	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T11	T12	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T11	T14	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T11	T16	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T11	T18	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T11	T23	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T11	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T13	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T13	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T13	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T13	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T13	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T13	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T15	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T15	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T15	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T15	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T15	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T15	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T17	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T17	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T17	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T17	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T17	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T17	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T19	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T19	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T19	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T20	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T20	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T20	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T20	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T20	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T20	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T21	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T21	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T21	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T21	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T21	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T21	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T22	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T22	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T22	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T22	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T22	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T22	T24	note_5742
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T26	T28	note_5742
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T26	T29	note_5742
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	OS - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T27	T28	note_5742
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	OS - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T27	T29	note_5742
NonRel	IRF significantly improved [s1] OS [e1] since the last visit when brought back at shorter interval .	[s2] IRF [e2] significantly improved OS since the last visit when brought back at shorter interval .	laterality	lesion	T31	T30	note_5742
NonRel	IRF [s1] significantly improved [e1] OS since the last visit when brought back at shorter interval .	[s2] IRF [e2] significantly improved OS since the last visit when brought back at shorter interval .	severity	lesion	T32	T30	note_5742
NonRel	NIDDM with [s1] mild [e1] NPDR OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH OU 2 .	NIDDM with mild [s2] NPDR [e2] OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH OU 2 .	severity	lesion	T3	T1	1795334_note_4352
NonRel	NIDDM with [s1] mild [e1] NPDR OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH OU 2 .	NIDDM with mild NPDR OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single [s2] DBH [e2] OU 2 .	severity	lesion	T3	T2	1795334_note_4352
NonRel	NIDDM with mild NPDR [s1] OU [e1] - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH OU 2 .	NIDDM with mild [s2] NPDR [e2] OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH OU 2 .	laterality	lesion	T4	T1	1795334_note_4352
NonRel	NIDDM with mild NPDR [s1] OU [e1] - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH OU 2 .	NIDDM with mild NPDR OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single [s2] DBH [e2] OU 2 .	laterality	lesion	T4	T2	1795334_note_4352
NonRel	NIDDM with mild NPDR OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH [s1] OU [e1] 2 .	NIDDM with mild [s2] NPDR [e2] OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH OU 2 .	laterality	lesion	T5	T1	1795334_note_4352
NonRel	NIDDM with mild NPDR OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single DBH [s1] OU [e1] 2 .	NIDDM with mild NPDR OU - VA DATE and DATE - Last A1c 5.6 - Mac OCT without CME - Exam with single [s2] DBH [e2] OU 2 .	laterality	lesion	T5	T2	1795334_note_4352
NonRel	OCT , Retina - OU - Both Eyes IRF without significant interval changes OU OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 4 / 8 / 2018 Patient Name : Robert L Chaffin Jr. Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : [s1] OD [e1] Pre - op DX : CSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Retina - OU - Both Eyes IRF without significant interval changes OU OPH - OD Intravitreal Injection , Pharmacologic Agent Date : 4 / 8 / 2018 Patient Name : Robert L Chaffin Jr. Procedure : Intravitreal Injection , OD Intravitreal Injection Procedure Note Eye : OD Pre - op DX : [s2] CSME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T11	T1	note_1128
NonRel	OPH - OS Intravitreal Injection , Pharmacologic Agent Date : 4 / 8 / 2018 Patient Name : Robert L Chaffin Jr. Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : [s1] OS [e1] Pre - op DX : CSME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	OPH - OS Intravitreal Injection , Pharmacologic Agent Date : 4 / 8 / 2018 Patient Name : Robert L Chaffin Jr. Procedure : Intravitreal Injection , OS Intravitreal Injection Procedure Note Eye : OS Pre - op DX : [s2] CSME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Pladget used : yes Procedure performed : Intravitreal injection of 0.05 mL of Avastin standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T12	T2	note_1128
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	Type 2 diabetes mellitus with both eyes affected by moderate [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	severity	lesion	T13	T3	note_1128
NonRel	Type 2 diabetes mellitus with both eyes affected by [s1] moderate [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	severity	lesion	T13	T4	note_1128
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	Type 2 diabetes mellitus with both eyes affected by moderate [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	laterality	lesion	T14	T3	note_1128
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by moderate nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	Type 2 diabetes mellitus with both eyes affected by moderate nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3313 250.50 OCT , Retina - OU - Both Eyes Z79.4 362.05 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent V58.67 Hx of ciCSME OU being treated with IVA OU .	laterality	lesion	T14	T4	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T15	T5	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T15	T6	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T15	T7	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T15	T8	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T15	T9	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] [s1] Moderate [e1] NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T15	T10	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T16	T5	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T16	T6	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T16	T7	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T16	T8	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T16	T9	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME [s1] OU [e1] OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T16	T10	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T17	T5	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T17	T6	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T17	T7	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T17	T8	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T17	T9	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU [s1] OD [e1] - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T17	T10	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T18	T5	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T18	T6	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T18	T7	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T18	T8	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T18	T9	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - [s1] Moderate [e1] NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T18	T10	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA [s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T19	T5	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA [s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T19	T6	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA [s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T19	T7	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA [s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T19	T8	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA [s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T19	T9	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA [s1] OS [e1] - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	laterality	lesion	T19	T10	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate [s2] NPDR [e2] with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T20	T5	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with [s2] CSME [e2] OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T20	T6	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate [s2] NPDR [e2] with CSME , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T20	T7	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with [s2] CSME [e2] , stable on IVA OS - Moderate NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T20	T8	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate [s2] NPDR [e2] with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T20	T9	note_1128
NonRel	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - [s1] Moderate [e1] NPDR with CSME , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	Treatment History IVA OU - 4 / 6 / 18 IVA OU - 3 / 2 / 18 IVA OU - 1 / 26 / 17 IVA OU - 12 / 15 / 17 IVA OU - 11 / 9 / 17 IVA OU - 10 / 6 / 17 IVA OS - 7 / 20 / 2017 IVA OS - 6 / 13 / 2017 IVA OU - Kay ( 4 / 7 / 17 ) Intravitreal injection OU ( with Dr. Kay , April 2017 ) 1 ) IDDM - [ Dx 2002 ] Moderate NPDR with CSME OU OD - Moderate NPDR with CSME , stable on IVA OS - Moderate NPDR with [s2] CSME [e2] , stable on IVA Plateau response to IVA Consider switch to IVL OU if any worsening .	severity	lesion	T20	T10	note_1128
NonRel	OCT , Posterior Segment - OU - [s1] Both Eyes [e1] IRF , exudation Intravitreal Injection Procedure Note Eye : OS Pre - op DX : DME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF , [s2] exudation [e2] Intravitreal Injection Procedure Note Eye : OS Pre - op DX : DME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T2	T1	note_1962
NonRel	OCT , Posterior Segment - OU - [s1] Both Eyes [e1] IRF , exudation Intravitreal Injection Procedure Note Eye : OS Pre - op DX : DME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF , exudation Intravitreal Injection Procedure Note Eye : OS Pre - op DX : [s2] DME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T2	T23	note_1962
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T3	T4	note_1962
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T3	T6	note_1962
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T5	T4	note_1962
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3313 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T5	T6	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - [s1] OS [e1] : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T7	T10	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - [s1] OS [e1] : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T7	T13	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - [s1] OS [e1] : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T7	T16	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : [s1] Moderate [e1] / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T8	T10	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : [s1] Moderate [e1] / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T8	T13	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : [s1] Moderate [e1] / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T8	T16	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / [s1] severe NPDR [e1] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T9	T10	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / [s1] severe NPDR [e1] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T9	T13	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / [s1] severe NPDR [e1] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T9	T16	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] OD [e1] : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T11	T10	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] OD [e1] : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T11	T13	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] OD [e1] : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T11	T16	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : [s1] Moderate [e1] NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T12	T10	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : [s1] Moderate [e1] NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T12	T13	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : [s1] Moderate [e1] NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T12	T16	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 [s1] OD - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T14	T10	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 [s1] OD - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T14	T13	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 [s1] OD - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T14	T16	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T15	T10	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T15	T13	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T15	T16	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T17	T19	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T18	T19	note_1962
NonRel	OCT , Posterior Segment - OU - Both Eyes IRF , exudation Intravitreal Injection Procedure Note Eye : [s1] OS [e1] Pre - op DX : DME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF , [s2] exudation [e2] Intravitreal Injection Procedure Note Eye : OS Pre - op DX : DME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T22	T1	note_1962
NonRel	OCT , Posterior Segment - OU - Both Eyes IRF , exudation Intravitreal Injection Procedure Note Eye : [s1] OS [e1] Pre - op DX : DME Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	OCT , Posterior Segment - OU - Both Eyes IRF , exudation Intravitreal Injection Procedure Note Eye : OS Pre - op DX : [s2] DME [e2] Post - op DX : same Attending : Siva Iyer , MD Anesthesia : Topical Tetracaine / Proparacaine Procedure performed : Intravitreal injection of 0.05 mL of Eylea standard dose Description of Procedure : The patient was brought to the examination room .	laterality	lesion	T22	T23	note_1962
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T12	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T12	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T13	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T13	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T14	T3	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T14	T4	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T14	T5	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T15	T3	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T15	T4	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T15	T5	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T16	T3	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T16	T4	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T16	T5	1162635_note_2414
NonRel	OS - [s1] Severe [e1] NPDR with ME .	OS - Severe [s2] NPDR [e2] with ME .	severity	lesion	T17	T6	1162635_note_2414
NonRel	OS - [s1] Severe [e1] NPDR with ME .	OS - Severe NPDR with [s2] ME [e2] .	severity	lesion	T17	T7	1162635_note_2414
NonRel	[s1] OS [e1] - Severe NPDR with ME .	OS - Severe [s2] NPDR [e2] with ME .	laterality	lesion	T18	T6	1162635_note_2414
NonRel	[s1] OS [e1] - Severe NPDR with ME .	OS - Severe NPDR with [s2] ME [e2] .	laterality	lesion	T18	T7	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T19	T8	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T19	T9	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T19	T10	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T19	T11	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD [s1] OD [e1] OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T19	T26	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T20	T8	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T20	T9	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T20	T10	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T20	T11	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos [s1] OS [e1] with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T20	T26	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	severity	lesion	T21	T8	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	severity	lesion	T21	T9	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	severity	lesion	T21	T10	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	severity	lesion	T21	T11	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with [s1] significant [e1] cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	severity	lesion	T21	T26	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T22	T23	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T22	T24	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T25	T23	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T25	T24	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without [s2] macular edema [e2] OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T27	T8	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant [s2] cotton wool spots [e2] , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T27	T9	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , [s2] exudates [e2] and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T27	T10	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and [s2] hemorrhages [e2] OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T27	T11	1162635_note_2414
NonRel	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally [s1] OS [e1] OCT with diabetic macular edema Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	RTC Friday DATE for IVA OD OD OCT without macular edema OD photo with dot blot hemorrhages IVFA OD with several areas of hyperfluorescence , mild ischemia peripherally OS OCT with [s2] diabetic macular edema [e2] Optos OS with significant cotton wool spots , exudates and hemorrhages OS with significant areas of vascular leakage NAME , MD participated in the care of this patient .	laterality	lesion	T27	T26	1162635_note_2414
NonRel	Color Fundus Photography - OU - Both Eyes [s1] OD [e1] : 2 - 3 DD area of sub - hyaloid hemorrhage superior to the nerve .	Color Fundus Photography - OU - Both Eyes OD : 2 - 3 DD area of [s2] sub - hyaloid hemorrhage [e2] superior to the nerve .	laterality	lesion	T3	T1	note_3128
NonRel	Mac OCT [s1] OS [e1] shows laser scarring with no IRF .	Mac OCT OS shows laser scarring with no [s2] IRF [e2] .	laterality	lesion	T7	T6	note_3956
NonRel	Mac OCT [s1] OD [e1] shows atrophy and IRF .	Mac OCT OD shows atrophy and [s2] IRF [e2] .	laterality	lesion	T8	T5	note_3956
NonRel	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal NVE ; small vit heme [s1] OS [e1] .	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal [s2] NVE [e2] ; small vit heme OS .	laterality	lesion	T10	T4	note_3956
NonRel	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal NVE ; small vit heme [s1] OS [e1] .	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal NVE ; small [s2] vit heme [e2] OS .	laterality	lesion	T10	T9	note_3956
NonRel	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal NVE ; [s1] small [e1] vit heme OS .	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal [s2] NVE [e2] ; small vit heme OS .	severity	lesion	T11	T4	note_3956
NonRel	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal NVE ; [s1] small [e1] vit heme OS .	Exam showed inferotemporal fibrovascular membrane w / subhyaloid hemorrhage OD and Nasal NVE ; small [s2] vit heme [e2] OS .	severity	lesion	T11	T9	note_3956
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3593 250.50 362.02 Pt w / hx of diabetic retinopathy seen previously by outside retina specialist who no longers takes her insurance .	[s2] Proliferative diabetic retinopathy [e2] of both eyes associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3593 250.50 362.02 Pt w / hx of diabetic retinopathy seen previously by outside retina specialist who no longers takes her insurance .	laterality	lesion	T12	T1	note_3956
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3593 250.50 362.02 Pt w / hx of diabetic retinopathy seen previously by outside retina specialist who no longers takes her insurance .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , [s2] macular edema [e2] presence unspecified E11.3593 250.50 362.02 Pt w / hx of diabetic retinopathy seen previously by outside retina specialist who no longers takes her insurance .	laterality	lesion	T12	T2	note_3956
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3593 250.50 362.02 Pt w / hx of diabetic retinopathy seen previously by outside retina specialist who no longers takes her insurance .	Proliferative diabetic retinopathy of both eyes associated with type 2 diabetes mellitus , macular edema presence unspecified E11.3593 250.50 362.02 Pt w / hx of [s2] diabetic retinopathy [e2] seen previously by outside retina specialist who no longers takes her insurance .	laterality	lesion	T12	T3	note_3956
NonRel	Treatment Hx IVFA - PRP and focal laser scars with [s1] active [e1] NVE OU .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible [s2] NVE [e2] seen clinically .	severity	lesion	T9	T3	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with [s1] active [e1] NVE OU .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o [s2] PDR [e2] OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	severity	lesion	T9	T18	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with active NVE [s1] OU [e1] .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible [s2] NVE [e2] seen clinically .	laterality	lesion	T10	T3	note_439
NonRel	Treatment Hx IVFA - PRP and focal laser scars with active NVE [s1] OU [e1] .	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o [s2] PDR [e2] OU s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	laterality	lesion	T10	T18	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR OU s / p PRP OU Referred from Dr. Grieser for evaluation of [s1] possible [e1] NVE seen clinically .	Treatment Hx IVFA - PRP and focal laser scars with active [s2] NVE [e2] OU .	severity	lesion	T11	T4	note_439
NonRel	Today with active + NVE [s1] OU [e1] demonstrated on IVFA .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	laterality	lesion	T12	T6	note_439
NonRel	Today with [s1] active [e1] + NVE OU demonstrated on IVFA .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	severity	lesion	T13	T6	note_439
NonRel	OD - [s1] Mild [e1] NVE in mid - periphery , but well - lasered .	Today with active + [s2] NVE [e2] OU demonstrated on IVFA .	severity	lesion	T14	T5	note_439
NonRel	OD - [s1] Mild [e1] NVE in mid - periphery , but well - lasered .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	severity	lesion	T14	T7	note_439
NonRel	[s1] OD [e1] - Mild NVE in mid - periphery , but well - lasered .	Today with active + [s2] NVE [e2] OU demonstrated on IVFA .	laterality	lesion	T15	T5	note_439
NonRel	[s1] OD [e1] - Mild NVE in mid - periphery , but well - lasered .	S / P Focal OS - Mild [s2] NVE [e2] in mid periphery .	laterality	lesion	T15	T7	note_439
NonRel	S / P Focal OS - [s1] Mild [e1] NVE in mid periphery .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	severity	lesion	T16	T6	note_439
NonRel	S / P Focal [s1] OS [e1] - Mild NVE in mid periphery .	OD - Mild [s2] NVE [e2] in mid - periphery , but well - lasered .	laterality	lesion	T17	T6	note_439
NonRel	Diabetes mellitus due to underlying condition with chronic kidney disease on chronic dialysis , with long - term current use of insulin E08 . 22 249.40 N18.6 585.9 Z79.4 V45.11 Z99.2 V58.67 Mr. Caine is a 72 year old male with a h / o PDR [s1] OU [e1] s / p PRP OU Referred from Dr. Grieser for evaluation of possible NVE seen clinically .	Treatment Hx IVFA - PRP and focal laser scars with active [s2] NVE [e2] OU .	laterality	lesion	T19	T4	note_439
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T5	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T7	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T9	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T1	T12	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T1	T16	note_7572
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T1	T17	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T5	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T7	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T9	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T3	T12	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T3	T16	note_7572
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T3	T17	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T6	T2	note_7572
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T6	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T8	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T8	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T10	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T10	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T11	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T11	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T13	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T13	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T4	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T15	T2	note_7572
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.02 Treatment Hx IVL OD - 1 / 16 / 18 IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OU Fluorescein Angiography 362.06 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T15	T4	note_7572
NonRel	[s1] OS [e1] - PDR now s / p PRP .	Atrophic appearance of macula on mac OCT with interval decrease in [s2] CME [e2] .	laterality	lesion	T19	T25	note_7572
NonRel	NVE along superior arcade demonstrated on IVFA from 12 / 16 then s / p PRP . 2 ) Macular Atrophy OS - + subjective APD , OCT confirms atrophic macula with [s1] mild [e1] CME decreased today on Mac OCT as above .	Atrophic appearance of macula on mac OCT with interval decrease in [s2] CME [e2] .	severity	lesion	T22	T25	note_7572
NonRel	She has proliferative diabetic retinopathy s / p panretinal photocoagulation ( PRP ) [s1] OU [e1] ( x 1 ; x 2 ) , both eyes ( Bangladesh ) , and s / p IVL OS ( 4 months ago in Bangladesh ) .	The [s2] neovascularization [e2] ( 2 ) is persistent , increasing , or a new area is now present on the retina or iris requiring further PRP treatments OS .	laterality	lesion	T6	T3	2555907_note_7978
NonRel	The neovascularization ( 2 ) is persistent , increasing , or a new area is now present on the retina or iris requiring further PRP treatments [s1] OS [e1] .	She has [s2] proliferative diabetic retinopathy [e2] s / p panretinal photocoagulation ( PRP ) OU ( x 1 ; x 2 ) , both eyes ( Bangladesh ) , and s / p IVL OS ( 4 months ago in Bangladesh ) .	laterality	lesion	T7	T2	2555907_note_7978
NonRel	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal mild DME [s1] OS [e1] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	laterality	lesion	T11	T13	2555907_note_7978
NonRel	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal [s1] mild [e1] DME OS Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	severity	lesion	T12	T13	2555907_note_7978
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] - Both Eyes E11.3593 250.50 Appt req Opthalmology 362.02 2 .	OCT , Posterior Segment - OU - Both Eyes SD - OCT macula : chronic TRD with MH OD ; juxtafoveal mild [s2] DME [e2] OS Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T14	T10	2555907_note_7978
NonRel	BRVO ( branch retinal vein occlusion ) - Left Eye H34.8392 362.36 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes Here for evaluation of retinal hemorrhages [s1] OS [e1] by Dr Cameron Patient with CKD stage 3 , unsure what caused it but patient reports a ) diabetes and b ) urinary retention from prostate issues as is now on Flomax ( had 2 episoded of sepsis last year , likely secondary to urosepsis ) 1 ) Branch retinal vein occlusion OS - Patient asymptomatic .	Seen by Dr Cameron for glasses Rx . - VA 20 / 20 OS - Exam with a branch retinal vein occlusion inferotemporally , questionable [s2] NVE [e2] in area but unable to confirm with IVFA given his kidney disease .	laterality	lesion	T8	T2	note_702
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 2 diabetes mellitus E11.3591 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent 3 .	laterality	lesion	T8	T9	note_7659
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3592 250.50 Pan Retinal Photocoagulation - OS - Left Eye 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus E11.3591 250.50 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.02 2 .	laterality	lesion	T10	T7	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T13	T19	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T15	T19	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	severity	lesion	T16	T19	note_7659
NonRel	IDDM , + 81 mg ASA Treatment Hx : IVA OU - 6 / 30 / 17 ( today ) PRP OS - 6 / 30 / 17 ( today ) IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] .	laterality	lesion	T18	T19	note_7659
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T5	T8	note_9150
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T5	T10	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T7	T4	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T7	T6	note_9150
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	severity	lesion	T7	T11	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T9	T4	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T9	T6	note_9150
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	laterality	lesion	T9	T11	note_9150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T12	T8	note_9150
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent T2DM x 30 years became insulin dependent 6 - 8 years ago Has had laser in right eye .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T12	T10	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe [s2] NPDR [e2] with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T16	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with [s2] macular edema [e2] OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T17	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - [s2] DBH [e2] and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T19	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and [s2] MAs [e2] in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T20	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small [s2] IRF [e2] adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T22	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , [s2] IRMA [e2] , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T23	note_9150
NonRel	1 . Vitreous hemorrhage [s1] OD [e1] - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of [s2] MAs [e2] temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	laterality	lesion	T14	T24	note_9150
NonRel	[s1] Severe [e1] NPDR with macular edema OD - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	1 . [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	severity	lesion	T15	T13	note_9150
NonRel	Severe NPDR with macular edema [s1] OD [e1] - DBH and MAs in posterior pole - Small IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	1 . [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	laterality	lesion	T18	T13	note_9150
NonRel	Severe NPDR with macular edema OD - DBH and MAs in posterior pole - [s1] Small [e1] IRF adjacent to fovea , likely visually significant with VA 20 / 30 - Venous beading in multiple quadrants , IRMA , cluster of MAs temporally - Would hold off on injection at this time due to good VA and will stabilize OD first Discussed options with patient : 1 - Observe and RTC 1 month 2 - IVA and RTC 1 month 3 - Vitrectomy ( not recommended ) Plan for IVA OD and RTC 1 month Kaihan Fakhar , MD participated in the care of this patient .	1 . [s2] Vitreous hemorrhage [e2] OD - In setting of long - standing insulin - dependent T2DM - Recent rise in A1C from 7.9 ( 1 year ago ) to 10.2 ( in the last 120 days ) - No trauma , caughing , straining - VA CF , IOP 20 - Vit heme most dense inferiorly , no tears / detachment noted superiorly with good view - Inadequate PRP - B - scan with vit heme , no RD 2 .	severity	lesion	T21	T13	note_9150
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T17	T4	2710850_note_9151
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T17	T5	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T18	T2	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.02 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T18	T3	2710850_note_9151
NonRel	Severe nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	[s2] Vitreous hemorrhage [e2] of right eye H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	laterality	lesion	T18	T6	2710850_note_9151
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	Severe [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T19	T4	2710850_note_9151
NonRel	Vitreous hemorrhage of [s1] right eye [e1] H43.11 379.23 OPH - OD Intravitreal Injection , Pharmacologic Agent On Saturday morning he had a hazey view in a small spot that enlarged to cover his entire vision .	Severe nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition E08 . 3412 249.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.06 3 .	laterality	lesion	T19	T5	2710850_note_9151
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 4 .	[s2] Vitreous hemorrhage [e2] , left H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	laterality	lesion	T2	T3	note_5950
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 4 .	Vitreous hemorrhage , left H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new [s2] vit heme [e2] Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	laterality	lesion	T2	T5	note_5950
NonRel	Cystoid macular edema of [s1] left eye [e1] H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 4 .	Vitreous hemorrhage , left H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of [s2] retinal edema [e2] / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	laterality	lesion	T2	T6	note_5950
NonRel	Vitreous hemorrhage , [s1] left [e1] H43.12 379.23 OD : NS Normal OS : NS CRVO with inactive proliferation and macular scar S / p PRP + IVA 8 / 13 / 2015 Now with new vit heme Area of retinal edema / elevation along inferior arcade with likely resolved vitreoadhesion - possible cause of vit heme OCT poor quality but flat with scar .	[s2] Cystoid macular edema [e2] of left eye H35.352 362.53 OCT , Posterior Segment - OU - Both Eyes 4 .	laterality	lesion	T4	T1	note_5950
NonRel	Type 2 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E11.3511 250.50 362.02 362.07 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	laterality	lesion	T14	T3	1483426_note_3695
NonRel	Type 2 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E11.3511 250.50 362.02 362.07 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	laterality	lesion	T14	T4	1483426_note_3695
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	Type 2 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E11.3511 250.50 362.02 362.07 2 .	laterality	lesion	T15	T1	1483426_note_3695
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 CANCELED : Pan Retinal Photocoagulation - OS - Left Eye 362.02 CANCELED : OCT , Retina - OS - Left Eye 3 .	Type 2 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E11.3511 250.50 362.02 362.07 2 .	laterality	lesion	T15	T2	1483426_note_3695
NonRel	Vitreous hemorrhage of [s1] left eye [e1] H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion .	laterality	lesion	T16	T5	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( [s1] mild [e1] NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion .	severity	lesion	T17	T5	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR [s1] OD [e1] ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion .	laterality	lesion	T18	T5	1483426_note_3695
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild [s2] NVD [e2] ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T19	T7	1483426_note_3695
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / [s2] VH [e2] / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T19	T10	1483426_note_3695
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion .	[s2] Vitreous hemorrhage [e2] of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T19	T12	1483426_note_3695
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent [s2] PDR [e2] OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T19	T23	1483426_note_3695
NonRel	PDR [s1] OS [e1] with nasal NVE and peripheral non - perfusion .	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active [s2] PDR [e2] OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	laterality	lesion	T19	T25	1483426_note_3695
NonRel	[s1] Mild [e1] NVD that can be observed at this time .	OS - PDR s / p PRP DATE , IVFA demonstrated new areas of [s2] NVE [e2] on DATE .	severity	lesion	T20	T6	1483426_note_3695
NonRel	[s1] Mild [e1] NVD that can be observed at this time .	OS - [s2] PDR [e2] s / p PRP DATE , IVFA demonstrated new areas of NVE on DATE .	severity	lesion	T20	T22	1483426_note_3695
NonRel	[s1] OS [e1] - PDR s / p PRP DATE , IVFA demonstrated new areas of NVE on DATE .	Mild [s2] NVD [e2] that can be observed at this time .	laterality	lesion	T21	T8	1483426_note_3695
NonRel	[s1] OS [e1] - PDR s / p PRP DATE , IVFA demonstrated new areas of NVE on DATE .	Today with new [s2] VH [e2] .	laterality	lesion	T21	T11	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : [s1] Quiescent [e1] PDR OD ( mild NVD ) , Active PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion .	severity	lesion	T24	T5	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , Active PDR [s1] OS [e1] PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion .	laterality	lesion	T26	T5	1483426_note_3695
NonRel	Vitreous hemorrhage of left eye H43.12 379.23 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment History IVA OS - DATE ( today ) IVFA ( DATE ) : Quiescent PDR OD ( mild NVD ) , [s1] Active [e1] PDR OS PPV / VH / SF 6 OD - DATE PRP OS - ( DATE ) - IVFA - Guided to Nasal Retina OS IVFA ( DATE ) - No view OD due to vit heme .	PDR OS with nasal [s2] NVE [e2] and peripheral non - perfusion .	severity	lesion	T27	T5	1483426_note_3695
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T15	T6	2542462_note_7938
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T15	T7	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T16	T4	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Right Eye E10.3511 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Pan Retinal Photocoagulation - OD - Right Eye OPH - OS Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T16	T5	2542462_note_7938
NonRel	Diabetic macular edema of [s1] left eye [e1] with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	laterality	lesion	T16	T8	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	severity	lesion	T17	T6	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	severity	lesion	T17	T7	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T17	T9	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T17	T10	2542462_note_7938
NonRel	IDDM ( Type I ) - [s1] Active [e1] PDR OU . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T17	T11	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	[s2] Diabetic macular edema [e2] of left eye with proliferative retinopathy associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T18	T6	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Diabetic macular edema of left eye with [s2] proliferative retinopathy [e2] associated with type 1 diabetes mellitus - Left Eye E10.3512 250.51 OPH - OU Fluorescein Angiography 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 OPH - OS Intravitreal Injection , Pharmacologic Agent Treatment history : PRP OD [ IVFA - guided ] - DATE ( today ) IVA OS - DATE ( today ) 1 .	laterality	lesion	T18	T7	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T18	T9	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T18	T10	2542462_note_7938
NonRel	IDDM ( Type I ) - Active PDR [s1] OU [e1] . ( DM duration 30 years .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T18	T11	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	laterality	lesion	T19	T8	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	laterality	lesion	T19	T12	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) [s1] OD [e1] - Active PDR without CSME ( + DME ) on exam .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	laterality	lesion	T19	T33	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	IDDM ( Type I ) - Active [s2] PDR [e2] OU . ( DM duration 30 years .	severity	lesion	T20	T8	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T20	T12	2542462_note_7938
NonRel	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - [s1] Active [e1] PDR without CSME ( + DME ) on exam .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T20	T33	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	severity	lesion	T21	T9	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	severity	lesion	T21	T10	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	severity	lesion	T21	T11	2542462_note_7938
NonRel	OS - [s1] Active [e1] PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] . Treat with IVA concurrently today .	severity	lesion	T21	T13	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active [s2] PDR [e2] without CSME ( + DME ) on exam .	laterality	lesion	T22	T9	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without [s2] CSME [e2] ( + DME ) on exam .	laterality	lesion	T22	T10	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Unknown last A1c. Stage III CKD , CAD s / p CABG , Peripheral Neuropathy ) OD - Active PDR without CSME ( + [s2] DME [e2] ) on exam .	laterality	lesion	T22	T11	2542462_note_7938
NonRel	[s1] OS [e1] - Active PDR with sub - hyaloid hemorrhage .	Mild temporal [s2] macular edema [e2] . Treat with IVA concurrently today .	laterality	lesion	T22	T13	2542462_note_7938
NonRel	[s1] Mild [e1] temporal macular edema . Treat with IVA concurrently today .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T23	T12	2542462_note_7938
NonRel	[s1] Mild [e1] temporal macular edema . Treat with IVA concurrently today .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T23	T33	2542462_note_7938
NonRel	Mild [s1] temporal [e1] macular edema . Treat with IVA concurrently today .	OS - Active [s2] PDR [e2] with sub - hyaloid hemorrhage .	severity	lesion	T24	T12	2542462_note_7938
NonRel	Mild [s1] temporal [e1] macular edema . Treat with IVA concurrently today .	OS - Active PDR with [s2] sub - hyaloid hemorrhage [e2] .	severity	lesion	T24	T33	2542462_note_7938
NonRel	Type 2 diabetes mellitus with [s1] both eyes [e1] affected by proliferative retinopathy and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 Patient does not speak English .	laterality	lesion	T4	T1	2677988_note_8903
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 Patient does not speak English .	Type 2 diabetes mellitus with both eyes affected by [s2] proliferative retinopathy [e2] and traction retinal detachments involving maculae , unspecified long term insulin use status E11.3523 250.50 OCT , Retina - OU - Both Eyes 362.02 Fluorescein Angiography - OU - Both Eyes 361.81 3 .	laterality	lesion	T5	T2	2677988_note_8903
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	severity	lesion	T1	T6	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	severity	lesion	T1	T8	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	laterality	lesion	T3	T6	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	laterality	lesion	T3	T8	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	severity	lesion	T5	T2	note_3786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	severity	lesion	T5	T4	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T2	note_3786
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 362.05 New retina patient here today for evaluation .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Color Fundus Photography - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T4	note_3786
NonRel	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Mild [s2] DME [e2] .	severity	lesion	T10	T14	note_3786
NonRel	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Mild [s2] DME [e2] .	laterality	lesion	T12	T14	note_3786
NonRel	[s1] Mild [e1] DME .	Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T13	T11	note_3786
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] Active [e1] PDR OU 1 .	DMII - Active [s2] PDR [e2] OU .	severity	lesion	T1	T5	note_1196
NonRel	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active PDR [s1] OU [e1] 1 .	DMII - Active [s2] PDR [e2] OU .	laterality	lesion	T3	T5	note_1196
NonRel	DMII - [s1] Active [e1] PDR OU .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	severity	lesion	T4	T2	note_1196
NonRel	DMII - Active PDR [s1] OU [e1] .	S / P 25 g PPV / ML / SDEM / EL / AFx OD 4 / 3 / 17 Z98.890 V45.69 OCT , Posterior Segment - OU - Both Eyes Treatment History PPV / TRD / AFx OD - 4 / 3 / 17 IVA OD ( preop ) - 3 / 31 / 17 PRP OS ( IVFA guided ) - 3 / 31 / 17 IVFA ( 3 / 28 / 2017 ) - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T6	T2	note_1196
NonRel	[s1] Proliferative diabetic retinopathy [e1] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T1	T9	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of left eye with [s1] macular edema [e1] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T2	T9	1145464_note_2230
NonRel	Severe [s1] NPDR [e1] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T12	T9	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s1] PDR [e1] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T13	T9	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s1] NPDR [e1] OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T14	T9	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s1] PDR [e1] with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T15	T9	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s1] ME [e1] .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the [s2] optic nerve [e2] .	lesion	eye_part	T16	T9	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T3	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T4	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T5	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T6	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T7	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T8	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T25	T10	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T11	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	[s2] Vitreous hemorrhage [e2] , right H43.11 379.23 CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T25	T51	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T53	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T54	1145464_note_2230
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T25	T55	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T26	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T26	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T26	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T26	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T26	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T26	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T26	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T27	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T27	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T27	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T27	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T27	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T27	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : [s1] Severe [e1] NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T27	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T28	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T28	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T28	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T28	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T28	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T28	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR [s1] OU [e1] IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T28	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T29	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T29	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T29	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T29	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T29	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T29	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : [s1] Severe [e1] NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T29	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T30	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T30	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T30	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T30	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T30	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T30	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR [s1] OS [e1] IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T30	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T31	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T31	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T31	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T31	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T31	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T31	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates [s1] OD [e1] , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T31	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T32	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T32	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T32	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T32	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T32	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T32	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , [s1] OS [e1] with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T32	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T33	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T33	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T33	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T33	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T33	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T33	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : [s1] Suspected [e1] PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T33	T16	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T34	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T34	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T34	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T34	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T34	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T34	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T34	T16	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T3	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T4	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T5	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T6	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T7	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T8	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T35	T10	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T11	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T35	T17	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T53	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T54	1145464_note_2230
NonRel	[s1] Severe [e1] NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T35	T55	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T3	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T4	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T5	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T6	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T7	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T8	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T36	T10	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T11	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T36	T17	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T53	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T54	1145464_note_2230
NonRel	Severe NPDR [s1] OS [e1] . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T36	T55	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T3	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T4	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T5	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T6	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T7	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T8	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T37	T10	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T11	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T37	T17	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T53	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T54	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T37	T55	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T3	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T4	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T5	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T6	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T7	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T8	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T38	T10	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T11	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T38	T17	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T53	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T54	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T38	T55	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T3	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T4	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T5	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T6	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T7	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T8	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T39	T10	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T11	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	laterality	lesion	T39	T17	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T53	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T54	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Early PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T39	T55	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T3	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T4	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T5	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T6	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T7	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T8	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T40	T10	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T11	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T40	T17	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T53	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T54	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Early [e1] PDR with temporal ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T40	T55	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T3	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T4	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe [s2] NPDR [e2] OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T5	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe [s2] NPDR [e2] OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T6	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , [s2] macular exudates [e2] OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T7	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal [s2] macular exudates [e2] and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T8	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T41	T10	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T11	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	With previous [s2] VH [e2] OD , stable to last visit with observation .	severity	lesion	T41	T17	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of [s2] MAs [e2] , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T53	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + [s2] IRMA [e2] superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T54	1145464_note_2230
NonRel	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with [s1] temporal [e1] ME .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior [s2] vitreous heme [e2] , macular exudates OD , OS with temporal macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T41	T55	1145464_note_2230
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T42	T12	1145464_note_2230
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	laterality	lesion	T42	T13	1145464_note_2230
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	laterality	lesion	T42	T14	1145464_note_2230
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	laterality	lesion	T42	T15	1145464_note_2230
NonRel	With previous VH [s1] OD [e1] , stable to last visit with observation .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	laterality	lesion	T42	T16	1145464_note_2230
NonRel	Repeat of IVFA demonstrated one spot of [s1] mild [e1] NVE .	Clinically still has significant vitreous hemorrhage inferiorly He has [s2] macular edema [e2] .	severity	lesion	T43	T19	1145464_note_2230
NonRel	Repeat of IVFA demonstrated one spot of [s1] mild [e1] NVE .	Clinically still has significant [s2] vitreous hemorrhage [e2] inferiorly He has macular edema .	severity	lesion	T43	T57	1145464_note_2230
NonRel	Rec treatment with PRP OS - [s1] Severe [e1] NPDR with CSME .	Clinically still has significant vitreous hemorrhage inferiorly He has [s2] macular edema [e2] .	severity	lesion	T44	T19	1145464_note_2230
NonRel	Rec treatment with PRP OS - [s1] Severe [e1] NPDR with CSME .	Clinically still has significant [s2] vitreous hemorrhage [e2] inferiorly He has macular edema .	severity	lesion	T44	T57	1145464_note_2230
NonRel	Rec treatment with PRP [s1] OS [e1] - Severe NPDR with CSME .	Clinically still has significant vitreous hemorrhage inferiorly He has [s2] macular edema [e2] .	laterality	lesion	T45	T19	1145464_note_2230
NonRel	Rec treatment with PRP [s1] OS [e1] - Severe NPDR with CSME .	Clinically still has significant [s2] vitreous hemorrhage [e2] inferiorly He has macular edema .	laterality	lesion	T45	T57	1145464_note_2230
NonRel	Fluorescein Angiography - OU - Both Eyes [s1] OD [e1] : Diffuse peripheral non - perfusion and leakage .	Single pinpoint [s2] NVE [e2] superonasal to the nerve .	laterality	lesion	T48	T22	1145464_note_2230
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T52	T1	1145464_note_2230
NonRel	Vitreous hemorrhage , [s1] right [e1] H43.11 379.23 CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	laterality	lesion	T52	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T56	T1	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3512 250.51 Fluorescein Angiography - OU - Both Eyes 362.07 OCT , Retina - OU - Both Eyes 362.02 3 .	severity	lesion	T56	T2	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T56	T12	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Early PDR with temporal ME .	severity	lesion	T56	T13	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Early PDR with temporal ME .	severity	lesion	T56	T14	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early [s2] PDR [e2] with temporal ME .	severity	lesion	T56	T15	1145464_note_2230
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of right eye and macular edema E10.3511 250.51 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes 362.07 Attending Note IVFA - DATE : Severe NPDR OU IVFA - DATE : Severe NPDR OS IVFA - DATE : Dispersed areas of staning with leakage suggestive of MAs , + IRMA superonasally , + blocking from preretinal heme , diffuse capillary droput in midperiphery , OS with areas of dropout similar findings , without areas of NV Color Fundus Photos DATE : diabetic changes in both eyes with preretinal heme OD and inferior vitreous heme , macular exudates OD , OS with [s1] temporal [e1] macular exudates and no signs of NV IVFA - DATE : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe NPDR OS . 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Early PDR with temporal [s2] ME [e2] .	severity	lesion	T56	T16	1145464_note_2230
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Repeat of IVFA demonstrated one spot of mild [s2] NVE [e2] .	severity	lesion	T58	T18	1145464_note_2230
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Rec treatment with PRP OS - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T58	T20	1145464_note_2230
NonRel	Clinically still has [s1] significant [e1] vitreous hemorrhage inferiorly He has macular edema .	Rec treatment with PRP OS - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T58	T21	1145464_note_2230
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T15	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - [s1] OD [e1] - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T15	T10	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T16	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T16	T10	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T17	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) [s1] OD [e1] : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T17	T10	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	[s2] Proliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T18	T3	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T18	T4	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Mild [s2] NPDR [e2] now .	severity	lesion	T18	T11	note_169
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T18	T20	note_169
NonRel	[s1] Mild [e1] NPDR now .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T5	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T6	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T7	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T8	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T19	T9	note_169
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T19	T10	note_169
NonRel	[s1] Mild [e1] NPDR now .	Mac OCT without [s2] Edema [e2] , mild ERM , no posterior hyloid IVFA with shallow ITQ tractional RD with leakage Consented for PRP left eye mid periphery x 360 Kevin Talbot , MD participated in the care of this patient .	severity	lesion	T19	T12	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T5	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T6	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T7	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T8	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T21	T9	note_169
NonRel	Proliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3599 250.51 Pan Retinal Photocoagulation - OD - Right Eye 362.02 Pan Retinal Photocoagulation - OS - Left Eye IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS Treatment Hx : PRP OU - 4 / 21 / 17 ( today ) OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally Consented for PRP right eye focusing in temporal mid - periphery and temporal far periphery OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T21	T10	note_169
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] mild [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	severity	lesion	T1	T6	note_50
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by mild nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	Mild [s2] nonproliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	laterality	lesion	T4	T6	note_50
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	severity	lesion	T5	T2	note_50
NonRel	[s1] Mild [e1] nonproliferative diabetic retinopathy of left eye associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	severity	lesion	T5	T3	note_50
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	laterality	lesion	T7	T2	note_50
NonRel	Mild nonproliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3292 250.50 OCT , Posterior Segment - OU - Both Eyes 362.04 Color Fundus Photography - OU - Both Eyes 3 .	Type 2 diabetes mellitus with right eye affected by mild nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3211 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.04 Color Fundus Photography - OU - Both Eyes 362.07 V58.67 2 .	laterality	lesion	T7	T3	note_50
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	laterality	lesion	T5	T3	note_1344
NonRel	Diabetic macular edema of [s1] right eye [e1] with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	laterality	lesion	T5	T4	note_1344
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	[s2] Diabetic macular edema [e2] of right eye with proliferative retinopathy associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	laterality	lesion	T6	T1	note_1344
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 Noticing peripheral and central vision changes after PRP .	Diabetic macular edema of right eye with [s2] proliferative retinopathy [e2] associated with type 2 diabetes mellitus E11.3511 250.50 Color Fundus Photography - OU - Both Eyes 362.07 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	laterality	lesion	T6	T2	note_1344
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T13	T5	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T13	T6	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T13	T7	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T13	T8	2512733_note_7749
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T13	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T14	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T14	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T14	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T14	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T14	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T15	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T15	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T15	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T15	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T15	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T16	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T16	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T16	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T16	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T16	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T17	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T17	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T17	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T17	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T17	T9	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T1	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T2	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T3	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T4	2512733_note_7749
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T18	T27	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T1	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T2	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T3	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T4	2512733_note_7749
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T19	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T20	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T21	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T22	T27	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T1	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T2	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T3	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T4	2512733_note_7749
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T23	T27	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T28	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T28	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T28	T9	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T29	T5	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T29	T6	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T29	T7	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T29	T8	2512733_note_7749
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS DATE ( today ) ? ? ? IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T29	T9	2512733_note_7749
NonRel	Moderate [s1] nonproliferative diabetic retinopathy [e1] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T5	T8	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without [s1] macular edema [e1] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into [s2] fovea [e2] , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T6	T8	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T1	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , [s2] exudates [e2] OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T2	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : [s2] IRF [e2] with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T3	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into fovea , [s2] exudates [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	severity	lesion	T17	T4	1036182_note_1786
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	severity	lesion	T17	T7	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : [s2] CSME [e2] , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T1	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , [s2] exudates [e2] OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T2	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : [s2] IRF [e2] with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T3	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates OS : IRF with extension into fovea , [s2] exudates [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T18	T4	1036182_note_1786
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - [s1] Both Eyes [e1] E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	[s2] Diabetic macular edema [e2] not clinically significant - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	laterality	lesion	T18	T7	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - [s1] Severe [e1] NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	severity	lesion	T19	T13	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T20	T5	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : CSME , exudates OS : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T20	T6	1036182_note_1786
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T21	T5	1036182_note_1786
NonRel	Diabetic macular edema [s1] not clinically significant [e1] - Both Eyes E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	severity	lesion	T21	T6	1036182_note_1786
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T22	T5	1036182_note_1786
NonRel	Diabetic macular edema not clinically significant - [s1] Both Eyes [e1] E11.311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.01 3 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T22	T6	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - [s1] Severe [e1] NPDR OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	severity	lesion	T23	T13	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR [s1] OU [e1] 1 ) NPDR OU OD - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	laterality	lesion	T24	T13	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR [s1] OU [e1] OD - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	laterality	lesion	T25	T13	1036182_note_1786
NonRel	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU [s1] OD [e1] - Severe NPDR with ciCSME .	Mild / stable [s2] IRF [e2] with 20 / 80 vision , although some of decreased vision likely from cataract .	laterality	lesion	T26	T13	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) [s2] NPDR [e2] OU OD - Severe NPDR with ciCSME .	severity	lesion	T27	T9	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe [s2] NPDR [e2] OU 1 ) NPDR OU OD - Severe NPDR with ciCSME .	severity	lesion	T27	T10	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe [s2] NPDR [e2] with ciCSME .	severity	lesion	T27	T11	1036182_note_1786
NonRel	[s1] Mild / stable [e1] IRF with 20 / 80 vision , although some of decreased vision likely from cataract .	Treatment Hx : IVFA ( DATE ) - Severe NPDR OU 1 ) NPDR OU OD - Severe NPDR with [s2] ciCSME [e2] .	severity	lesion	T27	T12	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T30	T5	1036182_note_1786
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : CSME , exudates [s1] OS [e1] : IRF with extension into fovea , exudates Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with diabetes mellitus due to underlying condition , unspecified laterality - Both Eyes E08 . 3399 249.50 OCT , Posterior Segment - OU - Both Eyes 362.05 2 .	laterality	lesion	T30	T6	1036182_note_1786
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T7	T3	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T7	T4	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T8	T1	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T8	T2	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	[s2] Vitreous hemorrhage [e2] , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T8	T5	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T8	T6	note_4013
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T8	T10	note_4013
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T9	T3	note_4013
NonRel	Vitreous hemorrhage , [s1] right eye [e1] H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T9	T4	note_4013
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T11	T3	note_4013
NonRel	Vitreous hemorrhage , right eye H43.11 379.23 Treatment Hx : IVA OD - 12 / 1 / 17 IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 3 .	laterality	lesion	T11	T4	note_4013
NonRel	1 ) ARMD OU ( Nonexudative OD , Exudative [s1] OS [e1] s / p PPV for SMH ) OD - stable on exam .	Without heme or [s2] IRF [e2] / SRF .	laterality	lesion	T6	T3	note_7183
NonRel	1 ) ARMD OU ( Nonexudative OD , Exudative [s1] OS [e1] s / p PPV for SMH ) OD - stable on exam .	Without heme or IRF / [s2] SRF [e2] .	laterality	lesion	T6	T4	note_7183
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , [s1] small [e1] intraretinal hemorrhage noted OD lv but not present on exam today .	No CNVM , no [s2] IRF [e2] / SRF ; although there are high risk features .	laterality	lesion	T1	T3	342322_note_924
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , [s1] small [e1] intraretinal hemorrhage noted OD lv but not present on exam today .	No CNVM , no IRF / [s2] SRF [e2] ; although there are high risk features .	laterality	lesion	T1	T4	342322_note_924
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , small intraretinal hemorrhage noted [s1] OD [e1] lv but not present on exam today .	No CNVM , no [s2] IRF [e2] / SRF ; although there are high risk features .	laterality	lesion	T7	T3	342322_note_924
NonRel	Dry ARMD H35.3190 362.51 1 ) ARMD OU ( Advanced Nonexudtative OU - High Risk Features ) - VAcc excellent and stable OU - DFE with heavy large drusen throughout OU , small intraretinal hemorrhage noted [s1] OD [e1] lv but not present on exam today .	No CNVM , no IRF / [s2] SRF [e2] ; although there are high risk features .	laterality	lesion	T7	T4	342322_note_924
NonRel	Treatment Hx : IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe [s2] NPDR [e2] without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T16	T6	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without [s2] CSME [e2] OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T16	T7	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without CSME OU OD - resolution of [s2] MA [e2] in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T16	T8	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with [s2] DBH [e2] and exudates throughout macula and periphery , vision still excellent .	severity	lesion	T16	T9	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with DBH and [s2] exudates [e2] throughout macula and periphery , vision still excellent .	severity	lesion	T16	T10	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe [s2] NPDR [e2] without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T17	T6	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without [s2] CSME [e2] OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T17	T7	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without CSME OU OD - resolution of [s2] MA [e2] in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T17	T8	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with [s2] DBH [e2] and exudates throughout macula and periphery , vision still excellent .	laterality	lesion	T17	T9	1305452_note_2916
NonRel	Treatment Hx : IVFA ( DATE ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	Severe NPDR without CSME OU OD - resolution of MA in fovea , with DBH and [s2] exudates [e2] throughout macula and periphery , vision still excellent .	laterality	lesion	T17	T10	1305452_note_2916
NonRel	[s1] Severe [e1] NPDR without CSME OU OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Treatment Hx : IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	severity	lesion	T18	T5	1305452_note_2916
NonRel	Severe NPDR without CSME [s1] OU [e1] OD - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Treatment Hx : IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	laterality	lesion	T19	T5	1305452_note_2916
NonRel	Severe NPDR without CSME OU [s1] OD [e1] - resolution of MA in fovea , with DBH and exudates throughout macula and periphery , vision still excellent .	Treatment Hx : IVFA ( DATE ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , HgA 1 C 8.4 , 11 / 2018 ] .	laterality	lesion	T20	T5	1305452_note_2916
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T14	T4	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T14	T5	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T8	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T9	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T28	2487564_note_7561
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T30	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T15	T4	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T15	T5	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T8	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T9	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T28	2487564_note_7561
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T30	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T16	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T16	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T17	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T17	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T18	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T18	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T19	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T19	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T20	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	severity	lesion	T20	T2	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T21	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T21	T2	2487564_note_7561
NonRel	[s1] OS [e1] - PDR now s / p PRP .	Mild increase in [s2] ME [e2] , but given atrophic appearance will observe .	laterality	lesion	T23	T6	2487564_note_7561
NonRel	[s1] Mild [e1] increase in ME , but given atrophic appearance will observe .	OS - [s2] PDR [e2] now s / p PRP .	severity	lesion	T24	T7	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T29	T1	2487564_note_7561
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 Attending note : Treatment Hx IVL OD - DATE ( today ) IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE IVL OD - DATE PRP OS DATE IVL OD - DATE IVL OD - DATE IVFA ( DATE ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - DATE 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 2 .	laterality	lesion	T29	T2	2487564_note_7561
NonRel	2 ) LD OS - temporally with PVD present but given the hx of HST + SRF [s1] OD [e1] will likely consider laser prophylaxis OS at later date .	Today will enhance ( still with [s2] VH [e2] ) and recheck in 6 weeks .	laterality	lesion	T1	T5	note_1744
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T2	2482683_note_7206
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T4	2482683_note_7206
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T7	2482683_note_7206
NonRel	[s1] Proliferative diabetic retinopathy [e1] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T10	T8	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T2	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T4	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in [s2] posterior pole [e2] , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T7	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s1] macular edema presence [e1] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , [s2] preretinal [e2] hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	lesion	eye_part	T11	T8	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T13	T10	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA [s1] OD [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T13	T11	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T14	T10	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , [s1] extensive [e1] neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T14	T11	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T15	T10	2482683_note_7206
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit [s1] OS [e1] : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T15	T11	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive [s2] neovascularization [e2] and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T1	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T3	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T5	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive [s2] neovascularization [e2] in posterior pole , preretinal hemorrhage BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T6	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	OCT , Posterior Segment - OU - Both Eyes OD : Extensive macular TRD with subretinal fibrosis OS : Extensive macular TRD with subretinal fibrosis Color Fundus Photography - OS - Left Eye See optos photos Table top RD OU with extensive neovascularization and areas of subretinal fibrosis B - Scan Ultrasound - OU - Both Eyes B - Scan OU : Bilateral tractional retinal detachment , nonmobile Fluorescein Angiography - OU - Both Eyes IVFA OD : Delayed filling time , extensive neovascularization in posterior pole , preretinal hemorrhage Transit OS : Delayed filling time , extensive neovascularization in posterior pole , preretinal [s2] hemorrhage [e2] BUN : 14 Creatinine : 0.84 Reported A1c : 12 Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T16	T9	2482683_note_7206
NonRel	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye Severe [s2] proliferative diabetic retinopathy [e2] with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	laterality	lesion	T16	T12	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye [s1] Severe [e1] proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T17	T10	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye [s1] Severe [e1] proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	severity	lesion	T17	T11	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - [s1] Left Eye [e1] Severe proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	[s2] Proliferative diabetic retinopathy [e2] associated with type 2 diabetes mellitus , macular edema presence unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T18	T10	2482683_note_7206
NonRel	TRD ( traction retinal detachment ) , bilateral H33.43 361.81 OCT , Posterior Segment - OU - Both Eyes Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - [s1] Left Eye [e1] Severe proliferative diabetic retinopathy with bilateral tabletop tractional retinal detachments OU - Pt with rapid progression of TRD and vision loss over last few months - Recent diagnosis with diabetes with recent A1c reported 12 ( glucose meter 254 in ED last night ) and BUN / Cr 14 / 0.84 - Pt is a minister that travels frequently for work ; discussed that he will not be able to travel by air during the course of treatment and that he will need to reschedule work arrangements Counseling : Discussed extensive , severe disease OD > OS with extremely guarded visual prognosis .	Proliferative diabetic retinopathy associated with type 2 diabetes mellitus , [s2] macular edema presence [e2] unspecified E11.359 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OS - Left Eye B - Scan Ultrasound - OU - Both Eyes Hemoglobin A1c CBC and differential Basic metabolic panel Appt req Endocrinology Pre - op Urgent Diabetes Management Fluorescein Angiography - OU - Both Eyes CANCELED : Fluorescein Angiography - OS - Left Eye 2 .	laterality	lesion	T18	T11	2482683_note_7206
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T1	T6	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T1	T8	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	severity	lesion	T1	T9	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T6	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T8	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T3	T9	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T5	T2	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T5	T4	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	severity	lesion	T5	T11	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	severity	lesion	T5	T14	note_3801
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	severity	lesion	T5	T16	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T2	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T7	T4	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T7	T11	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace [s2] DME [e2] with trace increase since lv OS - ciCSME with trace interval increase .	laterality	lesion	T7	T14	note_3801
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv OS - [s2] ciCSME [e2] with trace interval increase .	laterality	lesion	T7	T16	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	severity	lesion	T10	T9	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T12	T9	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T13	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T13	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - trace DME with trace increase since lv OS - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T13	T9	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T15	T6	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic retinopathy .	laterality	lesion	T15	T8	note_3801
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR OU OD - trace DME with trace increase since lv [s1] OS [e1] - ciCSME with trace interval increase .	Moderate nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus ( CMS - HCC code ) E10.3313 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 362.05 Lab Results Component Value Date HGBA 1 C 6.7 ( H ) 11 / 21 / 2018 Hx of treatment for diabetic [s2] retinopathy [e2] .	laterality	lesion	T15	T9	note_3801
NonRel	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with [s1] scattered [e1] IRF and exudates .	Suspicious area ITQ OD on exam and OCT of ? early [s2] NVE [e2] - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	severity	lesion	T8	T5	note_2913
NonRel	Suspicious area ITQ OD on exam and OCT of ? [s1] early [e1] NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered [s2] IRF [e2] and exudates .	severity	lesion	T9	T3	note_2913
NonRel	Suspicious area ITQ OD on exam and OCT of ? [s1] early [e1] NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered IRF and [s2] exudates [e2] .	severity	lesion	T9	T4	note_2913
NonRel	Suspicious area ITQ [s1] OD [e1] on exam and OCT of ? early NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered [s2] IRF [e2] and exudates .	laterality	lesion	T10	T3	note_2913
NonRel	Suspicious area ITQ [s1] OD [e1] on exam and OCT of ? early NVE - IVFA obtained today - Discussed need for strict glucose control - Discussed systemic and ocular effects of diabetes mellitus 2 .	NIDDM , Severe - Diagnosed 20 years ago but reports is Type 1 - VA 20 / 25 and 20 / 20 - OCT with scattered IRF and [s2] exudates [e2] .	laterality	lesion	T10	T4	note_2913
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T6	T4	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T6	T5	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	laterality	lesion	T7	T1	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T2	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	laterality	lesion	T7	T3	1590841_note_3799
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	laterality	lesion	T7	T13	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T8	T4	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T8	T5	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate [s2] NPDR [e2] OU OD - nciDME , stable .	severity	lesion	T9	T1	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye without macular edema associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	severity	lesion	T9	T2	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Moderate nonproliferative diabetic retinopathy of right eye without [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3391 250.50 OCT , Retina - OU - Both Eyes 362.05 2 .	severity	lesion	T9	T3	1590841_note_3799
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - [s2] nciDME [e2] , stable .	severity	lesion	T9	T13	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - nciDME , stable .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - [s1] Moderate [e1] NPDR OU OD - nciDME , stable .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T10	T5	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - nciDME , stable .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T11	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR [s1] OU [e1] OD - nciDME , stable .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T11	T5	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - nciDME , stable .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU [s1] OD [e1] - nciDME , stable .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T12	T5	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - nciDME , [s1] stable [e1] .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T14	T4	1590841_note_3799
NonRel	Previous dx included glaucoma and ARMD . + apixaban ( A - fib ) Treatment Hx : Focal Laser OS - DATE 1 ) IDDM - Moderate NPDR OU OD - nciDME , [s1] stable [e1] .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T14	T5	1590841_note_3799
NonRel	Today without [s1] SRF [e1] .	1 ) [s2] Maculopathy [e2] ( w / RPE loss ) - evidence of prior SRF , mild RPE attenuation .	lesion	eye_part	T3	T2	1896876_note_5099
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT [s1] OD [e1] : dme OS : dme Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 2 .	laterality	lesion	T9	T13	note_4421
NonRel	Review of Systems : Heart problems : no complaints Respiratory problems : no complaints General problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist cc 20 / 40 + 2 20 / 70 + 2 Method : Snellen - Linear Tonometry Right Left Pressure 15 16 Method : Tonopen Time : 3 : 37 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 38 PM Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Clear Clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens Posterior subcapsular cataract Posterior subcapsular cataract Other testing : Macular OCT OD : dme [s1] OS [e1] : dme Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 2 .	laterality	lesion	T11	T13	note_4421
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 2 .	severity	lesion	T14	T13	note_4421
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse OS , refractory to avastin .	severity	lesion	T14	T16	note_4421
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	severity	lesion	T14	T17	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	Moderate [s2] nonproliferative diabetic retinopathy [e2] ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	laterality	lesion	T18	T15	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	2 ) [s2] PDR [e2] - inactive , good prp Repeat IVA OU done today .	laterality	lesion	T18	T21	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal [s1] OD [e1] , diffuse OS , refractory to avastin .	Moderate [s2] nonproliferative diabetic retinopathy [e2] ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	laterality	lesion	T19	T15	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal [s1] OD [e1] , diffuse OS , refractory to avastin .	2 ) [s2] PDR [e2] - inactive , good prp Repeat IVA OU done today .	laterality	lesion	T19	T21	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse [s1] OS [e1] , refractory to avastin .	Moderate [s2] nonproliferative diabetic retinopathy [e2] ( 362.05 ) PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 3 .	laterality	lesion	T20	T15	note_4421
NonRel	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse [s1] OS [e1] , refractory to avastin .	2 ) [s2] PDR [e2] - inactive , good prp Repeat IVA OU done today .	laterality	lesion	T20	T21	note_4421
NonRel	2 ) PDR - inactive , good prp Repeat IVA [s1] OU [e1] done today .	[s2] Diabetic macular edema [e2] ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic DME OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T26	T16	note_4421
NonRel	2 ) PDR - inactive , good prp Repeat IVA [s1] OU [e1] done today .	Diabetic macular edema ( 362.07 ) RETINA ( OCT ) , PR COMPUTERIZED OPHTHALMIC IMAGING RETINA , PR AVASTIN , PR AVASTIN , PR INJECT INTRAVITREAL PHARMCOLOGIC , PR INJECT INTRAVITREAL PHARMCOLOGIC 1 ) Chronic [s2] DME [e2] OU , more focal OD , diffuse OS , refractory to avastin .	laterality	lesion	T26	T17	note_4421
NonRel	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior SRF , [s1] mild [e1] RPE attenuation .	Macular atrophy , retinal - Left Eye H35.89 362.51 OCT , Retina - OU - Both Eyes No significant [s2] PMH [e2] , no hx of steroid usage .	severity	lesion	T3	T1	note_5103
NonRel	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior SRF , [s1] mild [e1] RPE attenuation .	Today without [s2] SRF [e2] .	severity	lesion	T3	T4	note_5103
NonRel	Macular atrophy , retinal - Left Eye H35.89 362.51 OCT , Retina - OU - Both Eyes No [s1] significant [e1] PMH , no hx of steroid usage .	Pt is Family Medicine physician in Crystal River 1 ) Maculopathy ( w / RPE loss ) - evidence of prior [s2] SRF [e2] , mild RPE attenuation .	severity	lesion	T5	T2	note_5103
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T6	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T8	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T9	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T17	T10	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T17	T11	note_7750
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T17	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T18	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T18	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T18	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T19	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T19	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of [s1] severe [e1] NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T19	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T20	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T20	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR [s1] OU [e1] with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T20	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T21	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T21	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME [s1] OU [e1] , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T21	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	severity	lesion	T22	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	severity	lesion	T22	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : [s1] Severe [e1] NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	severity	lesion	T22	T29	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe [s2] NPDR [e2] OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T6	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci [s2] DME [e2] OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T8	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , [s2] ciCSME [e2] OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T9	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe [s2] NPDR [e2] with nciDME .	laterality	lesion	T23	T10	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with [s2] nciDME [e2] .	laterality	lesion	T23	T11	note_7750
NonRel	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR [s1] OU [e1] 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	Severe NPDR OU with [s2] nci [e2] DME OD , ciCSME OS OD - Severe NPDR with nciDME .	laterality	lesion	T23	T29	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T1	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T2	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T3	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T4	note_7750
NonRel	[s1] Severe [e1] NPDR OU with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T24	T5	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T1	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T2	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T3	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T4	note_7750
NonRel	Severe NPDR [s1] OU [e1] with nci DME OD , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T25	T5	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T1	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T2	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T3	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T4	note_7750
NonRel	Severe NPDR OU with nci DME [s1] OD [e1] , ciCSME OS OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T7	T5	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T1	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T2	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T3	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T4	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME [s1] OS [e1] OD - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T26	T5	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T1	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T2	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T3	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T4	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS [s1] OD [e1] - Severe NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	laterality	lesion	T27	T5	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T1	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T2	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe [s2] NPDR [e2] OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T3	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with [s2] DME [e2] OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe NPDR OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T4	note_7750
NonRel	Severe NPDR OU with nci DME OD , ciCSME OS OD - [s1] Severe [e1] NPDR with nciDME .	Severe nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 2 diabetes mellitus ( CMS - HCC code ) E11.3413 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.06 Hx of severe NPDR OU with DME OU , stable per patient with stable BS . Treatment Hx : IVA OS 2 / 19 / 19 ( today ) ? ? ? IVFA ( 1 / 19 / 18 ) : Severe [s2] NPDR [e2] OU 1 ) IDDM [ Type 2 , Hg A1C 6.8 ( previous above 10 years ago ) ] .	severity	lesion	T28	T5	note_7750
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active [s2] PDR [e2] .	laterality	lesion	T6	T2	note_8730
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of [s2] PDR [e2] OU OD - Active PDR .	laterality	lesion	T6	T8	note_8730
NonRel	[s1] Both eyes [e1] affected by proliferative diabetic retinopathy with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - [s2] PDR [e2] OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	laterality	lesion	T6	T13	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	laterality	lesion	T7	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T7	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU [s1] OD [e1] - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T7	T4	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	laterality	lesion	T9	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T9	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR [s1] OU [e1] OD - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T9	T4	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	severity	lesion	T12	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	[s2] VH [e2] with SHH for duration of one month .	severity	lesion	T12	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR OU , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - [s1] Active [e1] PDR .	VH with [s2] SHH [e2] for duration of one month .	severity	lesion	T12	T4	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	Both eyes affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachments involving maculae , associated with type 2 diabetes mellitus E11.3523 250.50 362.02 361.81 3 .	laterality	lesion	T14	T1	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	[s2] VH [e2] with SHH for duration of one month .	laterality	lesion	T14	T3	note_8730
NonRel	Age - related nuclear cataract of both eyes H25.13 366.16 Attending Note : Treatment Hx : IVFA ( 11 / 3 / 17 ) - PDR [s1] OU [e1] , OS with midperipheral and peripheral ischemia Previous PRP 1 ) DM - Hx of PDR OU OD - Active PDR .	VH with [s2] SHH [e2] for duration of one month .	laterality	lesion	T14	T4	note_8730
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.07 362.02 2 .	[s2] Subhyaloid hemorrhage [e2] of right eye H35.61 362.81 3 .	laterality	lesion	T5	T3	note_3664
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 3 .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T6	T1	note_3664
NonRel	Subhyaloid hemorrhage of [s1] right eye [e1] H35.61 362.81 3 .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3519 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.02 2 .	laterality	lesion	T6	T2	note_3664
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered [s2] exudates [e2] , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T5	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered [s2] exudates [e2] w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T6	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild [s2] IRF [e2] just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T7	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no [s2] IRF [e2] / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T8	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / [s2] SRF [e2] - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T9	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered [s2] exudates [e2] , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T10	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild [s2] IRF [e2] superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T11	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered [s2] exudates [e2] , no IRF / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T12	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no [s2] IRF [e2] / SRF NAME , MD participated in the care of this patient .	severity	lesion	T17	T13	20773_note_35
NonRel	Cataract , left eye H26.9 366.9 1 - [s1] Mild [e1] NPDR with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / [s2] SRF [e2] NAME , MD participated in the care of this patient .	severity	lesion	T17	T14	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T18	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT [s1] OD [e1] with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T18	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T19	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / [s1] mild [e1] IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T19	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T20	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT [s1] OS [e1] w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T20	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T21	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes [s1] OD [e1] : scattered exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T21	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T22	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : [s1] scattered [e1] exudates , early / mild IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T22	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T23	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / [s1] mild [e1] IRF superior to fovea OS : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T23	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T24	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea [s1] OS [e1] : scattered exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	laterality	lesion	T24	T4	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild [s2] NPDR [e2] with macular edema - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T25	T3	20773_note_35
NonRel	Has new labs ordered next month - MAC OCT OD with scattered exudates w / early / mild IRF just superior to fovea - MAC OCT OS w / scattered exudates , no IRF / SRF - discussed potential anti - vegf therapy in the future vs focal laser , will have the patient seen by retina service to discuss treatment options - discussed importance of good glucose control to prevent further changes from DM that can lead to vision loss 2 - PCIOL OD - doing well , happy with VA 3 - NSC OS - reports glare - VAcc DATE - will consider phaco / IOL OS once # 1 is stable - monitor OCT , Retina - OU - Both Eyes OD : scattered exudates , early / mild IRF superior to fovea OS : [s1] scattered [e1] exudates , no IRF / SRF NAME , MD participated in the care of this patient .	Cataract , left eye H26.9 366.9 1 - Mild NPDR with [s2] macular edema [e2] - HgA 1 c 10.0 DATE ; pt reports has had medication changes and feels her sugars have been better since .	severity	lesion	T25	T4	20773_note_35
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Drusen , no SRF OS : Geo atrophy , Drusen .	No [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T4	T2	note_1142
NonRel	OCT , Posterior Segment - OU - Both Eyes OD : Drusen , no SRF [s1] OS [e1] : Geo atrophy , Drusen .	No [s2] SRF [e2] Assessment and Plan : ICD - 10 - CM ICD - 9 - CM 1 .	laterality	lesion	T5	T2	note_1142
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s1] MAs [e1] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T7	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s1] MAs [e1] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T7	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s1] exudate [e1] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T8	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s1] exudate [e1] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T8	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s1] dbh [e1] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T9	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s1] dbh [e1] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T9	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s1] MAs [e1] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T10	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s1] MAs [e1] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T10	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s1] dbh [e1] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T11	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s1] dbh [e1] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T11	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s1] exudate [e1] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T12	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s1] exudate [e1] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T12	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s1] MA ' s [e1] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T13	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s1] MA ' s [e1] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T13	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s1] NV [e1] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T14	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s1] NV [e1] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T14	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s1] MA ' s [e1] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T15	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s1] MA ' s [e1] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T15	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s1] NVE [e1] Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to [s2] fovea [e2] ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T16	T30	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s1] NVE [e1] Assessment Assessment and Plan : 1 .	no neo [s2] Macula [e2] few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	lesion	eye_part	T16	T33	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T19	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate [s1] OS [e1] : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T19	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T20	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos [s1] OD [e1] , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T20	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T21	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : [s1] OD [e1] : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T21	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	severity	lesion	T22	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : [s1] scattered [e1] MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T22	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	laterality	lesion	T23	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV [s1] OS [e1] : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	laterality	lesion	T23	T31	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T5	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard [s2] exudates [e2] Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T6	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe [s2] NDPR [e2] OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	severity	lesion	T24	T18	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few ma ' s , mild thickening nasal to fovea [s2] ma ' s [e2] with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T29	257077_note_501
NonRel	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : [s1] scattered [e1] MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	no neo Macula few [s2] ma ' s [e2] , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	severity	lesion	T24	T31	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T7	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T8	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T9	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T10	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T11	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T12	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T13	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T14	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T25	T15	257077_note_501
NonRel	no neo Macula few ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of [s1] hard [e1] exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T25	T16	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T7	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T8	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T9	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T10	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T11	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T12	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T13	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T14	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T27	T15	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / [s1] severe [e1] NDPR OD Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T27	T16	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T7	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T8	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T9	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T10	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T11	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T12	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T13	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T14	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T15	257077_note_501
NonRel	Type II or unspecified type diabetes mellitus with ophthalmic manifestations , not stated as uncontrolled ( 250.50 ) ( 250.50 ) RETINA ( OCT ) 1 ) Mod / severe NDPR [s1] OD [e1] Insulin dependent diabetic for last few mos , has been diabetic many years , cannot tell me how long .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	laterality	lesion	T28	T16	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , [s2] MAs [e2] , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T7	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , [s2] exudate [e2] OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T8	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , [s2] dbh [e2] , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T9	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : [s2] MAs [e2] , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T10	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , [s2] dbh [e2] , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T11	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , [s2] exudate [e2] IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T12	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered [s2] MA ' s [e2] , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T13	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no [s2] NV [e2] OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T14	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered [s2] MA ' s [e2] , temporal area of leakage , multiple peripheral areas of leakage suggestive of NVE Assessment Assessment and Plan : 1 .	severity	lesion	T32	T15	257077_note_501
NonRel	no neo Macula [s1] few [e1] ma ' s , mild thickening nasal to fovea ma ' s with mild thickening nasal to fovea , circinate ring of he with hemes suptemp to macula , Vessels Tortuous Tortuous Periphery scattered d / b hemes all quads , scattered areas of hard exudates scattered d / b hemes all quads , scattered areas of hard exudates Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal No annotated images are attached to the encounter .	Other testing : OCT : normal / dry OU except temporal slight edema Fundus photos OD , MAs , dbh , exudate OS : MAs , dbh , exudate IVFA : OD : scattered MA ' s , no NV OS : scattered MA ' s , temporal area of leakage , multiple peripheral areas of leakage suggestive of [s2] NVE [e2] Assessment Assessment and Plan : 1 .	severity	lesion	T32	T16	257077_note_501
NonRel	[s1] OD [e1] - midperipheral ischemia on IVFA with NVE . + ME .	OS - extensive [s2] ME [e2] , ERM , midperipheral ischemia .	laterality	lesion	T3	T2	2485245_note_7318
NonRel	OS - [s1] extensive [e1] ME , ERM , midperipheral ischemia .	OD - midperipheral ischemia on IVFA with [s2] NVE [e2] . + ME .	severity	lesion	T4	T1	2485245_note_7318
NonRel	[s1] OS [e1] - extensive ME , ERM , midperipheral ischemia .	OD - midperipheral ischemia on IVFA with [s2] NVE [e2] . + ME .	laterality	lesion	T5	T1	2485245_note_7318
NonRel	VA down 20 / 70 - vs 20 / 60 LV No NVA on gonio today [s1] OU [e1] History of newly diagnosed APL currently on treatment .	OCT [s2] ME [e2] worse today than priors .	laterality	lesion	T1	T2	note_3194
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T7	note_2442
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T8	note_2442
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T1	T9	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T7	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T8	note_2442
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T2	T9	note_2442
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T3	note_2442
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T4	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T3	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T4	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T3	note_2442
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T4	note_2442
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T4	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T5	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T6	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	severity	lesion	T14	T7	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	severity	lesion	T14	T8	note_7563
NonRel	[s1] Severe [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	severity	lesion	T14	T9	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T4	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T5	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe [s2] NDPR [e2] OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T6	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active [s2] PDR [e2] OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	laterality	lesion	T15	T7	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe [s2] NPDR [e2] + diffuse CSME .	laterality	lesion	T15	T8	note_7563
NonRel	Severe nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse [s2] CSME [e2] .	laterality	lesion	T15	T9	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T3	note_7563
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T17	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - [s1] Severe [e1] NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T17	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR [s1] OS [e1] Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T19	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR [s1] OD [e1] , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T19	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T20	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - [s1] Severe [e1] NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T20	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T21	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , Active PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] [s1] OD [e1] - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T21	T2	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T25	T3	note_7563
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 CANCELED : Fluorescein Angiography - OU - Both Eyes 362.02 Attending note : Treatment Hx IVL OD - 1 / 16 / 18 ( today ) IVL OD - 12 / 5 / 17 IVL OD - 10 / 24 / 17 IVL OD - 8 / 11 / 17 IVL OD - 6 / 30 / 17 IVL OD - 5 / 26 / 17 IVL OD - 4 / 21 / 17 IVL OD - 3 / 17 / 17 PRP OS 2 / 24 / 17 IVL OD - 2 / 14 / 17 IVL OD - 1 / 13 / 17 IVFA ( 12 / 16 / 16 ) - Severe NDPR OD , [s1] Active [e1] PDR OS Focal Macular Laser OD + IVL OD - 12 / 16 / 16 1 ) DM [ NIDDM , unknown HgA 1 C ] OD - Severe NPDR + diffuse CSME .	Severe [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3411 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.06 CANCELED : Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T25	T2	note_7563
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active [s2] NVE [e2] OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T3	2447977_note_6711
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and [s2] NVE [e2] , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T4	2447977_note_6711
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex [s2] TRD [e2] OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T5	2447977_note_6711
NonRel	Proliferative diabetic retinopathy with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - [s1] OU [e1] - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active [s2] PDR [e2] OU OD - VH + extensive TRD encircling macula .	laterality	lesion	T8	T6	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T9	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE [s1] OS [e1] Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T9	T2	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T10	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD [s1] OD [e1] and NVE , retina attached OS 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T10	T2	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T11	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached [s1] OS [e1] 1 ) DM - IDDM - Active PDR OU OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T11	T2	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	[s2] Proliferative diabetic retinopathy [e2] with macular edema associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T12	T1	2447977_note_6711
NonRel	No IRF / SRF Attending Note : OCT ( today ) : loss of subfoveal RPE / ellipsoid layer OD , OS wnl IVFA ( today ) : vast ischemia temporally OU with tractional detachment OD , and active NVE OS Color Fundus Photos ( today ) : diabetic changs in both eyes with complex TRD OD and NVE , retina attached OS 1 ) DM - IDDM - Active PDR [s1] OU [e1] OD - VH + extensive TRD encircling macula .	Proliferative diabetic retinopathy with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.351 250.50 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes 362.02 OCT , Retina - OU - Both Eyes Color Fundus Photography - OU - Both Eyes OD TRD OS PDR OCT , Retina - OU - Both Eyes OD vitreous debris , retina flat without edema OS normal foveal contour , hard exudates .	laterality	lesion	T12	T2	2447977_note_6711
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 2 diabetes mellitus E11.3591 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye associated with type 2 diabetes mellitus E11.3592 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 3 .	laterality	lesion	T2	T3	note_7667
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] associated with type 2 diabetes mellitus E11.3592 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 3 .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 2 diabetes mellitus E11.3591 250.50 OCT , Posterior Segment - OU - Both Eyes 362.02 2 .	laterality	lesion	T4	T1	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : [s1] Active [e1] PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	severity	lesion	T5	T11	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR [s1] OD [e1] , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	laterality	lesion	T7	T11	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - [s1] Active [e1] PDR OU ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	severity	lesion	T8	T11	note_7667
NonRel	IDDM , + 81 mg ASA Treatment Hx : PRP OD - 8 / 4 / 17 ( inadequate ) IVA OU - 6 / 30 / 17 PRP OS - 6 / 30 / 17 IVFA ( 6 / 15 / 17 ) : Active PDR OD , Global Ischemia OS PRP OD - 6 / 30 / 17 IVA OU - 6 / 30 / 17 Focal / PRP OU previously 1 ) DM - Active PDR [s1] OU [e1] ( NVG OU ) OD - LP vs NLP vision with vast ischemia demonstrated on IVFA .	+ [s2] NVI [e2] , no NV in angle .	laterality	lesion	T10	T11	note_7667
NonRel	[s1] OS [e1] - no NVI on exam today , angle open on gonio .	Hx of + [s2] NVD [e2] , + NVE , vast ischemia nasally s / p IVA and PRP .	laterality	lesion	T12	T14	note_7667
NonRel	[s1] OS [e1] - no NVI on exam today , angle open on gonio .	Hx of + NVD , + [s2] NVE [e2] , vast ischemia nasally s / p IVA and PRP .	laterality	lesion	T12	T15	note_7667
NonRel	NVE inf [s1] OS [e1] : Diffuse NVE / NVD .	[s2] NVD [e2] .	laterality	lesion	T19	T2	note_2162
NonRel	[s1] OS [e1] + NVD / NVE / NVI / NVA .	Combined TRD / RRD with choroidal effusion shallowing peripheral AC but IOP 12 with open angles and [s2] NVA [e2] . - All of the following was discussed in lay terms .	laterality	lesion	T26	T27	note_2162
NonRel	[s1] Right eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 2 .	Left eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 3 .	laterality	lesion	T1	T4	note_8850
NonRel	[s1] Left eye [e1] affected by proliferative diabetic retinopathy with traction retinal detachment not involving macula , associated with type 2 diabetes mellitus E11.3532 250.50 362.02 361.81 3 .	Right eye affected by [s2] proliferative diabetic retinopathy [e2] with traction retinal detachment involving macula , associated with type 2 diabetes mellitus E11.3521 250.50 362.02 361.81 2 .	laterality	lesion	T3	T2	note_8850
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T3	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T4	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T5	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T6	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T11	T7	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T11	T8	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR [s1] OU [e1] s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	laterality	lesion	T11	T15	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T13	T1	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	severity	lesion	T13	T2	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	Mild [s2] NPDR [e2] now .	severity	lesion	T13	T9	39541_note_166
NonRel	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE [s1] temporally [e1] OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	[s2] Nonproliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	severity	lesion	T13	T17	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T3	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T4	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T5	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T6	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T12	T7	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T12	T8	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE [s1] temporally [e1] .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	severity	lesion	T12	T15	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T3	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T4	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T5	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T6	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	severity	lesion	T14	T7	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	severity	lesion	T14	T8	39541_note_166
NonRel	[s1] Mild [e1] NPDR now .	Mac OCT without [s2] Edema [e2] , mild ERM , no posterior hyloid IVFA with shallow ITQ tractional RD with leakage Plan : Tomorrow 11 : 45 AM PRP right eye focusing in temporal mid - periphery and temporal far periphery PRP left eye mid periphery x 360 NAME , MD participated in the care of this patient .	severity	lesion	T14	T10	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : [s2] PDR [e2] OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T16	T1	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New [s2] NVE [e2] temporally .	laterality	lesion	T16	T2	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	[s2] Nonproliferative diabetic retinopathy [e2] associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - OU - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	laterality	lesion	T16	T17	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No [s2] NVI [e2] or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T3	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or [s2] NVD [e2] or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T4	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or [s2] NVA [e2] Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T5	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without [s2] Edema [e2] , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T6	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms [s2] NVE [e2] temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No Neovascularization .	laterality	lesion	T18	T7	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	No NVI or NVD or NVA Mac OCT without Edema , mild ERM IVFA confirms NVE temporally OS : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous No [s2] Neovascularization [e2] .	laterality	lesion	T18	T8	39541_note_166
NonRel	Nonproliferative diabetic retinopathy associated with type 1 diabetes mellitus E10.3299 250.51 OCT , Posterior Segment - [s1] OU [e1] - Both Eyes 362.03 Color Fundus Photography - OU - Both Eyes IDDM type 1 since age 18 Last A1c 6.2 % POH : PDR OU s / p PRP OU and PPV / EL OS OD : Dense PRP ( room for fill - in ) with flat peripheral retina and clear vitreous New NVE temporally .	[s2] Proliferative diabetic retinopathy [e2] of right eye associated with type 1 diabetes mellitus E10.3591 250.51 OCT , Posterior Segment - OU - Both Eyes 362.02 Color Fundus Photography - OU - Both Eyes 2 .	laterality	lesion	T18	T15	39541_note_166
NonRel	Proliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T4	T7	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	severity	lesion	T6	T3	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	severity	lesion	T6	T5	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with [s2] PDR [e2] OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	severity	lesion	T6	T9	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : [s2] PDR [e2] with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	severity	lesion	T6	T13	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with [s2] NVD [e2] , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	severity	lesion	T6	T14	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of [s2] intraretinal hemorrhages [e2] , NVE .	severity	lesion	T6	T15	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - [s1] Active [e1] PDR OU 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , [s2] NVE [e2] .	severity	lesion	T6	T16	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	[s2] Proliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	laterality	lesion	T8	T3	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	Proliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3513 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 Intravitreal Injection , Pharmacologic Agent - OD - Right Eye 362.02 2 .	laterality	lesion	T8	T5	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with [s2] PDR [e2] OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T8	T9	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : [s2] PDR [e2] with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T8	T13	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with [s2] NVD [e2] , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	laterality	lesion	T8	T14	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of [s2] intraretinal hemorrhages [e2] , NVE .	laterality	lesion	T8	T15	note_8432
NonRel	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active PDR [s1] OU [e1] 1 .	DM type II with PDR OU and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , [s2] NVE [e2] .	laterality	lesion	T8	T16	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T10	T7	note_8432
NonRel	DM type II with PDR [s1] OU [e1] and tractional RD OS OD : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	No [s2] NVI [e2] .	laterality	lesion	T10	T17	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	TRD ( traction retinal detachment ) , left H33.42 361.81 OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx : IVA OD - 8 / 4 / 17 ( today ) PRP OD - 6 / 30 / 17 IVA OD - 6 / 30 / 17 IVFA - Active [s2] PDR [e2] OU 1 .	laterality	lesion	T12	T7	note_8432
NonRel	DM type II with PDR OU and tractional RD OS [s1] OD [e1] : PDR with NVD , 3 quadrants of venous beading , 4 quadrants of intraretinal hemorrhages , NVE .	No [s2] NVI [e2] .	laterality	lesion	T12	T17	note_8432
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T14	T3	note_2415
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T14	T4	note_2415
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T14	T5	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T15	T3	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T15	T4	note_2415
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T15	T5	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T16	T1	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T16	T2	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T16	T6	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T16	T7	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T17	T1	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T17	T2	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T17	T6	note_2415
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T17	T7	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T1	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T18	T2	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T18	T6	note_2415
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T18	T7	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T19	T3	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T19	T4	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T19	T5	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe [s2] NPDR [e2] with CSME .	laterality	lesion	T19	T8	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe NPDR with [s2] CSME [e2] .	laterality	lesion	T19	T9	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T20	T3	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T20	T4	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non [s2] proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T20	T5	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe [s2] NPDR [e2] with CSME .	severity	lesion	T20	T8	note_2415
NonRel	Last A1C 6.2 ( 06 / 2017 ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe NPDR with [s2] CSME [e2] .	severity	lesion	T20	T9	note_2415
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T21	T6	note_2415
NonRel	OS - [s1] Severe [e1] NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T21	T7	note_2415
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T22	T6	note_2415
NonRel	[s1] OS [e1] - Severe NPDR with CSME .	Last A1C 6.2 ( 06 / 2017 ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T22	T7	note_2415
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Mild [s2] DME [e2] that has improved with better BS and observation .	severity	lesion	T2	T4	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T2	T6	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - [s1] Moderate [e1] NPDR OU .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	severity	lesion	T2	T7	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Mild [s2] DME [e2] that has improved with better BS and observation .	laterality	lesion	T3	T4	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T6	note_3797
NonRel	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate NPDR [s1] OU [e1] .	Moderate nonproliferative diabetic retinopathy of both eyes with [s2] macular edema [e2] associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	laterality	lesion	T3	T7	note_3797
NonRel	[s1] Mild [e1] DME that has improved with better BS and observation .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T5	T1	note_3797
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] both eyes [e1] with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	laterality	lesion	T8	T1	note_3797
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of both eyes with macular edema associated with type 1 diabetes mellitus E10.3313 250.51 OCT , Retina - OU - Both Eyes 362.07 362.05 Hx of treatment for diabetic retinopathy .	Previous dx included glaucoma and ARMD . Treatment Hx : Focal Laser OS - 2015 / 2016 1 ) IDDM - Moderate [s2] NPDR [e2] OU .	severity	lesion	T9	T1	note_3797
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s1] vit heme [e1] and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T1	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s1] MA [e1] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T2	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s1] exudates [e1] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T3	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T4	T16	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T4	T17	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates [s1] temporally [e1] one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T4	T20	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s1] MA [e1] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T5	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s1] exudates [e1] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T6	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T7	T16	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T7	T17	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates [s1] temporally [e1] Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	severity	lesion	T7	T20	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s1] NVE [e1] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T8	T19	note_4416
NonRel	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s1] NVE [e1] along superior arcade without TRD Periphery inferior vit heme and layered heme .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T9	T19	note_4416
NonRel	Senile nuclear sclerosis ( 366.16 ) 1 ) Chronic DME [s1] OU [e1] , more focal OD , diffuse OS , refractory to avastin .	[s2] Vitreous hemorrhage [e2] ( 379.23 ) 6 .	laterality	lesion	T12	T10	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s2] vit heme [e2] and layered heme .	severity	lesion	T18	T1	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s2] MA [e2] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T2	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s2] exudates [e2] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T3	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s2] MA [e2] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T5	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s2] exudates [e2] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T6	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s2] NVE [e2] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T8	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s2] NVE [e2] along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T18	T9	note_4416
NonRel	NVE along arcades , [s1] temporal [e1] DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	severity	lesion	T18	T22	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior [s2] vit heme [e2] and layered heme .	severity	lesion	T21	T1	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one [s2] MA [e2] and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T2	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and [s2] exudates [e2] temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T3	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one [s2] MA [e2] and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T5	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and [s2] exudates [e2] temporally Vessels Regressed NVE along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T6	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed [s2] NVE [e2] along superior arcade without TRD regressed NVE along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T8	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	Review of Systems : Respiratory problems : no complaints General problems : no complaints ENT problems : no complaints Gastrointestinal problems : no complaints Objective : Testing : Base Ophthalmology Exam Visual Acuity Right Left Dist sc 20 / 25 - 2 Method : Snellen - Linear Tonometry Method : Applanation Time : 2 : 17 PM Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 2 : 17 PM Pupils Pupils Right PERRL Left PERRL Main Ophthalmology Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Normal Normal Conjunctiva / Sclera White and quiet White and quiet Cornea Debris in tear film Debris in tear film Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive Round and reactive Lens 2 + Posterior subcapsular cataract 2 + Posterior subcapsular cataract Vitreous vit heme vit heme Fundus Exam Right Left Disc Normal Normal C / D Ratio 0.2 0.3 Macula one MA and exudates temporally one MA and exudates temporally Vessels Regressed NVE along superior arcade without TRD regressed [s2] NVE [e2] along superior arcade without TRD Periphery inferior vit heme and layered heme .	severity	lesion	T21	T9	note_4416
NonRel	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with [s1] few [e1] DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	DM Eye Manif Type II : H / o [s2] PDR [e2] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	severity	lesion	T21	T22	note_4416
NonRel	DM Eye Manif Type II : H / o [s1] PDR [e1] ( OU ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	NVE along [s2] arcades [e2] , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	lesion	eye_part	T22	T19	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	[s2] NVE [e2] along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	laterality	lesion	T23	T16	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	NVE along arcades , temporal [s2] DBH [e2] , otherwise good PRP laser 360 good PRP laser 360 with few DBH , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	laterality	lesion	T23	T17	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	NVE along arcades , temporal DBH , otherwise good PRP laser 360 good PRP laser 360 with few [s2] DBH [e2] , one area of new heme inferotemporally Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Other testing : OCT Macula OD - Reliable - focal edema unchanged OS - Reliable - diffuse edema , unchanged Assessment and Plan : 1 .	laterality	lesion	T23	T20	note_4416
NonRel	DM Eye Manif Type II : H / o PDR ( [s1] OU [e1] ) S / p Laser and injections both eyes ( 250.50 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 2 .	[s2] Proliferative diabetic retinopathy [e2] ( 362.02 ) RETINA ( OCT ) , PR INJECT INTRAVITREAL PHARMCOLOGIC , bevacizumab ( AVASTIN ) 400 MG / 16 ML injection 3 .	laterality	lesion	T23	T24	note_4416
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T7	note_2433
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T8	note_2433
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T1	T9	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T7	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T8	note_2433
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T2	T9	note_2433
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T5	T3	note_2433
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T5	T4	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	severity	lesion	T6	T3	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	severity	lesion	T6	T4	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T10	T3	note_2433
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.07 V58.67 2 .	laterality	lesion	T10	T4	note_2433
NonRel	POW # ID [s1] OD [e1] from PPV for VH , vitritis , TRD from secondary complications .	Hx of previous [s2] exudative [e2] RD OU .	laterality	lesion	T4	T2	2748168_note_9227
NonRel	Hx of previous exudative RD [s1] OU [e1] .	POW # ID OD from PPV for [s2] VH [e2] , vitritis , TRD from secondary complications .	laterality	lesion	T5	T1	2748168_note_9227
NonRel	Hx of [s1] previous [e1] exudative RD OU .	POW # ID OD from PPV for [s2] VH [e2] , vitritis , TRD from secondary complications .	severity	lesion	T6	T1	2748168_note_9227
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	laterality	lesion	T19	T8	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of [s1] right eye [e1] , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	laterality	lesion	T19	T9	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	severity	lesion	T20	T8	460233_note_1091
NonRel	Nonproliferative diabetic retinopathy of right eye , with macular edema , with [s1] moderate [e1] nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	severity	lesion	T20	T9	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T21	T5	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T21	T6	460233_note_1091
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	severity	lesion	T21	T7	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	[s2] Nonproliferative diabetic retinopathy [e2] of right eye , with macular edema , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T22	T5	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with [s2] macular edema [e2] , with moderate nonproliferative retinopathy E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T22	T6	460233_note_1091
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVA OS - DATE ( today ) IVA OU - Kay ( DATE ) Intravitreal injection OU ( with Dr. NAME , April 2017 ) 1 .	Nonproliferative diabetic retinopathy of right eye , with macular edema , with moderate [s2] nonproliferative retinopathy [e2] E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 362.05 2 .	laterality	lesion	T22	T7	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD [s1] Moderate [e1] NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	severity	lesion	T23	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with [s1] mild [e1] DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	severity	lesion	T24	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME OS [s1] Moderate [e1] NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	severity	lesion	T25	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) [s1] OD [e1] Moderate NPDR with mild DME OS Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T26	T28	460233_note_1091
NonRel	Recent treatment with Dr. NAME having injections in both eyes ( DATE ) OD Moderate NPDR with mild DME [s1] OS [e1] Moderate NPDR with CI - DME Patient now under the care of internal medicine and gastroenterology .	Plan IVA OS today OCT : interval increase in [s2] ME [e2] NAME , MD participated in the care of this patient .	laterality	lesion	T27	T28	460233_note_1091
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T5	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T6	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical [s2] PDR [e2] without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T7	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without [s2] CSME [e2] ( + NVE , - NVI ) .	laterality	lesion	T16	T8	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - [s2] NVI [e2] ) .	laterality	lesion	T16	T9	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + [s2] NVE [e2] , - NVI ) .	laterality	lesion	T16	T10	1158336_note_2399
NonRel	Proliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] Right Eye [e1] E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active [s2] PDR [e2] OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	laterality	lesion	T16	T27	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T17	T3	1158336_note_2399
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T17	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T18	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - [s1] left eye [e1] E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T18	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T19	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] [s1] OD [e1] - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T19	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T28	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - [s1] Active [e1] PDR OU 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	severity	lesion	T28	T4	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	[s2] Proliferative diabetic retinopathy [e2] without macular edema associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T29	T3	1158336_note_2399
NonRel	Moderate nonproliferative diabetic retinopathy without macular edema associated with type 2 diabetes mellitus - left eye E11.3399 250.50 OPH - OU Fluorescein Angiography 362.05 CANCELED : OCT , Posterior Segment - OU - Both Eyes Attending Note : Treatment Hx PRP OD ( IVFA - guided ) - DATE ( today ) IVFA ( DATE ) - Active PDR [s1] OU [e1] 1 ) DM [ IDDM 20 year duration , HgA 1 C 9.1 ( DATE ) down from 11 ( DATE ) 75 lb weight loss ] OD - Clinical PDR without CSME ( + NVE , - NVI ) .	Proliferative diabetic retinopathy without [s2] macular edema [e2] associated with type 2 diabetes mellitus - Right Eye E11.3599 250.50 OPH - OU Fluorescein Angiography 362.02 Pan Retinal Photocoagulation - OD - Right Eye CANCELED : OCT , Posterior Segment - OU - Both Eyes 2 .	laterality	lesion	T29	T4	1158336_note_2399
NonRel	OS - IVFA showing PED [s1] OS [e1] with no changes since the last visit and no IRF / SRF on OCT .	Nuclear sclerotic cataract of both eyes H25.13 366.16 Attending Note : 1 ) ARMD OU [ Nonexudative OD ( high risk features ) , Nonexudative with Quiescent CNVM OS ] OD - plaqueoid moderate to large soft drusen / RPED with high risk features but without changes since last visit or [s2] IRF [e2] / SRF on OCT .	laterality	lesion	T7	T1	1342474_note_3109
NonRel	OS - IVFA showing PED [s1] OS [e1] with no changes since the last visit and no IRF / SRF on OCT .	Nuclear sclerotic cataract of both eyes H25.13 366.16 Attending Note : 1 ) ARMD OU [ Nonexudative OD ( high risk features ) , Nonexudative with Quiescent CNVM OS ] OD - plaqueoid moderate to large soft drusen / RPED with high risk features but without changes since last visit or IRF / [s2] SRF [e2] on OCT .	laterality	lesion	T7	T2	1342474_note_3109
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) [s2] NVD [e2] Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T2	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) [s2] CSME [e2] mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T3	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) [s2] CSME [e2] Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T4	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) [s2] NVE [e2] Normal ( - ) holes or tears ( - ) NVE Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T5	217884_note_474
NonRel	Other testing : OCT MAC OD : thickness : 221 , good foveal contour ( - ) IRF or SRF [s1] OS [e1] : thickness : 217 , good foveal contour ( - ) IRF or SRF Assessment and Plan : ICD - 9 - CM 1 .	Allergies : No Known Allergies ROS Positive for : Endocrine ( borderline DM ) , Eyes ( blurry vision ) , Respiratory ( Asthma ) Negative for : Constitutional , Gastrointestinal , Neurological , Skin , Genitourinary , Musculoskeletal , HENT , Cardiovascular , Psychiatric , Allergic / Imm , Heme / Lymph Objective : Base Eye Exam Visual Acuity Right Left Dist sc 20 / 30 - 1 20 / 30 - 2 Near sc J1 + J1 + Method : Snellen - Linear Tonometry Right Left Pressure 12 12 Method : icare Time : 2 : 57 PM Pupils Pupils Light React APD Right PERRL 3 2 - Left PERRL 3 2 - Visual Fields Right Left Result Full Full Method : Counting fingers Extraocular Movement Right Left Result Full , Ortho Full , Ortho Neuro / Psych Oriented x3 : Yes Mood / Affect : Normal Dilation Both eyes : 1.0 % Mydriacyl , 2.5 % Phenylephrine @ 3 : 11 PM Slit Lamp and Fundus Exam External Exam Right Left External Normal Normal Slit Lamp Exam Right Left Lids / Lashes Blepharitis , Meibomian gland dysfunction Blepharitis , Meibomian gland dysfunction Conjunctiva / Sclera scattered melanosis , mild inj scattered melanosis , mild inj Cornea clear , mild oil glands few PEE inf , otherwise clear Anterior Chamber Deep and quiet Deep and quiet Iris Round and reactive ( - ) NVI Round and reactive ( - ) NVI Lens mild Nuclear sclerosis , trace inj cortical trace Nuclear sclerosis Fundus Exam Right Left Vitreous Normal Normal Disc Normal , P & D ( - ) NVD Normal , P & D ( - ) NVD C / D Ratio 0.3 0.3 Macula mild mottling ( - ) CSME mild mottling ( - ) CSME Vessels Normal Normal Periphery Normal ( - ) holes or tears ( - ) NVE Normal ( - ) holes or tears ( - ) [s2] NVE [e2] Refraction Manifest Refraction Sphere Cylinder Axis Dist Add Near Right - 4.25 + 3.50 090 20 / 20 - 2 + 1.50 J1 + Left - 1.75 + 0.75 070 20 / 20 - 2 + 1.50 J1 + Manifest Refraction # 2 ( Retinoscopy ) Sphere Cylinder Axis Dist Add Near Right - 2.00 + 1.50 90 20 / 40 Left - 3.50 + 1.00 90 20 / 30 Comments : Pt reports that eyes are burning No annotated images are attached to the encounter .	laterality	lesion	T15	T6	217884_note_474
NonRel	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Continued superior and superotemporal edema and exudation OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	INVASIVE PROCEDURE NOTE Pre - op DX : [s2] PDR [e2] with DME Right Post - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T2	T3	note_2248
NonRel	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] : Continued superior and superotemporal edema and exudation OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	INVASIVE PROCEDURE NOTE Pre - op DX : PDR with [s2] DME [e2] Right Post - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	laterality	lesion	T2	T4	note_2248
NonRel	INVASIVE PROCEDURE NOTE Pre - op DX : PDR with DME [s1] Right Post [e1] - op DX : same Attending : Siva Iyer , M.D. Anesthesia : Topical Lidocaine Subconj Lido : no Procedure performed : Intravitreal injection of 0.05 cc Avastin Description of Procedure : Patient was anesthetized with ophthaine and topical lidocaine and 0.5 % povidone iodine was dripped into the conjunctival fornix .	Siva Iyer MD OCT , Posterior Segment - OU - Both Eyes OD : Continued superior and superotemporal edema and [s2] exudation [e2] OS : Interval improvement of edema compared to last visit OPH - OD Intravitreal Injection , Pharmacologic Agent Avastin # 04 Time out was taken , correct eye was identified and marked , correct dose of medication was confirmed .	laterality	lesion	T5	T1	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T12	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T15	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T16	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T11	T18	note_2248
NonRel	Type 1 diabetes mellitus with proliferative retinopathy of [s1] right eye [e1] and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T11	T20	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T10	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T14	T13	note_2248
NonRel	Diabetic retinopathy of [s1] left eye [e1] , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T14	T22	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T17	T10	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	severity	lesion	T17	T13	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with [s1] severe [e1] nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	severity	lesion	T17	T22	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with proliferative retinopathy of right eye and [s2] macular edema [e2] E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T19	T10	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Type 1 diabetes mellitus with [s2] proliferative retinopathy [e2] of right eye and macular edema E10.3511 250.51 Focal Laser - OD - Right Eye 362.02 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 2 .	laterality	lesion	T19	T13	note_2248
NonRel	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR [s1] OD [e1] with single pinpoint NVE superonasally to the optic nerve .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T19	T22	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T12	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T15	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T16	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	severity	lesion	T21	T18	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	severity	lesion	T21	T20	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T25	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T28	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T30	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	severity	lesion	T21	T33	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	severity	lesion	T21	T37	note_2248
NonRel	[s1] Severe [e1] NPDR OS .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	severity	lesion	T21	T38	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	[s2] Diabetic retinopathy [e2] of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T12	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with [s2] macular edema [e2] , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T15	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with macular edema , with severe [s2] nonproliferative retinopathy [e2] , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T16	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected [s2] PDR [e2] OD with single pinpoint NVE superonasally to the optic nerve .	laterality	lesion	T23	T18	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	Diabetic retinopathy of left eye , with macular edema , with severe nonproliferative retinopathy , associated with type 1 diabetes mellitus E10.3412 250.51 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.06 Treatment History Focal Laser OD - 4 / 21 / 17 ( today ) IVA OU - 4 / 21 / 2017 ( today ) IVA OU - 3 / 17 / 2017 Focal Laser OS - 3 / 17 / 17 IVA OU - 2 / 17 / 2017 IVA OS - 1 / 20 / 2017 IVA OU , PRP OD - 12 / 16 / 2016 IVFA - 12 / 13 / 2016 : Suspected PDR OD with single pinpoint [s2] NVE [e2] superonasally to the optic nerve .	laterality	lesion	T23	T20	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe [s2] NPDR [e2] OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T25	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe [s2] NPDR [e2] OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T28	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( [s2] PDR [e2] OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T30	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe [s2] NPDR [e2] OS ) OD - Active PDR with CSME now s / p PRP as above .	laterality	lesion	T23	T33	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active [s2] PDR [e2] with CSME now s / p PRP as above .	laterality	lesion	T23	T37	note_2248
NonRel	Severe NPDR [s1] OS [e1] .	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with [s2] CSME [e2] now s / p PRP as above .	laterality	lesion	T23	T38	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T24	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : [s1] Severe [e1] NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T24	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T26	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR [s1] OU [e1] IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T26	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T27	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : [s1] Severe [e1] NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T27	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T29	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR [s1] OS [e1] 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T29	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T31	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR [s1] OD [e1] , Severe NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T31	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T32	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , [s1] Severe [e1] NPDR OS ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T32	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T34	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR [s1] OS [e1] ) OD - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T34	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	laterality	lesion	T35	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) [s1] OD [e1] - Active PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	laterality	lesion	T35	T39	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	Severe [s2] NPDR [e2] OS .	severity	lesion	T36	T22	note_2248
NonRel	IVFA - 9 / 13 / 16 : Severe NPDR OU IVFA - 8 / 16 / 16 : Severe NPDR OS 1 ) DM ( Type I IDDM ) - ( PDR OD , Severe NPDR OS ) OD - [s1] Active [e1] PDR with CSME now s / p PRP as above .	Developed [s2] CSME [e2] after PRP .	severity	lesion	T36	T39	note_2248
NonRel	Inferior subhyaloid hemorrhage [s1] OS [e1] .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no [s2] macular edema [e2] OS - blunted foveal contour , no macular edema NAME .	laterality	lesion	T15	T6	1741070_note_4310
NonRel	Inferior subhyaloid hemorrhage [s1] OS [e1] .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema OS - blunted foveal contour , no [s2] macular edema [e2] NAME .	laterality	lesion	T15	T7	1741070_note_4310
NonRel	[s1] Inferior [e1] subhyaloid hemorrhage OS .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no [s2] macular edema [e2] OS - blunted foveal contour , no macular edema NAME .	severity	lesion	T16	T6	1741070_note_4310
NonRel	[s1] Inferior [e1] subhyaloid hemorrhage OS .	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema OS - blunted foveal contour , no [s2] macular edema [e2] NAME .	severity	lesion	T16	T7	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes [s1] OD [e1] - blunted foveal contour , no macular edema OS - blunted foveal contour , no macular edema NAME .	Inferior [s2] subhyaloid hemorrhage [e2] OS .	laterality	lesion	T17	T9	1741070_note_4310
NonRel	OCT , Posterior Segment - OU - Both Eyes OD - blunted foveal contour , no macular edema [s1] OS [e1] - blunted foveal contour , no macular edema NAME .	Inferior [s2] subhyaloid hemorrhage [e2] OS .	laterality	lesion	T18	T9	1741070_note_4310
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T2	T4	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	laterality	lesion	T2	T6	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - [s2] PDR [e2] with VH that has responded to treatment with IVA .	laterality	lesion	T2	T8	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with [s2] VH [e2] that has responded to treatment with IVA .	laterality	lesion	T2	T9	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T1	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] OD - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T3	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T7	T1	note_4009
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Treatment Hx : IVA OD - 12 / 1 / 17 ( today ) IVA OD - 10 / 27 / 17 IVA OD - 9 / 22 / 17 IVA OD - 8 / 22 / 17 PPV OS ( Hazariwala ) CE / IOL OS Focal Laser OS ( Hazariwala ) DM - IDDM [ Last A1C 5.7 % ] [s1] OD [e1] - PDR with VH that has responded to treatment with IVA .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T7	T3	note_4009
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	[s2] Proliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T2	T4	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	laterality	lesion	T2	T6	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] right eye [e1] with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of [s2] PDR [e2] OU , s / p PPV OS , and PRP OD .	laterality	lesion	T2	T12	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T1	note_4017
NonRel	Proliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR OU , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T5	T3	note_4017
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR [s1] OU [e1] , s / p PPV OS , and PRP OD .	[s2] Proliferative diabetic retinopathy [e2] of right eye with macular edema determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T13	T1	note_4017
NonRel	Proliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3512 250.50 362.07 362.02 Hx of PDR [s1] OU [e1] , s / p PPV OS , and PRP OD .	Proliferative diabetic retinopathy of right eye with [s2] macular edema [e2] determined by examination associated with type 2 diabetes mellitus E11.3511 250.50 362.07 362.02 2 .	laterality	lesion	T13	T3	note_4017
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T7	note_2444
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	laterality	lesion	T1	T8	note_2444
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	laterality	lesion	T1	T9	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T7	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	severity	lesion	T2	T8	note_2444
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with [s2] ciCSME [e2] being treated with IVA OS .	severity	lesion	T2	T9	note_2444
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T3	note_2444
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T5	T4	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T3	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA OS .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	severity	lesion	T6	T4	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T3	note_2444
NonRel	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin ( CMS - HCC code ) E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 V58.67 Return patient with ciCSME being treated with IVA [s1] OS [e1] .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin ( CMS - HCC code ) E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 362.07 V58.67 2 .	laterality	lesion	T10	T4	note_2444
NonRel	BRVO with macular edema [s1] OS [e1] - Previously treated at UFH , saw retina MD in LOCATION _ CITY , FL and was receiving IVA injections OS q6 - 8 weeks , last ~ DATE .	- Recurrence of [s2] ME [e2] last visit and treatment re - initiated with great response .	laterality	lesion	T10	T2	1936668_note_5255
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T12	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T14	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T16	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	severity	lesion	T7	T18	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T7	T23	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T7	T24	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T12	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T14	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate [s2] NPDR [e2] OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T16	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with [s2] CSME [e2] OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	laterality	lesion	T9	T18	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T9	T23	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] right eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T9	T24	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T11	T8	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T11	T10	note_5742
NonRel	[s1] Moderate [e1] nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T11	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T13	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T13	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of [s1] left eye [e1] with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T13	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T15	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T15	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - [s1] Moderate [e1] NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T15	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T17	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T17	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR [s1] OU [e1] with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T17	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T19	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T19	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME [s1] OS [e1] > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T19	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T20	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T20	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > [s1] OD [e1] 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T20	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T21	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	laterality	lesion	T21	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] [s1] OD [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T21	T25	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate [s2] nonproliferative diabetic retinopathy [e2] of right eye with macular edema associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T22	T8	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	Moderate nonproliferative diabetic retinopathy of right eye with [s2] macular edema [e2] associated with type 2 diabetes mellitus E11.3311 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OD Intravitreal Injection , Pharmacologic Agent 362.05 2 .	severity	lesion	T22	T10	note_5742
NonRel	Moderate nonproliferative diabetic retinopathy of left eye with macular edema associated with type 2 diabetes mellitus E11.3312 250.50 OCT , Posterior Segment - OU - Both Eyes 362.07 OPH - OS Intravitreal Injection , Pharmacologic Agent 362.05 Treatment History IVL OU - 7 / 13 / 18 IVL OU - 6 / 8 / 18 IVL OU - 4 / 20 / 18 IVL OU - 3 / 2 / 18 IVL OU - 1 / 19 / 17 Focal Laser OD - 12 / 22 / 17 IVL OU - 12 / 8 / 17 IVL OU - 10 / 27 / 17 IVL OU - 9 / 21 / 17 IVL OU - 7 / 21 / 17 IVL OU - 6 / 16 / 17 IVL OU - 5 / 11 / 17 IVL OU - 4 / 7 / 17 IVL OU - 3 / 3 / 17 IVL OU - 2 / 3 / 17 IVFA 1 / 31 / 2017 - Moderate NPDR OU with CSME OS > OD 1 ) IDDM - [ Diagnosed in 2002 ; HgA1C 9.1 , 1 / 24 / 18 ] OD - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T22	T25	note_5742
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	laterality	lesion	T26	T25	note_5742
NonRel	[s1] OS [e1] - Moderate NPDR with ciCSME .	[s2] IRF [e2] significantly improved OS since the last visit when brought back at shorter interval .	laterality	lesion	T26	T30	note_5742
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] seems slightly improved on OCT .	severity	lesion	T27	T25	note_5742
NonRel	OS - [s1] Moderate [e1] NPDR with ciCSME .	[s2] IRF [e2] significantly improved OS since the last visit when brought back at shorter interval .	severity	lesion	T27	T30	note_5742
NonRel	IRF significantly improved [s1] OS [e1] since the last visit when brought back at shorter interval .	OS - Moderate [s2] NPDR [e2] with ciCSME .	laterality	lesion	T31	T28	note_5742
NonRel	IRF significantly improved [s1] OS [e1] since the last visit when brought back at shorter interval .	OS - Moderate NPDR with [s2] ciCSME [e2] .	laterality	lesion	T31	T29	note_5742
NonRel	IRF [s1] significantly improved [e1] OS since the last visit when brought back at shorter interval .	OS - Moderate [s2] NPDR [e2] with ciCSME .	severity	lesion	T32	T28	note_5742
NonRel	IRF [s1] significantly improved [e1] OS since the last visit when brought back at shorter interval .	OS - Moderate NPDR with [s2] ciCSME [e2] .	severity	lesion	T32	T29	note_5742
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - [s1] OS [e1] : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T7	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : [s1] Moderate [e1] / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T8	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / [s1] severe NPDR [e1] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T9	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - [s1] OD [e1] : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T11	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : [s1] Moderate [e1] NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T12	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 [s1] OD - [e1] Moderate NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T14	T19	note_1962
NonRel	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	OS - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T15	T19	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T17	T10	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	laterality	lesion	T17	T13	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	laterality	lesion	T17	T16	note_1962
NonRel	[s1] OS - [e1] Moderate NPDR , s / p PRP and focal laser .	[s2] CSME [e2] that was refractory to IVA and IVL .	laterality	lesion	T17	T20	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe [s2] NPDR [e2] OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T18	T10	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate [s2] NPDR [e2] OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate NPDR , s / p PRP and focal laser .	severity	lesion	T18	T13	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	Treatment History IVE OS - 1 / 29 / 19 ( today ) IVE OS - 12 / 27 / 18 IVFA ( 10 / 30 / 18 ) - OS : Moderate / severe NPDR OU IVT OS - 12 / 22 / 17 IVL OS - 10 / 27 / 17 IVL OS - 9 / 22 / 17 IVL OS - 8 / 11 / 17 IVL OS - 7 / 6 / 17 IVA OS - 5 / 19 / 17 IVA OS - 4 / 7 / 17 IVFA ( 3 / 28 / 2017 ) - OD : Moderate NPDR OU 1 ) IDDM II - Most recent A1c from Apr 2018 was 8.4 OD - Moderate [s2] NPDR [e2] , s / p PRP and focal laser .	severity	lesion	T18	T16	note_1962
NonRel	OS - [s1] Moderate [e1] NPDR , s / p PRP and focal laser .	[s2] CSME [e2] that was refractory to IVA and IVL .	severity	lesion	T18	T20	note_1962
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T12	T3	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T12	T4	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] right eye [e1] affected by severe nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T12	T5	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T13	T3	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T13	T4	1162635_note_2414
NonRel	Type 2 diabetes mellitus with right eye affected by [s1] severe [e1] nonproliferative retinopathy without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T13	T5	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T14	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T14	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T14	T23	1162635_note_2414
NonRel	Type 2 diabetes mellitus with [s1] left eye [e1] affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T14	T24	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T15	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	severity	lesion	T15	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T15	T23	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by [s1] severe [e1] nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T15	T24	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe [s2] nonproliferative retinopathy [e2] without macular edema , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T1	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Type 2 diabetes mellitus with right eye affected by severe nonproliferative retinopathy without [s2] macular edema [e2] , with long - term current use of insulin E11.3491 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes V58.67 Fluorescein Angiography - OU - Both Eyes 2 .	laterality	lesion	T16	T2	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T16	T23	1162635_note_2414
NonRel	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval [s1] OU [e1] 1 ) T2DM - on insulin .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T16	T24	1162635_note_2414
NonRel	OS - [s1] Severe [e1] NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	severity	lesion	T17	T23	1162635_note_2414
NonRel	OS - [s1] Severe [e1] NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	severity	lesion	T17	T24	1162635_note_2414
NonRel	[s1] OS [e1] - Severe NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe [s2] NPDR [e2] without ME .	laterality	lesion	T18	T23	1162635_note_2414
NonRel	[s1] OS [e1] - Severe NPDR with ME .	Last A1C 6.2 ( DATE ) OD - Severe NPDR without [s2] ME [e2] .	laterality	lesion	T18	T24	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T22	T3	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	severity	lesion	T22	T4	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	severity	lesion	T22	T5	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe [s2] NPDR [e2] with ME .	severity	lesion	T22	T6	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) OD - [s1] Severe [e1] NPDR without ME .	OS - Severe NPDR with [s2] ME [e2] .	severity	lesion	T22	T7	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe [s2] nonproliferative retinopathy [e2] and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T25	T3	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and [s2] macular edema [e2] , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for non proliferative diabetic retinopathy eval OU 1 ) T2DM - on insulin .	laterality	lesion	T25	T4	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	Type 2 diabetes mellitus with left eye affected by severe nonproliferative retinopathy and macular edema , with long - term current use of insulin E11.3412 250.50 OCT , Posterior Segment - OU - Both Eyes Z79.4 362.06 Color Fundus Photography - OU - Both Eyes 362.07 Fluorescein Angiography - OU - Both Eyes V58.67 Referred by North Florida cataract specialist for [s2] non proliferative diabetic retinopathy [e2] eval OU 1 ) T2DM - on insulin .	laterality	lesion	T25	T5	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe [s2] NPDR [e2] with ME .	laterality	lesion	T25	T6	1162635_note_2414
NonRel	Last A1C 6.2 ( DATE ) [s1] OD [e1] - Severe NPDR without ME .	OS - Severe NPDR with [s2] ME [e2] .	laterality	lesion	T25	T7	1162635_note_2414
NonRel	Mac OCT [s1] OS [e1] shows laser scarring with no IRF .	Mac OCT OD shows atrophy and [s2] IRF [e2] .	laterality	lesion	T7	T5	note_3956
NonRel	Mac OCT [s1] OD [e1] shows atrophy and IRF .	Mac OCT OS shows laser scarring with no [s2] IRF [e2] .	laterality	lesion	T8	T6	note_3956
